<SEC-DOCUMENT>0001140361-26-023337.txt : 20260529
<SEC-HEADER>0001140361-26-023337.hdr.sgml : 20260529
<ACCEPTANCE-DATETIME>20260529165116
ACCESSION NUMBER:		0001140361-26-023337
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260526
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260529
DATE AS OF CHANGE:		20260529

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Momentus Inc.
		CENTRAL INDEX KEY:			0001781162
		STANDARD INDUSTRIAL CLASSIFICATION:	GUIDED MISSILES & SPACE VEHICLES & PARTS [3760]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				841905538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39128
		FILM NUMBER:		261045585

	BUSINESS ADDRESS:	
		STREET 1:		1762 AUTOMATION PARKWAY
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131
		BUSINESS PHONE:		6505647820

	MAIL ADDRESS:	
		STREET 1:		1762 AUTOMATION PARKWAY
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stable Road Acquisition Corp.
		DATE OF NAME CHANGE:	20190628
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20075150_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:mnts="http://momentus.space/20260526" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_465ff8118f4045be9d4bbfe221be34fa" contextRef="c20260526to20260526" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_e02417e95d0f41cbac55512ae4b05b2a" contextRef="c20260526to20260526">0001781162</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_21def3db9b1348bd8a8873b5a03b05b3" contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember">NASDAQ</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_58245bbc1d454731b2fed7c423e50cb8" contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mnts-20260526.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20260526to20260526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-26</xbrli:startDate><xbrli:endDate>2026-05-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-26</xbrli:startDate><xbrli:endDate>2026-05-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001781162</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mnts:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-26</xbrli:startDate><xbrli:endDate>2026-05-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_026ff3f0ceda44c0a4735e027f52eba4" contextRef="c20260526to20260526">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_8734d42f6ca14e3d890fc68480fad957" contextRef="c20260526to20260526" format="ixt:date-monthname-day-year-en">May 26, 2026</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (date of earliest event reported)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_7d899f1182f3430cbea00ea306701886" contextRef="c20260526to20260526">Momentus Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_4bb28ae4bbc649dfb2d91d7d4bbd6e8f" contextRef="c20260526to20260526" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_301dfe8e69f74a8b921cd390ed98f876" contextRef="c20260526to20260526">001-39128</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_8f60f2de694942d5a46063fb67610198" contextRef="c20260526to20260526">84-1905538</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(State or other jurisdiction of incorporation or organization)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 49%; vertical-align: top; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_e965dc006950484caabf13b509adfd1b" contextRef="c20260526to20260526">1762 Automation Parkway</ix:nonNumeric></span>
              <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_5891f18e8f504472924584e213edf96d" contextRef="c20260526to20260526">San Jose</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_f6a0d8b78f464a15b98a0f16be138c8f" contextRef="c20260526to20260526" format="ixt-sec:stateprovnameen">California</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_686573007ba2406e8df9796fe62e148e" contextRef="c20260526to20260526">95131</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_de7078c75aea471881bfb4bfc07ed435" contextRef="c20260526to20260526">650</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_8ad297f377524545b238390c2a639fd7" contextRef="c20260526to20260526">564-7820</ix:nonNumeric></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant's telephone number, including area code</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
        (see General Instruction A.2. below):</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_75216e99b7db45cbb1007e3fd915798d" contextRef="c20260526to20260526" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_fc7d882b610c4d2ca1ac4addec3772e7" contextRef="c20260526to20260526" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_0b417816a1264f4da4ded0cb6b553fd3" contextRef="c20260526to20260526" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_afd6e1c5866e4fad9d202eb56fa2f902" contextRef="c20260526to20260526" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0);">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to section 12(g) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 36.38%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Title of each class</div>
            </td>

    <td style="width: 23.56%; vertical-align: bottom; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Trading Symbol(s)</div>
            </td>

    <td style="width: 40.06%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 36.38%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_389490f996294a02937db8d594af3d23" contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember">Class A common stock</ix:nonNumeric><br/>
            </td>

    <td style="width: 23.56%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_6bd51fce4ac841638e4b9243c26cece9" contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember">MNTS</ix:nonNumeric><br/>
            </td>

    <td style="width: 40.06%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="-sec-ix-hidden:Fact_21def3db9b1348bd8a8873b5a03b05b3">The Nasdaq Stock Market LLC</span><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 36.38%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_9b3b2fbf1cf64d83a1674cc56488f4a7" contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember">Warrants</ix:nonNumeric><br/>
            </td>

    <td style="width: 23.56%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e667dfd95c824c20b27d53662efdcf06" contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember">MNTSW</ix:nonNumeric><br/>
            </td>

    <td style="width: 40.06%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;"><span style="-sec-ix-hidden:Fact_58245bbc1d454731b2fed7c423e50cb8">The Nasdaq Stock Market LLC</span><br/>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2
        of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_3b7bfca47e1e48b68de5832128790588" contextRef="c20260526to20260526" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On May 26, 2026, Momentus Inc., a Delaware corporation (&#8220;Momentus&#8221; or the &#8220;Company&#8221;), entered into a Securities Purchase Agreement (the &#8220;Securities
        Purchase Agreement&#8221;) with institutional investors (the &#8220;Investors&#8221;) for a private placement of (i) 2,173,420 shares of the Company&#8217;s Class A common stock, par value $0.00001 per share (the &#8220;Common Stock&#8221;), for $8.50 per share and (ii) pre-funded
        warrants to purchase up to 768,580 shares of Common Stock (the &#8220;Pre-Funded Warrants&#8221; and, together with the Common Stock, the &#8220;Securities&#8221;).</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The private placement closed on May 28, 2026. The Company received aggregate gross proceeds from the private placement of approximately $25 million,
        before deducting estimated placement agent commissions and expenses, which are payable by the Company.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Securities Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing,
        indemnification obligations of the Company and the Investors, other obligations of the parties and termination provisions. The representations, warranties and covenants in the Securities Purchase Agreement were made only for purposes of such
        agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The Company agreed to use the net proceeds from the private placement for general
          corporate purposes,</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;<span style="color: rgb(0, 0, 0);">which may include repayment of principal on the Company&#8217;s indebtedness, capital expenditures, and funding its working
            capital needs, but not in violation of the Foreign Corrupt Practices Act of 1977, as amended, or the regulations promulgated by the Office of Foreign Assets Control of the U.S. Treasury Department. The Securities Purchase Agreement is governed
            by the laws of the State of New York.</span></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company also agreed that, from the date of the Securities Purchase Agreement until 5 days after the date that the resale registration statement
        required by the Registration Rights Agreement (as defined below) becomes effective (the &#8220;Effective Date&#8221;), subject to certain limited exceptions set forth in the Securities Purchase Agreement, the Company will not (i)&#160;issue, enter into any
        agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as defined in the Securities Purchase Agreement), or (ii)&#160;file any registration statement or any amendment or supplement
        thereto other than as contemplated pursuant to the Registration Rights Agreement. Further, until 30 days after the Effective Date, the Company is prohibited from effecting or entering into an agreement to effect any issuance by the Company or any
        of its subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction (as defined in the Securities Purchase Agreement), subject to certain limited exceptions set forth in the
        Securities Purchase Agreement;&#160;provided,&#160;however, that sales of shares of Common Stock at a price no less than $20.00 per share in an &#8220;at the market&#8221; offering with A.G.P./Alliance Global Partners (the &#8220;Placement Agent&#8221;) acting as the sales agent
        may be made, and after 5 days following the Effective Date, such sales may be made at a price below $20.00 per share.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The purchase price of each Pre-Funded Warrant equals $8.50 per share minus the $0.00001 exercise price per share of the Pre-Funded Warrant. The
        Pre-Funded Warrants are exercisable at any time after their original issuance, and will not expire until exercised in full.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Pre-Funded Warrants provide that the Investor will not have the right to exercise any portion thereof if such exercise would cause the aggregate
        number of shares of Common Stock beneficially owned by the Investor (together with its affiliates) to exceed 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is
        determined in accordance with the terms of the Pre&#8209;Funded Warrants.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the private placement, the Company entered into a Registration Rights Agreement with the Investor (the &#8220;Registration Rights
        Agreement&#8221;) requiring the Company to file a registration statement covering the resale of all of the Registrable Securities (as defined in the Registration Rights Agreement) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) no later than the
        10th trading day following the date of the Registration Rights Agreement, and have the registration statement declared effective by the SEC as promptly as practicable after the filing thereof, but in any event no later than 15th calendar day
        following the date of the Registration Rights Agreement, or in the event of a &#8220;limited review&#8221; by the SEC, the 30th day following the date of the Registration Rights Agreement, or in the event of a &#8220;full review&#8221; by the SEC, the 45th day following
        the date of the Registration Rights Agreement.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Upon the occurrence of any Event (as defined in the Registration Rights Agreement), which, among others, prohibits the Investor from reselling the
        Securities for more than 10 consecutive calendar days or more than an aggregate of 15 calendar days during any 12-month period, the Company is obligated to pay to the Investor, on each monthly anniversary of each such Event, an amount in cash, as
        partial liquidated damages and not as a penalty, equal to the product of 1.5% multiplied by the aggregate subscription amount paid by such Investor pursuant to the Securities Purchase Agreement.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company may not file any other registration statements until all Registrable Securities (as defined in the Registration Rights Agreement) are
        registered pursuant to a registration statement that is declared effective by the SEC, provided that the Company may file amendments to registration statements filed prior to the date of the Registration Rights Agreement so long as no new
        securities are registered on any such existing registration statements. All fees and expenses incident to the performance of or compliance with the Registration Rights Agreement by the Company will be borne by the Company, whether or not any
        Registrable Securities (as defined in the Registration Rights Agreement) are sold pursuant to a registration statement.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the private placement, on May 26, 2026, the Company entered into a Placement Agency Agreement with the Placement Agent. As part of
        its compensation for acting as Placement Agent for the private placement, the Company paid the Placement Agent a cash fee of 7.0% of the aggregate gross proceeds and issued to the Placement Agent warrants to purchase 147,100 shares of Common Stock
        (the &#8220;Placement Agent Warrants&#8221;) at an exercise price of $9.35 per share, which are exercisable 180 days from the date of commencement of sales of the private placement offering.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The above summary of the private placement, the Pre-Funded Warrants, the Placement Agent Warrants, the Securities Purchase Agreement and the
        Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to such applicable agreements, copies of which are attached as Exhibits 4.1, 4.2, 10.1 and 10.2 to this Current Report on Form 8-K and
        incorporated herein by reference.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the Common Stock discussed herein, nor
        shall there be any offer, solicitation, or sale of Common Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or
        jurisdiction.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Unregistered Sales of Equity Securities.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information contained above in Item 1.01 of this Current Report on Form 8-K related to the Securities is hereby incorporated by reference into this
        Item 3.02. The Securities and the Placement Agent Warrants were sold without registration under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act as a
        transaction not involving a public offering and Rule 506(b) of Regulation D promulgated under the Securities Act as sales to accredited investors and in reliance on similar exemptions under applicable state laws.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Regulation FD Disclosure.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On May 27, 2026, Momentus issued a press release announcing the pricing of the private placement. A copy of the press release is attached as Exhibit
        99.1 to this Current Report on Form 8-K.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">This information and the information contained in Exhibit 99.1 is furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange
        Act, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act or the Securities Exchange Act of 1934, as amended, except as may be expressly set forth by
        specific reference in any such filing, regardless of any general incorporation language in the filing.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company does not have, and expressly disclaims, any obligation to release publicly any updates or any changes in its expectations or any change in
        events, conditions, or circumstances on which any forward-looking statement is&#160;based.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="font-weight: bold;">Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d)</div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;Exhibits</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Exhibit</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;"> Number</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-weight: bold;">Exhibit Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ef20075150_ex4-1.htm">4.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of Pre-Funded Warrant</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ef20075150_ex4-2.htm">4.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of Placement Agent Warrant</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ef20075150_ex10-1.htm">10.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of Securities Purchase Agreement</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ef20075150_ex10-2.htm">10.2</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Form of Registration Rights Agreement</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);"><a href="ef20075150_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Press Release, dated May 27, 2026, issued by Momentus Inc. announcing the pricing of the private placement.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">104</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 15%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: right; color: rgb(0, 0, 0);">By:</div>
            </td>

    <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 38%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">/s/ Lon Ensler</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 15%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;"><br/>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Name:</div>
            </td>

    <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 38%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Lon Ensler</div>
            </td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Dated:</div>
            </td>

    <td style="width: 15%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0);">May 29, 2026</div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Title:</div>
            </td>

    <td style="width: 3%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 38%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ef20075150_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold; font-size: 10pt;">Exhibit 4.1</font><font style="font-size: 10pt;"><br>
      </font></div>
    <div> <font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="z_cp_change_1"></a>NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES
        AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO
        AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
        LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">PRE-FUNDED</font><font style="font-size: 10pt;">&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">COMMON STOCK PURCHASE WARRANT</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MOMENTUS INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zeffabe7656844367a2830f3acb74b85f">

            <tr>
              <td style="width: 12%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Warrant Shares</font><font style="font-size: 10pt;">:</font></td>
              <td style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;"><br>
              </td>
              <td style="width: 46%; padding-bottom: 2px; font-size: 10pt;"><br>
              </td>
              <td style="width: 12%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Issue Date</font><font style="font-size: 10pt;">:</font></td>
              <td style="width: 10%; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;"><br>
              </td>
              <td style="width: 10%; padding-bottom: 2px; font-size: 10pt;">, 2026</td>
            </tr>

        </table>
      </div>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &#8220;<font style="font-family: 'Times New Roman';"><u>Warrant</u></font>&#8221;) certifies that, for value
        received, _________________ or its assigns (the &#8220;<font style="font-family: 'Times New Roman';"><u>Holder</u></font>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or
        after the date hereof (the &#8220;<font style="font-family: 'Times New Roman';"><u>Initial Exercise Date</u></font>&#8221;) and until this Warrant is exercised in full (the &#8220;<font style="font-family: 'Times New Roman';"><u>Termination Date</u></font>&#8221;) but not
        thereafter, to subscribe for and purchase from <font style="font-family: 'Times New Roman'; font-weight: bold;">MOMENTUS INC.,</font> a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), up to <font style="font-family: 'Times New Roman'; font-weight: bold;">__________ shares</font> (as subject to adjustment hereunder, the &#8220;<font style="font-family: 'Times New Roman';"><u>Warrant Shares</u></font>&#8221;) of the Company&#8217;s Common Stock. The purchase
        price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7dc6c79062394ef4a49b2f5fe557ea51" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Section 1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definitions</u></font><font style="font-size: 10pt;">.&#160; Capitalized terms used and not otherwise defined herein
                  shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Agreement</u></font>&#8221;), dated May&#160;___, 2026, among the Company and the purchaser signatory
                  thereto.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z2b16d83421164f07b05917051b58f8f9" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Section 2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercise</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%2%%%-->
      <table cellspacing="0" cellpadding="0" id="zde833bda549a4f75b7920e769e780658" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercise of Warrant</u></font><font style="font-size: 10pt;">.&#160; Exercise of the purchase rights represented by
                  this Warrant may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy or PDF copy submitted by e-mail
                  (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as Exhibit A (the &#8220;<font style="font-family: 'Times New Roman';"><u>Notice of Exercise</u></font>&#8221;).&#160; Within the earlier of (i) one (1) Trading Day and (ii) the
                  number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in
                  the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font> No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be
                  required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and this Warrant
                  has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial
                  exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to
                  the applicable number of Warrant Shares purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
                  Exercise within one (1) Trading Day of receipt of such notice.&#160; <font style="font-family: 'Times New Roman'; font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the
                    provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3f3ead81f34d46f6973dff4fafa1a399" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercise Price</u></font><font style="font-size: 10pt;">.&#160; The aggregate exercise price of this Warrant, except
                  for a nominal exercise price of $0.00001 per Warrant Share, was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.0001 per
                  Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price
                  under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.00001, subject to adjustment hereunder (the &#8220;<font style="font-family: 'Times New Roman';"><u>Exercise

                      Price</u></font>&#8221;).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0ce35da4947049209a2fdc31d43a3d48" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cashless Exercise</u></font><font style="font-size: 10pt;">. If at the time of exercise hereof there is no
                  effective registration statement registering, or the prospectus contained therein is not available for the issuance or resale of the Warrant Shares to or by the Holder, then this Warrant may also be exercised, in whole or in part, at such
                  time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such
        Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading
        hours&#8221; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable
        Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during
        &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of
        the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this
        Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Bid Price</u></font>&#8221; means, for any date, the price determined by the first of the following
        clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or
        quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date
        (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
        organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
        independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>VWAP</u></font>&#8221; means, for any date, the price determined by the first of the following clauses
        that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
        listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&#160; if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for
        such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
        organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
        independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
        Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised.&#160;&#160;The Company agrees not to take any position contrary to this Section 2(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1f2da800c3874e6fb03f665b0232254f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Mechanics of Exercise</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zbba7c9d2d3f34038953d70be998b35c7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Delivery of Warrant Shares Upon Exercise</u></font><font style="font-size: 10pt;">.&#160; The Company shall cause the
                  Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at
                  Custodian system (&#8220;<font style="font-family: 'Times New Roman';"><u>DWAC</u></font>&#8221;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant
                  Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the
                  Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (A) the earlier of (i)
                  one (1) Trading Day and (ii) the number of days comprising the Standard Settlement Period, in each case after the delivery to the Company of the Notice of Exercise and (B) one (1) Trading Day after delivery of the aggregate Exercise Price
                  to the Company (such date, the &#8220;<font style="font-family: 'Times New Roman';"><u>Warrant Share Delivery Date</u></font>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the
                  holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a
                  cashless exercise) is received by the Warrant Share Delivery Date.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay
                  to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day
                  (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such
                  exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;<font style="font-family: 'Times New Roman';"><u>Standard
                      Settlement Period</u></font>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of
                  Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial Exercise Date, which may be delivered at any time after the time of execution of
                  the Purchase Agreement, the Company agrees to deliver the Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for
                  purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zf3e6f0ef2f4e4e468b805d07e5a2d4a0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-size: 10pt;"><a name="BKMK_61"></a><font style="font-family: 'Times New Roman';">ii.</font></td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Delivery of New Warrants Upon Exercise</u></font><font style="font-size: 10pt;">.&#160; If this Warrant shall have been
                  exercised in part, the Company shall, at the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to
                  purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc64b736fa53f4b8ab15d2eb59a6d5232" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rescission Rights</u></font><font style="font-size: 10pt;">.&#160; If the Company fails to cause the Transfer Agent to
                  transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z30e5ae599f5448688427abba3bbbab5a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">iv.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u></font><font style="font-size: 10pt;">.&#160; In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above
                  pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases,
                  shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<font style="font-family: 'Times New Roman';"><u>Buy-In</u></font>&#8221;), then the
                  Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by
                  multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed,
                  and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) <a name="z_cp_change_4"></a>and return any amount received by the Company in respect of the Exercise Price for those Warrant Shares or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company
                  timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common
                  Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company
                  written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies
                  available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the
                  Warrant as required pursuant to the terms hereof.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="ze7b3d337138b47b38e71ef4fe7079ac7" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">v.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Fractional Shares or Scrip</u></font><font style="font-size: 10pt;">.&#160; No fractional shares or scrip
                  representing fractional shares shall be issued upon the exercise of this Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a
                  cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf7b89d0525804a0d97995cb4dc15055a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">vi.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Charges, Taxes and Expenses</u></font><font style="font-size: 10pt;">.&#160; Issuance of Warrant Shares shall be made
                  without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be
                  issued in the name of the Holder or in such name or names as may be directed by the Holder; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that
                  in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the
                  Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of
                  Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za24db7550900458cb5c79a8814630eb8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">vii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Closing of Books</u></font><font style="font-size: 10pt;">.&#160; The Company will not close its stockholder books or
                  records in any manner which prevents the timely exercise of this Warrant, pursuant to the terms hereof.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zdf35f0b8034844d183fd6e74e5a56aad" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Holder&#8217;s Exercise Limitations</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z0ec13611cbcb46f2937f2cd772fb8b4a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Beneficial Ownership</u></font><font style="font-size: 10pt;">. The Company shall not effect any exercise of this
                  Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, and return any amount received by the Company in respect of the Exercise Price for those Warrant Shares, pursuant to Section 2 or otherwise, to the
                  extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any
                  of the Holder&#8217;s Affiliates and return any amount received by the Company in respect of the Exercise Price for those Warrant Shares (such Persons, &#8220;<font style="font-family: 'Times New Roman';"><u>Attribution Parties</u></font>&#8221;)), would
                  beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution
                  Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
                  (A) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (B) exercise or conversion of the unexercised or nonconverted portion of any other
                  securities of the Company (including, without limitation, any other&#160; Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
                  Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e)(ii), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and
                  regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
                  for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e)(ii) applies, the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of
                  whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial
                  Ownership Limitation.&#160;&#160; In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
                  of this Section&#160;2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A)&#160;the Company&#8217;s most recent periodic or annual report filed
                  with the Commission, as the case may be, (B)&#160;a more recent public announcement by the Company or (C)&#160;a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding (the &#8220;<font style="font-family: 'Times New Roman';"><u>Reported Outstanding Share Number</u></font>&#8221;).&#160; Upon the written request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of
                  shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
                  Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;<font style="font-family: 'Times New Roman';"><u>Beneficial Ownership Limitation</u></font>&#8221;
                  shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.&#160; The Holder, upon written notice to the Company, may
                  increase or decrease the Beneficial Ownership Limitation provisions of this Section&#160;2(e)(ii), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
                  after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section&#160;2(e)(ii) shall continue to apply.&#160; Any increase in the Beneficial Ownership Limitation will
                  not be effective until the 61st day after such notice is delivered to the Company. <a name="z_cp_change_10"></a>If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding Common Shares is
                  less than the Reported Outstanding Share Number, the Company shall notify the Holder in writing of the number of Common Shares then outstanding and, to the extent that such Exercise Notice would otherwise cause the beneficial ownership of
                  Holder together with the Attribution Parties, as determined pursuant to this Section 2(e), to exceed the Beneficial Ownership Limitation, the Holder shall then notify the Company of a reduced number of Warrant Shares to be purchased
                  pursuant to such Exercise Notice (such notice, the &#8220;Reduction Notice&#8221;). Such issuance shall not be deemed to have occurred until the Holder provides the Reduction Notice (or a notice that no reduction is needed) to the Company. In the
                  event that the issuance of Common Shares to the Holder upon exercise of this Warrant results in the Holder, together with the Attribution Parties, collectively being deemed to beneficially own, in the aggregate, more than the Beneficial
                  Ownership Limitation, the number of shares so issued by which the aggregate Beneficial Ownership of the Holder and its Attribution Parties exceeds such limitation (the &#8220;Excess Shares&#8221;) shall be deemed null and void and shall be cancelled
                  ab initio, and the Holder and/or the Attribution Parties shall not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the
                  Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares and the Holder shall return the Excess Shares to the Company. The provisions of this paragraph shall be construed and implemented in a manner
                  otherwise than in strict conformity with the terms of this Section 2(e)(ii) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
                  make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z163c361db209491dbae76e5c1ca3d29a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Section 3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Certain Adjustments</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z43950c1b31ec488586585e5ef5c268b4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Stock Dividends and Splits</u></font><font style="font-size: 10pt;">. If the Company, at any time while this
                  Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance
                  of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Warrant), (ii)&#160;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#160;combines (including by way of reverse
                  stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#160;issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be
                  multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of
                  Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any
                  adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
                  the effective date in the case of a subdivision, combination or re&#8209;classification.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z72a0f4c4a91e413b9fbe0826508754ca" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Subsequent Rights Offerings</u></font><font style="font-size: 10pt;">.&#160; In addition to any adjustments pursuant to
                  Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock
                  (the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Rights</u></font>&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
                  acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
                  Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be
                  determined for the grant, issue or sale of such Purchase Rights (<font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that to the extent that the
                  Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
                  ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in
                  the Holder exceeding the Beneficial Ownership Limitation).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf72f5e303ae64b488bbb0d9f499b7d37" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pro Rata Distributions</u></font><font style="font-size: 10pt;">.&#160; During such time as this Warrant is
                  outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without
                  limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<font style="font-family: 'Times New Roman';"><u>Distribution</u></font>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the
                  Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the
                  Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
                  participation in such Distribution (<font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that to the extent that the Holder&#8217;s right to participate in
                  any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of
                  Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
                  exceeding the Beneficial Ownership Limitation).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z53187e79a3ff431c8233aa918dc9e358" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Fundamental Transaction</u></font><font style="font-size: 10pt;">. If, at any time while this Warrant is
                  outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
                  effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any direct or indirect purchase offer, tender offer or
                  exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the
                  holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
                  share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or
                  share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or
                  group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or
                  party to, such stock or share purchase agreement or other business combination) (each a &#8220;<font style="font-family: 'Times New Roman';"><u>Fundamental Transaction</u></font>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder
                  shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in
                  Section 2(e) on the exercise of this Warrant (the &#8220;<font style="font-family: 'Times New Roman';"><u>Fundamental Transaction Rights</u></font>&#8221;)), the number of shares of Common Stock of the successor or acquiring corporation or of the
                  Company, if it is the surviving corporation, and any additional consideration (the &#8220;<font style="font-family: 'Times New Roman';"><u>Alternate Consideration</u></font>&#8221;) receivable as a result of such Fundamental Transaction by a holder
                  of the number of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such
                  exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
                  Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Common Stock
                  are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant
                  following such Fundamental Transaction.&#160; The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<font style="font-family: 'Times New Roman';"><u>Successor Entity</u></font>&#8221;)

                  to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably
                  satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the
                  Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
                  equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which
                  applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such
                  number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
                  in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
                  of this Warrant and the other Transaction Documents referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company
                  under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein;<a name="z_cp_change_12"></a> provided, however, that to the extent that the Holder&#8217;s right to
                  participate in any such Fundamental Transaction Rights would result in the Holder and its Attribution Parties, collectively, beneficially owning in excess of the Beneficial Ownership Limitation of the Common Shares that would be issued
                  and outstanding following receipt of such Fundamental Transaction Rights (such excess amount of Common Shares, the &#8220;Excess Fundamental Transaction Rights&#8221;), then the Holder shall not be entitled to participate in such Fundamental
                  Transaction Rights to the extent of the Excess Fundamental Transaction Rights (and shall not have the right to acquire such Excess Fundamental Transaction Rights). The Excess Fundamental Transaction Rights shall be held in abeyance for
                  the benefit of the Holder until such time or times as (1) its right to receive some or all of the Excess Fundamental Transaction Rights would not result in the Holder and its Attribution Parties beneficially owning Common Shares in excess
                  of the Beneficial Ownership Limitation and (2) the Holder so certifies in writing to the Company and specifies the number of shares of Common Shares it is able to receive without exceeding the Beneficial Ownership Limitation, at which
                  time or times the Holder shall be granted that portion of the Excess Fundamental Transaction Rights (and any Excess Fundamental Transaction Rights granted, issued or sold on such initial Fundamental Transaction Rights or on any subsequent
                  Fundamental Transaction Rights to be held similarly in abeyance) to the same extent as if there had been no such limitation. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d)
                  regardless of whether the Company has sufficient authorized shares of Common Shares for the issuance of Warrant Shares. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e)
                  regardless of (i) whether the Company has sufficient authorized Common Shares for the issuance of Warrant Shares and/or whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z7ea316c822c6403b84bdcaf2a0f299d8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Calculations</u></font><font style="font-size: 10pt;">. All calculations under this Section 3 shall be made to the
                  nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of
                  Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="zd03e84eb0c5044339197fb7e31ac2a0e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notice to Holder</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4791343e43e649a2a41b8af27526eb08" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Adjustment to Exercise Price</u></font><font style="font-size: 10pt;">. Whenever the Exercise Price is adjusted
                  pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant
                  Shares and setting forth a brief statement of the facts requiring such adjustment.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z4ba9b01701f44fc1a86c9ed879e6a24b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">ii.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notice to Allow Exercise by Holder</u></font><font style="font-size: 10pt;">. If (A) the Company shall declare a
                  dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all
                  holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any
                  reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is
                  converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be
                  delivered by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date
                  hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of
                  the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is
                  expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
                  upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
                  required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Company&#8217;s subsidiaries, the Company shall
                  simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.&#160; The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the
                  event triggering such notice except as may otherwise be expressly set forth herein.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z426645b626a74ea0b23b3af134e2fc6b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Section 4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transfer of Warrant</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z27a72a0446e545c890015b9ad37c42bf" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transferability</u></font><font style="font-size: 10pt;">.&#160; This Warrant and all rights hereunder (including,
                  without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant
                  substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon such surrender and, if required, such payment,
                  the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor
                  a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
                  the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the
                  Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z42cbb6f361f547e5b4ba25154487aa92" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>New Warrants</u></font><font style="font-size: 10pt;">. This Warrant may be divided or combined with other
                  Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160;
                  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or
                  combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
                  thereto.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z0d8d57646a634dfbb1f10b918683439e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Warrant Register</u></font><font style="font-size: 10pt;">. The Company shall register this Warrant, upon records
                  to be maintained by the Company for that purpose (the &#8220;<font style="font-family: 'Times New Roman';"><u>Warrant Register</u></font>&#8221;), in the name of the record Holder hereof from time to time.&#160; The Company may deem and treat the
                  registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf472711be4794352b68c9522e37913d3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Section 5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Miscellaneous</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7839fcd5756548e78e448c9b3d32f20e" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u></font><font style="font-size: 10pt;">.&#160; This
                  Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160; Without
                  limiting the rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise,&#8221; and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle an
                  exercise of this Warrant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1dcb0c71c98347f392893cfd8d7ac70f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Loss, Theft, Destruction or Mutilation of Warrant</u></font><font style="font-size: 10pt;">. The Company covenants
                  that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction,
                  of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
                  will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z509415ce922e4bbdb8a0999d43b64df3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Saturdays, Sundays, Holidays, etc</u></font><font style="font-size: 10pt;">.&#160; If the last or appointed day for the
                  taking of any action or the expiration of any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze794b73b0965421a8f38e642b294b3ab" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Authorized Shares</u></font><font style="font-size: 10pt;">. The Company covenants that, at all times during the
                  period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160;
                  The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this
                  Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the
                  Trading Market upon which the Common Stock may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights
                  represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the
                  issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
        certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
        of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against
        impairment.&#160; Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all
        such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such
        authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">Before taking any action, which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
        Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6d04414df8cb44ab869faf1c334f8243" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Jurisdiction</u></font><font style="font-size: 10pt;">. All questions concerning the construction, validity,
                  enforcement and interpretation of this Warrant shall be determined in accordance with the provisions of the Purchase Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zafe744aea58249879ff5db9dfb563941" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restrictions</u></font><font style="font-size: 10pt;">.&#160; The Holder acknowledges that the Warrant Shares acquired
                  upon the exercise of this Warrant, if not registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za24266e314df41e79f410c41d4c5ae64" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Nonwaiver and Expenses</u></font><font style="font-size: 10pt;">.&#160; No course of dealing or any delay or failure to
                  exercise any right hereunder on the part of Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies, notwithstanding the fact that the right to exercise this Warrant terminates on the
                  Termination Date.&#160; Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
                  Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in
                  collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z027efcde334847c2b1c2fb35da70c9f8" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font><font style="font-size: 10pt;">.&#160; Any notice, request or other document required or permitted to
                  be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6984ac602d4e4be2aa7141fd177d46fb" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Limitation of Liability</u></font><font style="font-size: 10pt;">.&#160; No provision hereof, in the absence of any
                  affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common
                  Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6396d5d9c2344d9abaf730cfab52d608" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">j)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Remedies</u></font><font style="font-size: 10pt;">.&#160; The Holder, in addition to being entitled to exercise all
                  rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason
                  of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7ca82d5f72944252ad9d9abe69364a3f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">k)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">.&#160; Subject to applicable securities laws, this
                  Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this
                  Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z1a616558c233428a9731903296dd2b1a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">l)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Amendment</u></font><font style="font-size: 10pt;">.&#160; This Warrant may be modified or amended or the provisions
                  hereof waived with the written consent of the Company, on the one hand, and the Holder of this Warrant, on the other hand.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z84174d42ff144ac099925d033d38d577" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">m)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability</u></font><font style="font-size: 10pt;">.&#160; Wherever possible, each provision of this Warrant shall
                  be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such
                  prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z88a499968eec40ee8844e858f0867f7d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">n)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Headings</u></font><font style="font-size: 10pt;">.&#160; The headings used in this Warrant are for the convenience of
                  reference only and shall not, for any purpose, be deemed a part of this Warrant.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">********************</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Signature Page Follows)<a name="BKMK_69"></a></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
        indicated.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zaa7448f0166d4d0d8133e904b3c86f35" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';"><a name="BKMK_70"></a>&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-weight: bold;">MOMENTUS INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Name: John Rood</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Title: Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center; font-size: 10pt;"><a name="BKMK_71"></a><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit A</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;">MOMENTUS INC.</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt; font-family: 'Times New Roman'; font-size: 10pt;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if
        exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt; font-family: 'Times New Roman'; font-size: 10pt;">(2) Payment shall take the form of (check applicable box):</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 97.2pt; font-family: 'Times New Roman'; font-size: 10pt;">[&#160; ] in lawful money of the United States; or</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; margin-left: 97.2pt; font-family: 'Times New Roman'; font-size: 10pt;">[&#160; ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c),
        to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt; font-family: 'Times New Roman'; font-size: 10pt;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div style="text-align: justify; text-indent: 97.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 97.2pt; font-family: 'Times New Roman'; font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z8c72963571034183ab0dcc231ca9c280">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
              <td style="width: 55%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; text-indent: 97.2pt; font-family: 'Times New Roman'; font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <br>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 55%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 15%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
                <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 55%; padding-bottom: 2px;">
                  <div>&#160;</div>
                </td>
              </tr>

          </table>
          <br>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE OF HOLDER]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zc20f4804cfcd465999a1cba55bc2b293">

            <tr>
              <td style="width: 25%; padding-bottom: 2px;">
                <div><font style="font-size: 10pt; font-family: 'Times New Roman';">Name of Investing Entity:</font></div>
              </td>
              <td style="width: 75%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 35%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature of Authorized Si</font><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-style: italic;">gnatory of Investing Entity</font>:</font></font></td>
              <td style="width: 65%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt;"> </font>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 22%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Name of Authorized Signatory:</font><font style="font-size: 10pt;"> <br>
                </font></td>
              <td style="width: 78%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 20%; padding-bottom: 2px;" rowspan="1"><font style="font-size: 10pt; font-family: 'Times New Roman';">Title of Authorized Signatory:</font></td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1"><br>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;" rowspan="1">Date: </td>
              <td style="width: 95%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="text-align: left;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"> <br>
          </font></font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">ASSIGNMENT FORM</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 9.45pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to exercise the
        Warrant to purchase shares.)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 9.45pt; font-family: 'Times New Roman'; font-size: 10pt;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z86c8a2a6f57e4ff68b541624a8f78549" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';"><a name="BKMK_73"></a>Name:</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">Address:</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Phone Number:</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Email Address:</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;Dated:</td>
            <td style="width: 7%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 12pt;"><br>
              </div>
            </td>
            <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;&#8226;</td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0); text-align: right;" rowspan="1">&#160;,</td>
            <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px; text-align: center;" rowspan="1">&#160;&#8226;</td>
            <td style="width: 10%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#160;</td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1"><br>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">Holder&#8217;s Signature:<br>
              </div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 22.76%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; margin-right: 0.8pt; font-family: 'Times New Roman';">Holder&#8217;s Address:<br>
              </div>
            </td>
            <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;" colspan="5">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 6.39%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ef20075150_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <!--PROfilePageNumberReset%Num%1%%%-->
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 4.2</font><br>
    </div>
    <div><font style="font-weight: bold;"> </font><br>
      <div style="text-align: justify; font-weight: bold;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
        RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR
        PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF
        THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">MOMENTUS INC.</div>
      <div>&#160;
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z7acbfdda54474c209d25afc0572b52ed">

            <tr>
              <td style="width: 50.00%;"><font style="font-weight: bold;">Warrant Shares</font>: 147,100</td>
              <td style="width: 50%; text-align: right;"><font style="font-weight: bold;">Original Issue Date</font>: May 28, 2026</td>
            </tr>

        </table>
      </div>
      <div style="font-size: 12pt;"><font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify;">THIS WARRANT TO PURCHASE SHARES OF COMMON STOCK (this &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, A.G.P./Alliance Global Partners or its designees or assigns (the &#8220;<u>Holder</u>&#8221;) is entitled, upon the
        terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 23, 2026 (the &#8220;<u>Initial Exercise Date</u>&#8221;) and on or prior to 5:00 p.m. (New York City time) on May 26, 2031 (the &#8220;<u>Termination

          Date</u>&#8221;) but not thereafter, to subscribe for and purchase from <font style="font-weight: bold;">MOMENTUS INC.</font>, a Delaware corporation (the &#8220;<u>Company</u>&#8221;), up to <font style="font-weight: bold;">147,100 shares&#160;</font>of Common
        Stock, par value $0.00001 per share (the &#8220;<u>Common</u>&#160;<u>Stock</u>&#8221;), of the Company (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;). The purchase price of one Warrant Share under this Warrant shall be equal to the Exercise
        Price, as defined in Section 2(b).</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Section 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement (the &#8220;<u>Purchase</u>&#160;<u>Agreement</u>&#8221;),

        dated May 26, 2026, by and between the Company and the purchaser signatory thereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">Section 2.&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <u>Exercise</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
        Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto, and delivered in accordance with the notice
        requirements set forth in Section 5(h) herein (the &#8220;<u>Notice of Exercise</u>&#8221;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein)
        following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the
        cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of
        any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
        and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following the date on which the final Notice of Exercise is delivered to the
        Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount
        equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
        Exercise within one (1) Business Day of receipt of such notice. <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the
          purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Exercise Price</u>. The exercise price per share of Common Stock under this Warrant shall be <font style="font-weight: bold;">$9.35</font>, subject to adjustment
        hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Cashless Exercise</u>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not
        available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares
        equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: -31.6pt; margin-right: 36pt; margin-left: 144pt;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
        both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule
        600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
        Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular
        trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the
        applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such Trading Day;</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -31.6pt; margin-right: 36pt; margin-left: 144pt;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: -31.6pt; margin-right: 36pt; margin-left: 144pt;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
        by means of a cash exercise rather than a cashless exercise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading
        Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York
        City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common
        Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid
        price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities
        then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market,
        the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New
        York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the
        Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most
        recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the
        Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares
        shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any position contrary to this
        Section 2(c), except to the extent required by applicable law, rule or regulation.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder
        by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is then a participant in such system and either (A)
        there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
        pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which
        the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company (other than
        in the instance of a cashless exercise) and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case (i) or (ii) after the delivery to the Company of the Notice of Exercise and subject to payment of the aggregate
        Exercise Price (other than in the instance of a cashless exercise) by such date (such date, the &#8220;<u>Warrant Share Delivery Date</u>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the
        holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
        exercise) is received by the Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in
        cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
        Trading Day on the fifth Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a
        transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;<u>Standard Settlement</u>&#160;<u>Period</u>&#8221; means the standard settlement period, expressed in a number of Trading
        Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of
        this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all
        other respects be identical with this Warrant.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i) by the Warrant
        Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant</u>&#160;<u>Shares Upon Exercise</u>. In addition to any other rights available to the Holder, if the
        Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the
        Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the
        Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the shares of
        Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order
        giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise
        shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
        Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
        preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the
        amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to
        the Company&#8217;s failure to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any
        fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by
        the Exercise Price or round up to the next whole share.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Charges, Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense
        in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <u>provided</u>,
        <u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder
        and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise
        and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to
        the terms hereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this
        Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other Persons acting
        as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence,
        the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is
        being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or Attribution Parties and
        (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
        limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance
        with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the
        Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in
        relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise
        shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
        in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be
        determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the
        number of outstanding shares of Common Stock as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written
        notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the
        number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
        Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% of the number of shares of the Common Stock
        outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this
        Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this
        Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions
        of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
        Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">Section 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Certain Adjustments</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or
        distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of
        this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
        reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
        treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
        shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of
        stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that the Warrant is outstanding, the Company grants,
        issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of shares of Common Stock (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled
        to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
        regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record
        is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>, <u>however</u>, that to the extent that the Holder&#8217;s right to participate in
        any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as
        a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
        Limitation).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Pro Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution of its assets
        (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise, other than cash (including, without limitation, any distribution of stock or other securities, property or options by way of a
        dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;<u>Distribution</u>&#8221;), at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to
        participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on
        exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of
        Common Stock are to be determined for the participation in such Distribution (<u>provided</u>, <u>however</u>, that to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial
        Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
        Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding (i) the Company, directly or indirectly, in one or more related transactions effects
        any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
        all of the Company&#8217;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock
        are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
        one or more related transactions effects any reclassification, reorganization or recapitalization of shares of Common Stock or any compulsory share exchange pursuant to which the shares of Common Stock are effectively converted into or exchanged
        for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization,
        recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the voting power of the common equity of the Company (each a &#8220;<u>Fundamental
          Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
        Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving
        corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately prior
        to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
        Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a
        reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the
        Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the
        Company or any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within thirty (30) days after, the consummation of the Fundamental Transaction (or, if later, the date of the public
        announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder, as described below, an amount of consideration equal to the Black Scholes Value (as defined below) of the remaining unexercised
        portion of this Warrant on the date of the consummation of such Fundamental Transaction, provided, however, that, if the Fundamental Transaction is not within the Company&#8217;s control, including not approved by the Company&#8217;s Board of Directors, Holder
        shall only be entitled to receive from the Company or any Successor Entity, as of the date of the consummation of such Fundamental Transaction the same type or form of consideration (and in the same proportion), valued at the Black Scholes Value of
        the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
        thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided further, that if holders of Common Stock of the Company are not
        offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received shares of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in
        such Fundamental Transaction. &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable
        Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
        Transaction and the Termination Date, (B) an expected volatility equal to 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public
        announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash
        consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the consummation of
        the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&#8217;s request pursuant to this Section 3(d) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable
        Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the Holder&#8217;s election (or, if later, on
        the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor</u>&#160;<u>Entity</u>&#8221;) to assume in writing all of the
        obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder prior to such
        Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant
        which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any
        limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of
        Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately
        prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted
        for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents referring to the &#8220;<u>Company</u>&#8221; shall refer instead to the Successor Entity), and may exercise every right
        and power of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of
        this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">f)&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <u>Notice to Holder</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the
        Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the
        Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital
        stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or
        transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
        dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Warrant Register of the Company, at least
        20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record
        is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
        merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities,
        cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity
        of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall
        simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event
        triggering such notice except as may otherwise be expressly set forth herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify;"><u>Section 4</u>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Transfer of Warrant</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>. Subject to compliance with any applicable securities laws and the conditions set forth in this Section 4(a) and to the provisions of Section
        4.1 of the Purchase Agreement, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this
        Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the
        Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant
        evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new
        Warrant issued.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a
        written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or
        combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue
        Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &#8220;<u>Warrant Register</u>&#8221;), in
        the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
        purposes, absent actual notice to the contrary.</div>
      <div>&#160;</div>
      <div style="text-align: justify;">Section 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <u>Miscellaneous</u>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a
        stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &#8220;cashless exercise&#8221; pursuant to Section 2(c)
        or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">b)&#160;&#160;&#160;&#160; &#160; &#160; <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the
        loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
        shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such
        cancellation, in lieu of such Warrant or stock certificate.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall
        not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Authorized Shares</u>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
        sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its
        officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may
        be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the
        exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and
        nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any
        reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in
        good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
        foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in
        order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any
        public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant.</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 36pt;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such
        authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Jurisdiction</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the
        provisions of the Purchase Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not utilize
        cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Nonwaiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as a waiver of such
        right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
        results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate
        proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. Any and all notices or other communications or deliveries to be provided by the Holder hereunder including, without limitation, any Notice of
        Exercise, shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service, addressed to the Company, at 1762 Automation Parkway, San Jose, CA 95131, Attention: Chief Executive Officer, email
        address: <font style="font-style: italic;">john.rood@momentus.space</font>, or such other email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to
        be provided by the Company hereunder shall be in writing and delivered personally, by e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the e-mail address or address of such Holder appearing on the
        books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i) the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set
        forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after the time of transmission, if such notice or communication is delivered via e-mail at the e-mail address set forth in this Section on a day
        that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by
        the party to whom such notice is required to be given.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and
        no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by
        creditors of the Company.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
        performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
        assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and
        be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be
        enforceable by the Holder or holder of Warrant Shares.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and the Holder of
        this Warrant, on the other hand.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law, but if any
        provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
        of this Warrant.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.1pt;">********************</div>
      <div>&#160;</div>
      <div style="text-align: center; margin-right: 0.1pt; margin-left: 0.05pt;">[<font style="font-style: italic;">Signature page follows</font>]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zed60f22c2b7740ac963d4030492dbd6e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 60%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top;" colspan="2">
              <div style="margin-right: 1.8pt; font-weight: bold;">MOMENTUS INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;"><br>
            </td>
            <td style="vertical-align: top;" colspan="2"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="margin-right: 0.8pt;">By:</div>
            </td>
            <td style="width: 35%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 35%; vertical-align: top;">
              <div style="margin-right: 0.8pt;">Name: John Rood</div>
            </td>
          </tr>
          <tr>
            <td style="width: 60%; vertical-align: top;">&#160;</td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 35%; vertical-align: top;">
              <div style="margin-right: 0.8pt;">Title: Chief Executive Officer</div>
            </td>
          </tr>

      </table>
      <div style="text-align: center;"><a name="BKMK_71"></a><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-weight: bold;">Exhibit A</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">NOTICE OF EXERCISE</div>
      <div><br>
      </div>
      <div style="text-align: justify;">TO:&#160; &#160; &#160; &#160; &#160; <font style="font-weight: bold;">MOMENTUS INC.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">(1) The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the
        exercise price in full, together with all applicable transfer taxes, if any.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">(2) Payment shall take the form of (check applicable box):</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 97.2pt;">[&#160; ] in lawful money of the United States; or</div>
      <div><br>
      </div>
      <div style="text-align: justify; margin-left: 97.2pt;">[&#160; ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Warrant with respect to the
        maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">(3) Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zff33928155dd45838967e4e986890529">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 45%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 81pt;">(4) Accredited Investor. The undersigned is an &#8220;accredited investor&#8221; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zac6db302e6f84bc4a142510de420852a">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 45%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;"> <br>
      </div>
      <div style="text-align: justify; text-indent: 97.2pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="za087bd0dd64a428da1346b54a375f67b">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 45%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify;"> <br>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;" id="z682cff96d98c4c3c94583c50016cf390">

            <tr>
              <td style="width: 15%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
              <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 45%; padding-bottom: 2px;">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
        <br>
      </div>
      <div style="text-align: center;">[SIGNATURE OF HOLDER]</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z7bf1734f340348e389d93db0483c6811">

            <tr>
              <td style="width: 20%; padding-bottom: 2px;">Name of Investing Entity:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z8f45f3240583402dacc9a7cb9f4f2a0b">

            <tr>
              <td style="width: 40%; padding-bottom: 2px;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</td>
              <td style="width: 60%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z9d77891f13eb40159dbd0b5ea6d97e53">

          <tr>
            <td style="width: 22%; padding-bottom: 2px;">Name of Authorized Signatory:</td>
            <td style="width: 78%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z2cc4c06fc6ca487bb116597d7d5e7ffc">

            <tr>
              <td style="width: 22%; padding-bottom: 2px;">Title of Authorized Signatory:</td>
              <td style="width: 78%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="zfc0fd3e525b246558b1a38c899635802">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">Date:</td>
              <td style="width: 95%; border-bottom: 2px solid rgb(0, 0, 0);">
                <div>&#160;</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: right; font-weight: bold;">Exhibit B</div>
      <div><br>
      </div>
      <div style="text-align: center;">ASSIGNMENT FORM</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 9.45pt; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to exercise the Warrant to purchase shares.)</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 9.45pt;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="za450122ebd73459ca0f372498fca1147" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;"><a name="BKMK_73"></a>Name:</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;">Address:</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;">(Please Print)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="margin-right: 0.8pt;">Phone Number:</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="margin-right: 0.8pt;">Email Address:</div>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: justify; margin-right: 1.8pt;">Dated: _______________ __, ___________</div>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;">Holder&#8217;s Signature:</div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;"><br>
            </td>
            <td style="width: 25%; vertical-align: top;"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: justify; margin-right: 0.8pt;">Holder&#8217;s Address:</div>
            </td>
            <td style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
            </td>
            <td style="width: 5%; vertical-align: top;"><br>
            </td>
            <td style="width: 50%; vertical-align: top;"><br>
            </td>
          </tr>

      </table>
      <div><font style="font-style: italic;"> </font><br>
      </div>
      <div>&#160;</div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ef20075150_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--> <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-size: 10pt;"><font style="font-weight: bold;">Exhibit 10.1</font><br>
      </font></div>
  </div>
  <div><font style="font-size: 10pt;"><br>
    </font>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SECURITIES PURCHASE AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Securities Purchase Agreement (this &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is dated as of May&#160;26, 2026,
        between Momentus Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and each of the purchasers identified on the signature pages hereto (including its successors and assigns, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section&#160;4(a)(2) of the Securities Act (as defined below)
        and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described
        in this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and
        adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I.<font style="font-family: 'Times New Roman';"><br>
        </font>DEFINITIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Definitions</u></font>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this <font style="font-family: 'Times New Roman';"><u>Section
                1.1</u></font>:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Acquiring Person</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section 4.5</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Affiliate</u></font>&#8221; means any Person that, directly or indirectly through
        one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Applicable Laws</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(jj)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Authorizations</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(jj)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Beneficial Ownership Limitation</u></font>&#8221; shall have the meaning ascribed to
        such term in <font style="font-family: 'Times New Roman';"><u>Section&#160;2.1(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>BHCA</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(ii)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Board of Directors</u></font>&#8221; means the board of directors of the Company.<a name="BKMK_103"></a></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Business Day</u></font>&#8221; means any day except any Saturday, any Sunday, any
        day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close; <font style="font-family: 'Times New Roman';"><u>provided</u></font>,
        <font style="font-family: 'Times New Roman';"><u>however</u></font>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221; or
        any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City
        of New York generally are open for use by customers on such day.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Closing</u></font>&#8221; means the closing of the purchase and sale of the
        Securities pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Closing Date</u></font>&#8221; means the Trading Day on which all of the Transaction
        Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i)&#160;the Purchaser&#8217;s obligations to pay the Subscription Amount and (ii)&#160;the Company&#8217;s obligations to deliver the Securities, in each case,
        have been satisfied or waived, but in no event later than the first (1st) Trading Day following the date hereof.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Commission</u></font>&#8221; means the United States Securities and Exchange
        Commission.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Common Stock</u></font>&#8221; means the Class A common stock of the Company, par
        value $0.00001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Common Stock Equivalents</u></font>&#8221; means any securities of the Company or
        its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or
        exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Company Counsel</u></font>&#8221; means Bradley Arant Boult Cummings LLP.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Disclosure Schedules</u></font>&#8221; means the Disclosure Schedules of the Company
        delivered concurrently herewith.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Disclosure Time</u></font>&#8221; means, (i) if this Agreement is signed on a day
        that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as
        to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless
        otherwise instructed as to an earlier time by the Placement Agent.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Disqualification Event</u></font>&#8221; shall have the meaning ascribed to such
        term in <font style="font-family: 'Times New Roman';"><u>Section&#160;3.1(kk)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Exchange Act</u></font>&#8221; means the Securities Exchange Act of 1934<a name="BKMK_104"></a>, as amended, and the rules and regulations promulgated thereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Effective Date</u></font>&#8221; means the date that the Registration Statement
        required to be filed pursuant to the Registration Rights Agreement is declared effective by the Commission.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Exempt Issuance</u></font>&#8221; means (i) the issuance of securities to directors,
        officers, employees and consultants of the Company pursuant to employee benefit plans, equity incentive plans or other employee compensation plans existing on the date hereof and as described in the SEC Reports or pursuant to Nasdaq Rule
        5635(c)(4), (ii) the issuance of securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or the issuance of securities pursuant to the exercise, exchange or conversion of any options, warrants, restricted
        stock units, rights or convertible securities outstanding on the date hereof, provided that such options, warrants, restricted stock units, rights or convertible securities have not been amended since the date of this Agreement to increase the
        number of such securities or to decrease the exercise price, exchange price or conversion price of such securities or to extend the term of such securities, (iii) securities issued in connection with any joint venture, commercial or collaborative
        relationship, or the acquisition or license by the Company of the securities, businesses, property or other assets of another person, provided that such issuance is approved by the majority of the disinterested directors of the Company and provided
        such securities are issued as restricted securities, (iv)&#160;securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as
        &#8220;restricted securities&#8221; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in <font style="font-family: 'Times New Roman';"><u>Section 4.12</u></font>, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
        synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, and (v) issuances of shares of Common Stock upon the exercise or exchange of rights issued pursuant to any
        shareholder rights agreement entered into between the Company and Transfer Agent.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Issuer Covered Persons</u></font>&#8221; shall have the meaning ascribed to such
        term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(kk)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Lock-Up Agreements</u></font>&#8221; means the lock-up
        agreements in substantially the form of <font style="font-family: 'Times New Roman';"><u>Exhibit&#160;B</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Material Adverse Effect</u></font>&#8221; shall have the meaning assigned to such
        term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Per Pre-Funded Warrant Purchase Price</u></font>&#8221; means $8.49999, subject to
        adjustment for reverse and forward share splits, share dividends, share combinations and other similar transactions of the shares of Common Stock that occur after the date of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Per Share Purchase Price</u></font>&#8221; equals $8.50, subject to adjustment for
        reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement and prior to the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Person</u></font>&#8221; means an individual or corporation, partnership, trust,
        incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Placement Agent</u></font>&#8221; means A.G.P./Alliance Global Partners.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Pre-Funded Warrants</u></font>&#8221; means, collectively, the Pre-Funded Common
        Stock purchase warrants delivered to the Purchasers at the Closing in accordance with <font style="font-family: 'Times New Roman';"><u>Section&#160;2.2(a)</u></font> hereof, in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font>
        attached hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Pre-Funded Warrant Shares</u></font>&#8221; means the shares of Common Stock
        issuable upon exercise of the Pre-Funded Warrants.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Party</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.8</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Registration Rights Agreement</u></font>&#8221; means the Registration Rights
        Agreement, dated on or about the date hereof, among the Company and the Purchasers, in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit&#160;C</u></font> attached hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221; means a registration statement meeting the
        requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Rule 144</u></font>&#8221; means Rule 144 promulgated by the Commission pursuant to
        the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Rule 424</u></font>&#8221; means Rule 424 promulgated by the Commission pursuant to
        the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>SEC Reports</u></font>&#8221; shall have the meaning ascribed to such term in <font style="font-family: 'Times New Roman';"><u>Section 3.1(f)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Securities</u></font>&#8221; means the Shares, the Pre-Funded Warrants and the
        Pre&#8209;Funded Warrant Shares.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221; means the Securities Act of 1933, as amended, and
        the rules and regulations promulgated thereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Shares</u></font>&#8221; means the shares of Common Stock issued or issuable to each
        Purchaser pursuant to this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Short Sales</u></font>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of
        Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Subscription Amount</u></font>&#8221; means, as to the Purchaser, the aggregate
        amount to be paid for the Shares and Pre&#8209;Funded Warrants purchased hereunder as specified below the Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately
        available funds.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trading Day</u></font>&#8221; means a day on which the principal Trading Market is
        open for trading.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trading Market</u></font>&#8221; means any of the following markets or exchanges on
        which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the
        foregoing).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transaction Documents</u></font>&#8221; means this Agreement, the Pre-Funded
        Warrants, the Lock-Up Agreements, the Placement Agency Agreement, the Registration Rights Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
        hereunder.<a name="BKMK_106"></a></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transfer Agent</u></font>&#8221; means Continental Stock Transfer &amp; Trust
        Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Variable Rate Transaction</u></font>&#8221; shall have the meaning ascribed to such
        term in <font style="font-family: 'Times New Roman';"><u>Section&#160;4.12(b)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE II.<font style="font-family: 'Times New Roman';"><br>
        </font>PURCHASE AND SALE</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Closing</u></font>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase approximately $25,000,000.00 of
            the Securities, which includes the number of Pre-Funded Warrant Shares set forth under the heading &#8220;Subscription Amount&#8221; on the Purchaser&#8217;s signature page hereto, at the Per Pre-Funded Warrant Purchase Price. Notwithstanding anything herein to
            the contrary, to the extent that any Purchaser determines, in its sole discretion, that the Purchaser&#8217;s Subscription Amount would cause such Purchaser&#8217;s beneficial ownership of the shares of Common Stock to exceed the Beneficial Ownership
            Limitation, or as such Purchaser may otherwise choose, such Purchaser may elect to purchase Pre-Funded Warrants in lieu of the Shares as determined pursuant to <font style="font-family: 'Times New Roman';"><u>Section&#160;2.2(a)</u></font>. The &#8220;<font style="font-family: 'Times New Roman';"><u>Beneficial Ownership Limitation</u></font>&#8221; shall be 4.99% (or, at the election of each Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving
            effect to the issuance of the Securities on the Closing Date. Each Purchaser&#8217;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for &#8220;Delivery Versus Payment&#8221; (&#8220;<font style="font-family: 'Times New Roman';"><u>DVP</u></font>&#8221;) settlement with the Company or its designees. <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Notwithstanding the foregoing, with respect to any Notice(s) of
              Exercise (as defined in the Pre-Funded Warrants) delivered on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of this Agreement, the Company agrees to deliver the
              Pre-Funded Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes hereunder, provided
              that payment of the aggregate Exercise Price (as defined in the Pre-Funded Warrants) (other than in the case of a cashless exercise) is received by such Warrant Share Delivery Date. </font>The Company and each Purchaser shall deliver the
            other items set forth in <font style="font-family: 'Times New Roman';"><u>Section 2.2</u></font> deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in <font style="font-family: 'Times New Roman';"><u>Sections
                2.2</u></font> and <font style="font-family: 'Times New Roman';"><u>2.3</u></font>, the Closing shall occur remotely or such location as the parties shall mutually agree. Settlement of the Shares shall occur via DVP when such Purchaser
            makes payment of the Subscription Amount by wire transfer of immediately available funds to a bank account designated by the Company, upon which payment<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>the Company shall
            issue the Shares registered in such Purchaser&#8217;s name and address and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by such Purchaser; upon receipt of such Shares, the Placement Agent shall promptly
            electronically deliver such Shares to the Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Deliveries</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">On or prior to the
            Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbcc1d9b4bfb4d4e84ca321dd9adb1d4">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">this Agreement duly executed by the Company;<a name="BKMK_107"></a></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z28b46a9cbace4480a36319b86db4dca7">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a legal opinion of Company Counsel in a form reasonably acceptable to the Placement Agent;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1d0fe98ef6d44f998afdad916f23d3c8">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Company shall have provided each Purchaser with the Company&#8217;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z209bc515959b49d9b2d95a213dc807a9">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">subject to the last sentence of <font style="font-family: 'Times New Roman';"><u>Section 2.1</u></font>, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
                to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&#8220;<font style="font-family: 'Times New Roman';"><u>DWAC</u></font>&#8221;) Shares equal to the Purchaser&#8217;s Subscription Amount divided by
                the Per Share Purchase Price, registered in the name of the Purchaser;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze305520e81d74c76b0112a04632ab1b4">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">if applicable, a Pre-Funded Warrant registered in the name of each Purchaser to purchase up to a number of shares of Common Stock equal to the difference between (A) the Purchaser&#8217;s Subscription
                Amount applicable to the Pre-Funded Warrants divided by the Pre&#8209;Funded Warrant Purchase Price and (B) the number of Shares otherwise issuable to each Purchaser that would cause the Purchaser&#8217;s beneficial ownership of Common Stock to be more
                than the Beneficial Ownership Limitation with an exercise price equal to $0.00001 per share of Common Stock, subject to adjustment therein;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2ff129570454d939448baa4dc3572da">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vi)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Registration Rights Agreement duly executed by the Company;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc84eeaee7aa0402d9df8c2f4c658a78c">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(vii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">an Officer&#8217;s Certificate, in form and substance reasonably satisfactory to the Placement Agent;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 90pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(viii)</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">
                  <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">a Secretary&#8217;s Certificate, in form and substance reasonably satisfactory to the Placement Agent; and</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <br>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze2f410013d774f929490a5522a3c637d">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ix)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Lock-Up Agreements duly executed by each executive officer and director of the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">On or prior to the
            Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za8095b844d704a4f80fc2bac4f3b0b8a">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">this Agreement duly executed by such Purchaser;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z39c0ffe4426b42cc809801492658e826">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Purchaser&#8217;s Subscription Amount, which shall be made available for DVP settlement with the Company or its designees; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za09bf32484f9416595e408ba1e4f4f79">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the Registration Rights Agreement duly executed by such Purchaser.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Closing Conditions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zad92a1cda4874560a5b032ab8865da56">

          <tr>
            <td style="width: 72pt;">&#160;</td>
            <td style="width: 25.2pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c9e7d303a1e48b2b30adf290e80df33">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of
                the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8d5c8f5fad434926bc94095bd5277886">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78b7c9c2ceb648c29684cb3b0b06dcac">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the delivery by each Purchaser of the items set forth in <font style="font-family: 'Times New Roman';"><u>Section 2.2(b)</u></font> of this Agreement.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The respective
            obligations of each Purchaser in connection with the Closing are subject to the following conditions being met:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3ad507a87a30494695fe4f1f7e793a52">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of
                the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5776a2ca2aea4d4b90deff583287f830">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(ii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z34e8e4d960634b2e956b94f3e26c4c69">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iii)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">the delivery by the Company of the items set forth in <font style="font-family: 'Times New Roman';"><u>Section 2.2(a)</u></font> of this Agreement;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z84e8189dc09a4d918575e7c209619fbc">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(iv)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z56fd1001a7a548efa51f5f099037f766">

          <tr>
            <td style="width: 90pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(v)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and, at any time prior to the
                Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any
                Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
                calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Purchaser, makes it impracticable or inadvisable to purchase the Securities at the
                Closing.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE III.<font style="font-family: 'Times New Roman';"><br>
        </font>REPRESENTATIONS AND WARRANTIES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Representations and Warranties of the Company</u></font>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to
            the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to the Purchaser:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Organization and Good Standing</u></font>.<font style="font-family: 'Times New Roman'; font-style: italic;">&#160;</font>Each of the subsidiaries of the Company are set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(a)</u></font>. Each of the Company and its subsidiaries has been duly incorporated or organized, as applicable, is validly existing and is in good standing (to the extent the concept of good standing is
            applicable in such jurisdiction) under the laws of its jurisdiction of incorporation or organization. Each of the Company and its subsidiaries has the requisite power and authority to own its properties and conduct its business as currently
            being carried on and as described in the SEC Reports, and is duly qualified to do business as a foreign corporation or other entity in good standing in each jurisdiction in which the conduct of its business or ownership of property makes such
            qualification necessary and in which the failure to so qualify would have (a) a material adverse effect upon the business, properties, operations, financial condition or results of operations of the Company and its subsidiaries, taken as a
            whole, or (b) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under the Transaction Documents (&#8220;<font style="font-family: 'Times New Roman';"><u>Material Adverse Effect</u></font>&#8221;).<a name="BKMK_109"></a> Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective memorandum of association, articles of association, certificate or articles of incorporation, bylaws, operating
            agreement, or other organization or charter documents.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Violations or Defaults</u></font>. Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(b)</u></font>, neither the Company nor any of its subsidiaries (A)&#160;is in
            violation of its respective charters, bylaws or other organizational documents, (B)&#160;is in breach of or otherwise in default and no event has occurred which, with notice or lapse of time or both, would constitute such a default, in the
            performance or observance of any term, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a party or by which it is bound or to which any of
            its material property or assets is subject, or (C)&#160;is in violation in any respect of any law, ordinance, governmental rule, regulation or court order, decree or judgment to which it or its property or assets may be subject, including the
            Sarbanes&#8211;Oxley Act and the Exchange Act; except, in the case of clauses (A), (B)&#160;and (C)&#160;of this paragraph (b), for any breaches, violations or defaults which, singularly or in the aggregate, would not reasonably be expected to have a Material
            Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Authorization; No Conflicts; Authority</u></font>. This Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding obligation of the
            Company, enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar
            laws affecting the rights of creditors generally and subject to general principles of equity. The Registration Rights Agreement has been duly authorized, executed and delivered by the Company, and constitutes a valid, legal and binding
            obligation of the Company, enforceable in accordance with its terms, except as rights to indemnity hereunder may be limited by federal or state securities laws and except as such enforceability may be limited by bankruptcy, insolvency,
            reorganization or similar laws affecting the rights of creditors generally and subject to general principles of equity. The Pre&#8209;Funded Warrants have been duly authorized, and when executed and delivered by the Company, shall constitute a valid,
            legal and binding obligation of the Company, enforceable in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and
            subject to general principles of equity. The execution, delivery and performance of the Transaction Documents and the consummation of the transactions herein and therein contemplated will not (A) conflict with or result in a breach or violation
            of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to any indenture,
            mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the
            Company or any of its subsidiaries is subject and which is material to the Company and its subsidiaries taken as a whole, (B) result in any violation of the provisions of the Company&#8217;s charter or by-laws or (C) result in the violation of any
            law or statute or any judgment, order, rule, regulation or decree of any court or arbitrator or federal, state, local or foreign governmental agency or regulatory authority having jurisdiction over the Company or any of its subsidiaries or any
            of their properties or assets (each, a &#8220;<font style="font-family: 'Times New Roman';"><u>Governmental Authority</u></font>&#8221;), except in the case of clause (A) or (C) as would not result in a Material Adverse Effect. No consent, approval,
            authorization or order of, or registration or filing with any Governmental Authority is required for the execution, delivery and performance of this Agreement or for the consummation of the transactions contemplated hereby, including the
            issuance or sale of the Shares by the Company, except such as may be required under the Securities Act, the rules of the Financial Industry Regulatory Authority (&#8220;<font style="font-family: 'Times New Roman';"><u>FINRA</u></font>&#8221;) or state
            securities or blue sky laws; and the Company has full power and authority to enter into the Transaction Documents and to consummate the transactions contemplated hereby and thereby, including the authorization, issuance and sale of the
            Securities as contemplated by this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Issuance of the Securities</u></font>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully
            paid and nonassessable, free and clear of all Liens imposed by the Company. When paid for and issued in accordance with this Agreement, the Pre&#8209;Funded Warrants will constitute valid and binding obligations of the Company, enforceable against
            the Company in accordance with their respective terms, except&#160;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting the rights of creditors generally and subject to general principles of
            equity. The Pre&#8209;Funded Warrant Shares, when issued in accordance with the terms of the Pre&#8209;Funded Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from
            its duly authorized capital stock the maximum number of Shares issuable pursuant to this Agreement and shall reserve from its duly authorized capital stock the maximum number of Pre&#8209;Funded Warrant Shares issuable pursuant to the Pre&#8209;Funded
            Warrants.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Capitalization</u></font>. The capitalization of the Company as of the time of execution hereof is as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(e</u></font>). As of
            the date hereof, there are 12,288,990&#160;shares of Common Stock issued and outstanding and warrants to purchase 1,552,967 shares of Common Stock have been exercised, but the issuance of such shares of Common Stock has not been completed. All of
            the issued and outstanding shares of capital stock of the Company, including the outstanding shares of Common Stock, are duly authorized and validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state
            and foreign securities laws, were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities that have not been waived in writing, and the holders thereof are not subject to personal
            liability by reason of being such holders; the capital stock of the Company, including the Common Stock, conforms in all material respects to the description thereof in the SEC Reports. Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(e</u></font>), (A) there are no preemptive rights or other rights to subscribe for or to purchase, or any restriction upon the voting or transfer of, any shares of Common Stock pursuant to the Company&#8217;s charter,
            by&#8209;laws or any agreement or other instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound; and (B)&#160;neither the filing of the Registration Statement nor the offering or
            sale of the Securities as contemplated by this Agreement gives rise to any rights for or relating to the registration of any shares of Common Stock or other securities of the Company (collectively &#8220;<font style="font-family: 'Times New Roman';"><u>Registration
                Rights</u></font>&#8221;), except as have been validly waived or complied with in connection with the sale of Securities as contemplated by this Agreement. No further approval or authorization of any stockholder, the Board of Directors or others
            is required for the issuance and sale of the Securities. Except as set forth in the SEC Reports (as defined below), there are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock
            to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&#8217;s stockholders.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>SEC Reports</u></font>. Except as set forth in <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(f)</u></font>, the Company has filed all reports, schedules, forms, statements and other
            documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section&#160;13(a) or 15(d) thereof, for the two (2) years preceding the date hereof (or such shorter period as the Company was
            required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &#8220;<font style="font-family: 'Times New Roman';"><u>SEC Reports</u></font>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports
            complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact
            required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Financial Statements</u></font>. The financial statements of the Company, together with the related notes, set forth or incorporated by reference in the SEC Reports comply in all material respects
            with the requirements of the Securities Act and the Exchange Act and fairly present the financial condition of the Company and its consolidated subsidiaries as of the dates indicated and the results of operations and changes in cash flows for
            the periods therein specified in conformity with generally accepted accounting principles in the United States consistently applied throughout the periods involved; the supporting schedules included in the Registration Statement present fairly
            the information required to be stated therein; all non-GAAP financial information included in the SEC Reports complies with the requirements of Regulation G and Item 10 of Regulation S-K under the Securities Act; and, except as disclosed in the
            SEC Reports, there are no material off-balance sheet arrangements (as defined in Regulation S-K under the Securities Act, Item 303(a)(4)(ii)) or any other relationships with unconsolidated entities or other persons, that may have a material
            current effect or, to the Company&#8217;s knowledge, material future effect on the Company&#8217;s financial condition, results of operations, liquidity, capital expenditures, capital resources or significant components of revenue or expenses. No other
            financial statements or schedules are required to be included in the SEC Reports. To the Company&#8217;s knowledge, the Company&#8217;s independent accounting firm, Frank, Rimerman + Co. LLP, which has expressed its opinion with respect to the financial
            statements and schedules filed as a part of the SEC Reports and included in the SEC Reports is (x)&#160;an independent public accounting firm within the meaning of the Securities Act and the Rules and Regulations, (y)&#160;a registered public accounting
            firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act of 2002 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Sarbanes-Oxley Act</u></font>&#8221;)) and (z) not in violation of the auditor independence requirements of the
            Sarbanes-Oxley Act.<a name="BKMK_111"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Absence of Certain Events; Undisclosed Events, Liabilities or Developments</u></font>. Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(h)</u></font>, subsequent
            to the respective dates as of which information is given in the SEC Reports, neither the Company nor any of its subsidiaries has (i)&#160;incurred any material liabilities, direct or contingent, other than trade payables and accrued expenses
            incurred in the ordinary course of business consistent with past practices and liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to generally accepted accounting principles or disclosed in filings made with
            the SEC; (ii)&#160;declared or paid any dividends or made any distribution of any kind with respect to its capital stock; (iii)&#160;there has not been any change in the capital stock of the Company (other than a change in the number of outstanding
            shares of Common Stock due to the issuance of shares upon the exercise of outstanding options or warrants, settlement of restricted stock units or conversion of convertible securities); (iv)&#160;any issuance of options, warrants, restricted stock
            units, convertible securities or other rights to purchase the capital stock of the Company or any of its subsidiaries, or (v)&#160;any event or development that has had a Material Adverse Effect or any development which could reasonably be expected
            to result in any Material Adverse Effect. Except for (i) the issuance of the Securities contemplated by this Agreement, or (ii) as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(h)</u></font>, no material event,
            liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
            assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed prior to the date that this
            representation is made.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Absence of Proceedings</u></font>. Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(i)</u></font>, there is not pending or, to the knowledge of the Company,
            threatened, any action, suit or proceeding (a)&#160;to which the Company or any of its subsidiaries is a party or (b) which has as the subject thereof any officer or director of the Company or any subsidiary, any employee benefit plan sponsored by
            the Company or any subsidiary or any property or assets owned or leased by the Company or any subsidiary before or by any court or Governmental Authority, or any arbitrator, which, individually or in the aggregate, would reasonably be expected
            to result in any Material Adverse Effect, or would materially and adversely affect the ability of the Company to perform its obligations under the Transaction Documents. There are no current or, to the knowledge of the Company, pending, legal,
            governmental or regulatory actions, suits or proceedings (x) to which the Company or any of its subsidiaries is subject or (y)&#160;which has as the subject thereof any officer or director of the Company or any subsidiary, any employee plan
            sponsored by the Company or any subsidiary or any property or assets owned or leased by the Company or any subsidiary, that are required to be described in the SEC Reports by the Securities Act or by the Rules and Regulations and that have not
            been so described in all material respects.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Labor Relations</u></font>. No material labor dispute with the employees of the Company or any of its subsidiaries exists or, to the Company&#8217;s knowledge, is threatened or imminent, and the Company is
            not aware of any existing or imminent labor disturbance by the employees of any of its or its subsidiaries&#8217; principal suppliers, contractors or customers, that would reasonably be expected to have a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>[Reserved]</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Compliance with Environmental Laws</u></font>. Except as disclosed in the SEC Reports, neither the Company nor any of its subsidiaries is (i) in violation of any statute, any rule, regulation,
            decision or order of any Governmental Authority or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to
            hazardous or toxic substances (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Environmental Laws</u></font>&#8221;), (ii) owns or operates any real property contaminated with any substance that is subject to any environmental laws,
            (iii) is liable for any off-site disposal or contamination pursuant to any Environmental Laws, or (iv) is subject to any claim relating to any Environmental Laws, which violation, contamination, liability or claim would individually or in the
            aggregate, have a Material Adverse Effect.<a name="BKMK_112"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Ownership of Assets</u></font>. The Company and its subsidiaries have good and marketable title to all property (whether real or personal) described in the SEC Reports as being owned by them which is
            material to the Company and its subsidiaries taken as a whole, in each case free and clear of all liens, claims, security interests, other encumbrances or defects except such as are described in the SEC Reports or as would not, individually or
            in the aggregate, be reasonably expected to result in a Material Adverse Effect. The property held under lease by the Company and its subsidiaries is held by them under valid, subsisting and enforceable leases with only such exceptions with
            respect to any particular lease as do not interfere in any material respect with the conduct of the business of the Company or its subsidiaries.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Intellectual Property</u></font> The Company and each of its subsidiaries owns, possesses, or can acquire on reasonable terms, all Intellectual Property (as defined below) necessary for the conduct
            of the Company&#8217;s and it subsidiaries&#8217; business as now conducted or as described in the SEC Reports to be conducted, except as such failure to own, possess, or acquire such rights would not reasonably be expected to result in a Material Adverse
            Effect. Furthermore, except as described in the SEC Reports, (A) to the knowledge of the Company after reasonable investigation (&#8220;<font style="font-family: 'Times New Roman';"><u>Knowledge</u></font>&#8221;), there is no infringement,
            misappropriation or violation by third parties of any such Intellectual Property, except as such infringement, misappropriation or violation would not result in a Material Adverse Effect; (B) there is no pending or, to the Knowledge of the
            Company, threatened, action, suit, proceeding or claim by others challenging the Company&#8217;s or any of its subsidiaries&#8217; rights in or to any such Intellectual Property, and the Company is unaware of any objective facts which would form a
            reasonable basis for any such claim; (C) the Intellectual Property owned by the Company and its subsidiaries, and to the Knowledge of the Company, the Intellectual Property licensed to the Company and its subsidiaries, has not been adjudged
            invalid or unenforceable, in whole or in part, and there is no pending or, to the Knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property; (D) there is
            no pending or, to the Knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or any of its subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property or other proprietary
            rights of others, and neither the Company or any of its subsidiaries has received any written notice of such claim; and (E) to the Company&#8217;s knowledge, no employee of the Company or any of its subsidiaries is in or has ever been in violation of
            any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer where the
            basis of such violation relates to such employee&#8217;s employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed with the Company or any of its subsidiaries, except as such violation would not
            result in a Material Adverse Effect.&#160;&#8220;<font style="font-family: 'Times New Roman';"><u>Intellectual Property</u></font>&#8221; shall mean all patents, patent applications, trademarks, trademark registrations, service marks, service mark
            registrations, trade names, copyrights, copyright registrations, licenses, inventions, trade secrets, Internet domain names, Internet domain name registrations, technology, registrations, trade secret rights, know-how and other intellectual
            property.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Insurance</u></font>. The Company and each of its subsidiaries carries, or is covered by, insurance from insurers of recognized financial responsibility in such amounts and covering such risks as is
            customary for companies engaged in similar businesses in similar industries; all policies of insurance and any fidelity or surety bonds insuring the Company or any of its subsidiaries or its business, assets, employees, officers and directors
            are in full force and effect, except as would not have a Material Adverse Effect; the Company and its subsidiaries are in compliance with the terms of such policies and instruments in all material respects; and neither the Company nor any of
            its subsidiaries has reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a
            cost that would not have a Material Adverse Effect.<a name="BKMK_113"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Internal Accounting Controls</u></font>. The Company and its subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurances that (i)&#160;transactions are
            executed in accordance with management&#8217;s general or specific authorization; (ii)&#160;transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles in the United
            States and to maintain accountability for assets; (iii)&#160;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&#160;the recorded accountability for assets is compared with existing assets at
            reasonable intervals and appropriate action is taken with respect to any differences. Except as set forth in the SEC Reports, since the end of the latest audited fiscal year, there has been no change in the Company&#8217;s internal control over
            financial reporting (whether or not remediated) that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. The Company&#8217;s board of directors has, subject to the
            exceptions, cure periods and the phase in periods specified in the applicable stock exchange rules (<font style="font-family: 'Times New Roman'; font-style: italic;">&#8220;</font><font style="font-family: 'Times New Roman';"><u>Exchange Rules</u></font>&#8221;),
            validly appointed an audit committee to oversee internal accounting controls whose composition satisfies the applicable requirements of the Exchange Rules and the Company&#8217;s board of directors and/or the audit committee has adopted a charter
            that satisfies the requirements of the Exchange Rules.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Fees</u></font>. Except for fees payable to the Placement Agent, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any subsidiary to any broker, financial
            advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. Each Purchaser shall have no obligation with respect to any fees or with respect
            to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Investment Company</u></font>. The Company is not and, after giving effect to the offering and sale of the Securities, will not be an &#8220;investment company,&#8221; as such term is defined in the Investment
            Company Act of 1940, as amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Listing and Maintenance Requirements</u></font>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to
            its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as
            set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(s)</u></font>, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed
            or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in
            compliance with all such listing and maintenance requirements, except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 3.1(s)</u></font>. The Common Stock is currently eligible for electronic transfer through the
            Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Application of Takeover Protections</u></font>. The Company and the Board of Directors have taken all necessary
            action, if any, in order to render inapplicable any control share acquisition, business combination or other similar anti&#8209;takeover provision under the Company&#8217;s certificate of incorporation (or similar charter documents) or the laws of its
            state of incorporation that is or could become applicable to each Purchaser as a result of each Purchaser and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a
            result of the Company&#8217;s issuance of the Securities and the Purchaser&#8217;s ownership of the Securities.<a name="BKMK_114"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font><font style="font-size: 10pt;">&#160;&#160; &#160;
          &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Disclosure</u></font>. Except with respect to the material terms and conditions of the transactions
            contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided to each Purchaser or its agents or counsel with any information that it believes constitutes or might
            constitute material, non-public information which is not otherwise disclosed in the SEC Reports. The Company understands and confirms that each Purchaser will rely on the foregoing representation in effecting transactions in securities of the
            Company. All of the disclosure furnished by or on behalf of the Company to each Purchaser regarding the Company and its subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to
            this Agreement, when taken together as a whole, is true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the
            circumstances under which they were made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those
            specifically set forth in <font style="font-family: 'Times New Roman';"><u>Section 3.2</u></font> hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Integrated Offering</u></font>. Assuming the accuracy of the Purchaser&#8217;s representations and warranties set
            forth in <font style="font-family: 'Times New Roman';"><u>Section 3.2</u></font>, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any
            security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of any applicable stockholder approval provisions of
            any Trading Market on which any of the securities of the Company are listed or designated.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Private Placement</u></font>. Assuming the accuracy of the Purchaser&#8217;s representations and warranties set forth in
            <font style="font-family: 'Times New Roman';"><u>Section 3.2</u></font>, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and
            sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No General Solicitation</u></font>. Neither the Company nor any Person acting on behalf of the Company has offered
            or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other &#8220;accredited investors&#8221; within the meaning of Rule 501 under the
            Securities Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-size: 10pt;"><a name="z_Hlk176480453"></a><font style="font-family: 'Times New Roman';">(y</font><font style="font-size: 10pt; font-family: 'Times New Roman';">)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>[Reserved]</u></font>.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Tax Status</u></font>. The Company and its subsidiaries (A) have timely filed all federal, state, local and foreign
            income and franchise tax returns required to be filed and (B) are not in default in the payment of any taxes which were payable pursuant to said returns or any assessments with respect thereto, other than any which the Company or any of its
            subsidiaries is contesting in good faith; except those, in each of the cases described in clauses (A) and (B) of this paragraph (x), that would not, singularly or in the aggregate, reasonably be expected to have a Material Adverse Effect. There
            is no pending material dispute with any taxing authority relating to any of such returns, and the Company has no knowledge of any proposed material liability for any tax to be imposed upon the properties or assets of the Company for which there
            is not an adequate reserve reflected in the Company&#8217;s financial statements included in the SEC Reports.<a name="BKMK_115"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Anti-Bribery and Anti-Money Laundering Laws</u></font>. Each of the Company, its subsidiaries, its affiliates and
            any of their respective officers, directors, supervisors, managers, agents, or employees, each in their respective roles with the Company, has not violated, its participation in the offering will not violate, and the Company and each of its
            subsidiaries has instituted and maintains policies and procedures designed to ensure continued compliance in all material respects with, each of the following laws: anti-bribery laws, including but not limited to, any applicable law, rule, or
            regulation of any locality in which the Company does business, including but not limited to any applicable law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery of Foreign Public Officials in International
            Business Transactions, signed December&#160;17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977 (the &#8220;<font style="font-family: 'Times New Roman';"><u>FCPA</u></font>&#8221;), as amended, the U.K. Bribery Act 2010 (to the extent
            applicable), or any other applicable law, rule or regulation of similar purposes and scope, or anti-money laundering laws, including but not limited to, applicable federal, state, international, foreign or other laws, regulations or government
            guidance regarding anti-money laundering, including, without limitation, Title 18 US. Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an intergovernmental
            group or organization, such as the Financial Action Task Force on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or organization continues to concur, all as
            amended, and any executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Acknowledgment Regarding Purchaser&#8217;s Purchase of Securities</u></font>. The Company acknowledges and agrees that each Purchaser is acting solely in the capacity of an arm&#8217;s length purchaser with
            respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that each Purchaser is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to
            the Transaction Documents and the transactions contemplated thereby and any advice given by each Purchaser or any of its respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
            is merely incidental to the Purchaser&#8217;s purchase of the Securities. The Company further represents to each Purchaser that the Company&#8217;s decision to enter into this Agreement and the other Transaction Documents has been based solely on the
            independent evaluation of the transactions contemplated hereby by the Company and its representatives.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Acknowledgment Regarding Purchaser&#8217;s Trading Activity</u></font>. Anything in this Agreement or elsewhere herein to
            the contrary notwithstanding (except for <font style="font-family: 'Times New Roman';"><u>Sections&#160;3.2(f)</u></font> and <font style="font-family: 'Times New Roman';"><u>4.14</u></font> hereof), it is understood and acknowledged by the
            Company that: (i)&#160;each Purchaser has not been asked by the Company to agree, nor has each Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &#8220;derivative&#8221; securities based on securities
            issued by the Company or to hold the Securities for any specified term; (ii)&#160;past or future open market or other transactions by the Purchaser, specifically including, without limitation, Short Sales or &#8220;derivative&#8221; transactions, before or
            after the closing of this or future private placement transactions, may negatively impact the market price of the Company&#8217;s publicly-traded securities; (iii)&#160;the Purchaser, and counter-parties in &#8220;derivative&#8221; transactions, if any, to which each
            Purchaser is a party, directly or indirectly, presently may have a &#8220;short&#8221; position in the Common Stock, and (iv)&#160;each Purchaser shall not be deemed to have any affiliation with or control over any arm&#8217;s length counter-party in any &#8220;derivative&#8221;
            transaction. The Company further understands and acknowledges that (y)&#160;each Purchaser may engage in hedging activities at various times during the period that the Securities are outstanding, and (z)&#160;such hedging activities (if any) could reduce
            the value of the existing stockholders&#8217; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of
            any of the Transaction Documents.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Regulation M Compliance</u></font>. The Company has not, and to its knowledge no one acting on its behalf has,
            (i)&#160;taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii)&#160;sold, bid for,
            purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)&#160;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the
            case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Cybersecurity</u></font>. Except as would not, individually or in the aggregate, have a Material Adverse Effect, (i) the Company and the Subsidiaries are presently in compliance with all applicable
            laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of the Company&#8217;s or any
            Subsidiary&#8217;s information technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of it), equipment or
            technology (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>IT Systems and Data</u></font>&#8221;) and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification; (ii) the Company and
            the Subsidiaries have implemented and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data; and
            (iii) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with commercially reasonable industry standards and practices.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Stock Option Plans</u></font>. Except as described in the SEC Reports, there are no options, warrants, restricted stock units, agreements, contracts or other rights in existence to purchase or
            acquire from the Company or any subsidiary of the Company any shares of the capital stock of the Company or any subsidiary of the Company. The description of the Company&#8217;s stock option, stock bonus and other stock plans or arrangements (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company Stock Plans</u></font>&#8221;), and the options (the &#8220;<font style="font-family: 'Times New Roman';"><u>Options</u></font>&#8221;) or other rights granted thereunder, set forth in the SEC Reports
            accurately and fairly presents the information required to be shown with respect to such plans, arrangements, options and rights. Each grant of an Option (A) was duly authorized no later than the date on which the grant of such Option was by
            its terms to be effective by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required shareholder approval by the
            necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto and (B)&#160;was made in accordance in all material respects with the terms of the applicable
            Company Stock Plan, and all applicable laws and regulatory rules or requirements, including all applicable federal securities laws.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(gg)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Office of Foreign Assets Control</u></font>. Neither the Company nor any subsidiary nor, to the Company&#8217;s knowledge, any director, officer, agent, employee or affiliate of the Company or any
            subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<font style="font-family: 'Times New Roman';"><u>OFAC</u></font>&#8221;).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(hh)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>U.S. Real Property Holding Corporation</u></font>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of
            1986, as amended, and the Company shall so certify upon a Purchaser&#8217;s request.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Bank Holding Company Act</u></font>. Neither the Company nor any of its subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>BHCA</u></font>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<font style="font-family: 'Times New Roman';"><u>Federal Reserve</u></font>&#8221;). Neither the Company nor any of its
            subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is
            subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA
            and to regulation by the Federal Reserve.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(jj)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Regulatory</u></font>. Except as described in the SEC Reports and on Schedule&#160;3.1(f), the Company and its Subsidiaries (i)&#160;are and at all times have been in material compliance with all statutes,
            rules and regulations applicable to the Company including, without limitation, the federal Anti-Kickback Statute (42 U.S.C. &#167; 1320a-7b(b)), the regulations promulgated pursuant to such laws, and any successor government programs and comparable
            state laws, and all other local, state, federal, national, supranational and foreign laws, manual provisions, policies and administrative guidance relating to the regulation of the Company (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Applicable Laws</u></font>&#8221;); (ii)&#160;have not received any notice from any court or arbitrator or governmental or regulatory authority or third party alleging or asserting noncompliance with any Applicable Laws or any licenses,
            exemptions, certificates, approvals, clearances, authorizations, permits, registrations and supplements or amendments thereto required by any such Applicable Laws (&#8220;<font style="font-family: 'Times New Roman';"><u>Authorizations</u></font>&#8221;);
            (iii)&#160;possess all material Authorizations and such Authorizations are valid and in full force and effect and are not in violation of any term of any such Authorizations; (iv)&#160;have not received written notice of any claim, action, suit,
            proceeding, hearing, enforcement, investigation arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in violation of any Applicable
            Laws or Authorizations nor is any such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action threatened; (v)&#160;have not received any written notice that any court or arbitrator or governmental or
            regulatory authority has taken, is taking or intends to take, action to limit, suspend, materially modify or revoke any Authorizations nor is any such limitation, suspension, modification or revocation threatened; (vi)&#160;have filed, obtained,
            maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms,
            notices, applications, records, claims, submissions and supplements or amendments were complete and accurate on the date filed (or were corrected or supplemented by a subsequent submission); and (vii)&#160;are not a party to any corporate integrity
            agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">19</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(kk)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Disqualification Events</u></font>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of the Company, any of its predecessors,
            any affiliated issuer, any director, executive officer, other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&#8217;s outstanding voting equity securities, calculated on the basis of
            voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &#8220;<font style="font-family: 'Times New Roman';"><u>Issuer Covered Person</u></font>&#8221;
            and, together, &#8220;<font style="font-family: 'Times New Roman';"><u>Issuer Covered Persons</u></font>&#8221;) is subject to any of the &#8220;<font style="font-family: 'Times New Roman';"><u>Bad Actor</u></font>&#8221; disqualifications described in Rule
            506(d)(1)(i) to (viii) under the Securities Act (a &#8220;<font style="font-family: 'Times New Roman';"><u>Disqualification Event</u></font>&#8221;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised
            reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a
            copy of any disclosures provided thereunder.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ll)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Other Covered Persons</u></font>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly)
            remuneration for solicitation of purchasers in connection with the sale of any Securities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(mm)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notice of Disqualification Events</u></font>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification Event relating to any
            Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating to any Issuer Covered Person.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(nn)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Solvency</u></font>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the
            Securities hereunder, (i)&#160;the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s existing debts and other liabilities (including known contingent liabilities) as
            they mature, (ii)&#160;the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of
            the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)&#160;the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate
            all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts
            beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(oo)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Information Technology</u>. The Company&#8217;s and the Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites,
              applications, and databases (collectively, &#8220;<u>IT Systems</u>&#8221;) operate and perform in all material respects as required in connection with the operation of the business of the Company, the Subsidiaries and the Related Entities as currently
              conducted. The Company and the Subsidiaries maintain commercially reasonable controls, policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation, redundancy
              and security of all IT Systems and all personal, personally identifiable, sensitive, confidential or regulated data (&#8220;<u>Personal Data</u>&#8221;) processed and stored thereon, and to the knowledge of the Company, there have been no breaches,
              incidents, violations, outages, compromises or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal
              review or investigations relating to the same. The Company and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court
              or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from
              unauthorized use, access, misappropriation or modification, except for any such noncompliance that would not have a Material Adverse Effect.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Representations and Warranties of the Purchaser</u></font>. Each Purchaser hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which
            case they shall be accurate as of such date):</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Organization; Authority</u></font>. Each Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its
            incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out
            its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by each Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
            corporate, partnership, limited liability company or similar action, as applicable, on the part of the Purchaser. Each Transaction Document to which it is a party has been duly executed by the Purchaser, and when delivered by each Purchaser in
            accordance with the terms hereof, will constitute the valid and legally binding obligation of the Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy,
            insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other
            equitable remedies and (iii)&#160;insofar as indemnification and contribution provisions may be limited by applicable law.<a name="BKMK_117"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Understandings or Arrangements</u></font>. Each Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other
            persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting the Purchaser&#8217;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable
            federal and state securities laws). Each Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Purchaser Status</u></font>. At the time each Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Pre&#8209;Funded Warrants, it will be
            either: (i) an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) under the Securities Act or (ii) a &#8220;qualified institutional buyer&#8221; as defined in Rule&#160;144A(a) under the Securities Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Experience of the Purchaser</u></font>. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to
            be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Each Purchaser is able to bear the economic risk of an investment in the Securities
            and, at the present time, is able to afford a complete loss of such investment.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No General Solicitation</u></font>. Such Purchaser is not, to such Purchaser&#8217;s knowledge, purchasing the Securities as a result of any advertisement, article, notice or other communication regarding
            the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Access to Information</u></font>. Each Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports
            and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and
            risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii)
            the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Each Purchaser
            acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided each Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.
            Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company
            which each Purchaser agrees need not be provided to it. In connection with the issuance of the Securities to the Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to the Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Transactions and Confidentiality</u></font>. Other than consummating the transactions contemplated hereunder, each Purchaser has not, nor has any Person acting on behalf of or pursuant to any
            understanding with the Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that each Purchaser first received a term sheet
            (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, (A)
            in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of
            assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement, and (B) in the case of a Purchaser that has implemented internal information&#160; barriers pursuant to information
            controls policy to &#8220;wall-off&#8221; certain trading personnel, the representations set forth above shall only apply to such walled-off trading personnel. Other than to other Persons party to this Agreement or to the Purchaser&#8217;s representatives,
            including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, each Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction
            (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or
            borrowing shares in order to effect Short Sales or similar transactions in the future.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Brokers</u></font>. No agent, broker, investment banker, person or firm acting in a similar capacity on behalf of or under the authority of the Purchaser is or will be entitled to any broker&#8217;s or
            finder&#8217;s fee or any other commission or similar fee, directly or indirectly, for which the Company or any of its Affiliates after the Closing could have any liabilities in connection with this Agreement, any of the transactions contemplated by
            this Agreement, or on account of any action taken by the Purchaser in connection with the transactions contemplated by this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Independent Advice</u></font>. Each Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the
            purchase of the Securities constitutes legal, tax or investment advice.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company acknowledges and agrees that the representations contained in this <font style="font-family: 'Times New Roman';"><u>Section&#160;3.2</u></font>
        shall not modify, amend or affect the Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or
        instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a
        representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.<a name="BKMK_118"></a></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IV.<font style="font-family: 'Times New Roman';"><br>
        </font>OTHER AGREEMENTS OF THE PARTIES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Transfer Restrictions</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Securities may
            only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule&#160;144, to the Company or to an Affiliate of a Purchaser or
            in connection with a pledge as contemplated in <font style="font-family: 'Times New Roman';"><u>Section 4.1(b)</u></font>, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the
            transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under
            the Securities Act. As a condition of transfer (other than pursuant to an effective Registration Statement or Rule 144A), any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights
            Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Purchasers
            agree to the imprinting, so long as is required by this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.1</u></font>, of a legend on any of the Securities in the following form:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
        EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#8220;SECURITIES ACT&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
        AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
        WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE&#160;501(A) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
        broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &#8220;accredited investor&#8221; as defined in Rule&#160;501(a) under the Securities Act and, if required under the terms of such arrangement, such
        Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall
        be required in connection therewith. Further, no notice shall be required of such pledge. At the Company&#8217;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably
        request in connection with a pledge or transfer of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required prospectus supplement under Rule
        424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Certificates
            evidencing the Shares and Pre&#8209;Funded Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such
            security is effective under the Securities Act, (ii)&#160;following any sale of such Shares or Pre&#8209;Funded Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Pre&#8209;Funded Warrants), (iii)&#160;if requested by a Purchaser, if such Shares
            or Pre&#8209;Funded Warrant Shares are eligible for sale under Rule&#160;144 (assuming cashless exercise of the Pre&#8209;Funded Warrants) or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial
            interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly after the Effective Date if required by the Transfer Agent
            to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion of a Pre&#8209;Funded Warrant is exercised at a time when there is an effective registration statement to cover the resale of the
            Pre&#8209;Funded Warrant Shares, or if such Shares or Pre&#8209;Funded Warrant Shares may be sold under Rule&#160;144 and the Company is then in compliance with the current public information required under Rule&#160;144 (assuming cashless exercise of the Pre&#8209;Funded
            Warrants), or if the Shares or Pre&#8209;Funded Warrant Shares may be sold under Rule&#160;144 without the requirement for the Company to be in compliance with the current public information required under Rule&#160;144 as to such Shares or Pre&#8209;Funded Warrant
            Shares or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Pre&#8209;Funded Warrant Shares shall be
            issued free of all legends. The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder or if reasonably
            required by a Purchaser. The Company agrees that following the Effective Date, it will, no later than the earlier of (i)&#160;one (1) Trading Day and (ii)&#160;the number of Trading Days comprising the Standard Settlement Period (as defined below)
            following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Pre&#8209;Funded Warrant Shares, as the case may be, issued with a restrictive legend (such date, the &#8220;<font style="font-family: 'Times New Roman';"><u>Legend Removal Date</u></font>&#8221;), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its
            records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this <font style="font-family: 'Times New Roman';"><u>Section&#160;4</u></font>. Certificates for Securities subject to legend removal
            hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&#8217;s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &#8220;<font style="font-family: 'Times New Roman';"><u>Standard Settlement Period</u></font>&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of
            delivery of a certificate representing Shares or Pre&#8209;Funded Warrant Shares, as the case may be, issued with a restrictive legend. Notwithstanding anything herin to the contrary, all fees and expenses incurred in connection with the removal of
            any legends shall be paid by the Company.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, (i)&#160;as partial
        liquidated damages and not as a penalty, for each $1,000 of Shares or Pre&#8209;Funded Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend
        and subject to Section&#160;4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and
        (ii)&#160;if the Company fails to (a)&#160;issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and
        other legends and (b)&#160;if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
        of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock, that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to
        the excess of such Purchaser&#8217;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any)
        (the &#8220;<font style="font-family: 'Times New Roman';"><u>Buy-In Price</u></font>&#8221;) over the product of (A) such number of Shares or Pre&#8209;Funded Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date
        multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Pre&#8209;Funded Warrant Shares (as the case may
        be) and ending on the date of such delivery and payment under this Section 4.1(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Each Purchaser,
            severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery
            requirements, or an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the restrictive
            legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company&#8217;s reliance upon this understanding.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Furnishing of Information; Public Information</u></font>. Until the time that no Purchaser owns Securities, the Company covenants to maintain the registration of the Common Stock under Section&#160;12(b) or 12(g) of the Exchange Act
            and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act, even if the Company is not then subject
            to the reporting requirements of the Exchange Act, except in the event that the Company consummates (a)&#160;any transaction or series of related transactions as a result of which any Person (together with its Affiliates) acquires then outstanding
            securities of the Company representing more than fifty percent (50%) of the voting control of the Company; (b)&#160;a merger or reorganization of the Company with one or more other entities in which the Company is not the surviving entity; or (c)&#160;a
            sale of all or substantially all of the assets of the Company, where the consummation of such transaction results in the Company no longer subject to the reporting requirements of the Exchange Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Integration</u></font>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer
            or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing
            of such subsequent transaction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">26</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Securities Laws Disclosure; Publicity</u></font>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form
            8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have
            publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without
            limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. The Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide each Purchaser or its
            respective agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto each Purchaser shall have consented to the receipt of such information and
            agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. In addition, effective
            upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its subsidiaries or any of their
            respective officers, directors, agents, employees or Affiliates on the one hand, and each Purchaser or any of its Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms that each
            Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions
            contemplated hereby, and neither the Company nor each Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of the Purchaser, or
            without the prior consent of the Purchaser, with respect to any press release of the Company which names the Purchaser, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the
            disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of the Purchaser, or include the name of each
            Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of the Purchaser, except (a) as required by federal securities law in connection with (i) any registration statement
            contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall
            provide each Purchaser with prior notice of such disclosure permitted under this clause (b).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.</font><font style="font-size: 10pt;"><a name="BKMK_120"></a><font style="font-family: 'Times New Roman';">5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">[Reserved].</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Furnishing of Information</u></font>. The Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
            pursuant to the Exchange Act, even if the Company is not then subject to the reporting requirements of the Exchange Act, except in the event that the Company consummates: (a) any transaction or series of related transactions as a result of
            which any Person (together with its Affiliates) acquires then outstanding securities of the Company representing more than fifty percent (50%) of the voting control of the Company; (b) a merger or reorganization of the Company with one or more
            other entities in which the Company is not the surviving entity; or (c) a sale of all or substantially all of the assets of the Company, where the consummation of such transaction results in the Company no longer being subject to the reporting
            requirements of the Exchange Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">27</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
        may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information
        requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule&#160;144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &#8220;<font style="font-family: 'Times New Roman';"><u>Public Information Failure</u></font>&#8221;) then, in addition to such Purchaser&#8217;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay
        in or reduction of its ability to sell the Securities, an amount in cash equal to one and one-half percent (1.5%) of the Subscription Amount of such Purchaser&#8217;s Securities on the day of a Public Information Failure and on every thirtieth (30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>)
        day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer the
        Shares and Pre&#8209;Funded Warrant Shares pursuant to Rule 144, provided, however, that in no event will the aggregate amount of liquidated damages paid by the Company to a Purchaser exceed twelve percent (12%) of such Purchaser&#8217;s Subscription Amount.
        The payments to which a Purchaser shall be entitled pursuant to this Section 4.6 are referred to herein as &#8220;<font style="font-family: 'Times New Roman';"><u>Public Information Failure Payments</u></font>.&#8221; Public Information Failure Payments shall
        be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup>) Business Day after the event or failure giving rise to the Public Information
        Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until
        paid in full. Nothing herein shall limit such Purchaser&#8217;s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without
        limitation, a decree of specific performance and/or injunctive relief.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Use of Proceeds</u></font>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes, which shall include repayment of principal on the Company&#8217;s indebtedness, capital
            expenditures, and funding its working capital needs, but shall not use such proceeds in violation of FCPA or OFAC regulations.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">28</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Indemnification of the Purchaser</u></font>. Subject to the provisions of this <font style="font-family: 'Times New Roman';"><u>Section&#160;4.8</u></font>, the Company will indemnify and hold each Purchaser and its directors,
            officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls each
            Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role
            of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Party</u></font>&#8221;) harmless from any and all losses,
            liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer
            or incur as a result of or relating to (a) any material breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against
            each Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction
            Documents (unless such action is solely based upon a material breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any
            such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in
            connection with the Registration Statement the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without
            limitation, reasonable attorneys&#8217; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or
            in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case
            of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information
            regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law,
            or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the
            Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to each Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any
            such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company
            in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the
            position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company may not settle, compromise or consent
            to the entry of any judgment in any pending or threatened action in which indemnification may be sought by any Purchaser Party hereunder (whether or not any Purchaser Party is an actual or potential party thereto), without the prior written
            consent of each such Purchaser party (which will not be unreasonably delayed or withheld) unless such settlement, compromise or consent provides for an unconditional and irrevocable release of each such Purchaser Party from any and all
            liability arising out of such claim. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably
            withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser
            Party in this Agreement or in the other Transaction Documents. The indemnification required by this <font style="font-family: 'Times New Roman';"><u>Section 4.8</u></font> shall be made by periodic payments of the amount thereof during the
            course of the investigation or defense, as and when bills are received or are incurred; provided, however, that if it is subsequently determined by a final, non-appealable judgment of a court of competent jurisdiction that each Purchaser was
            not entitled to receive such payments, each Purchaser shall promptly (but in no event later than five (5) Business Days) return such payments to the Company. The indemnity agreements contained herein shall be in addition to any cause of action
            or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">29</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Reservation of Common Stock</u></font>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common
            Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and the Pre&#8209;Funded Warrant Shares pursuant to any exercise of the Pre&#8209;Funded Warrants.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Listing of Common Stock</u></font>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently
            with the Closing, the Company shall apply to list or quote all of the Shares and Pre&#8209;Funded Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Pre&#8209;Funded Warrant Shares on such Trading Market. The
            Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Pre&#8209;Funded Warrant Shares, and will take such other action as is
            necessary to cause all of the Shares and Pre&#8209;Funded Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of
            its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to use commercially reasonable efforts to
            maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or
            such other established clearing corporation in connection with such electronic transfer.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>[Reserved].</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Subsequent Equity Sales</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">From the date
            hereof until five (5) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock
            Equivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Registration Statement pursuant to the Registration Rights Agreement or filing a registration statement on Form&#160;S&#8209;8 in connection with any
            employee benefit plan. Notwithstanding the foregoing restrictions, the Company may at any time (i)&#160;file amendments or supplements to the Company&#8217;s registration statement on Form&#160;S-3 (File No.&#160;333-296218) or (ii)&#160;enter into and/or issue shares
            of Common Stock at a price no less than $20.00 per share in an &#8220;at the market&#8221; offering with the Placement Agent as sales agent.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">30</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">From the date
            hereof until thirty (30) days after the Effective Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents
            (or a combination of units thereof) involving a Variable Rate Transaction. &#8220;<font style="font-family: 'Times New Roman';"><u>Variable Rate Transaction</u></font>&#8221; means a transaction in which the Company (i) issues or sells any debt or equity
            securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or
            varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some
            future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters
            into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an &#8220;at-the-market offering&#8221;, whereby the Company may issue securities at a future determined price regardless of whether shares
            pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;<u>provided</u>, <u>however</u>, that </font>the
            following <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">shall not be deemed a Variable Rate Transaction: (i)&#160;the entry into and/or issuance of shares of Common Stock </font>at a price no less than $20.00 per share <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">in an &#8220;at the market offering&#8221; with the Placement Agent as sales agent, (ii) the entry into and/or issuance of shares of Common Stock at any price in an &#8220;at the market offering&#8221;
              with the Placement Agent as sales agent following the fifth (5</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">) day after the Effective Date and (iii)</font>&#160;any transaction
            involving the issuance shares of Common Stock or Common Stock Equivalents to the Purchasers<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font> Any Purchaser shall be entitled to obtain injunctive relief against the
            Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Notwithstanding
            the foregoing, this <font style="font-family: 'Times New Roman';"><u>Section 4.12</u></font> shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.13</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Equal Treatment of Purchasers.</u></font> No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the
            Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and
            negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or
            voting of Securities or otherwise.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">31</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.14</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Certain Transactions and Confidentiality</u></font>. Each Purchaser covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
            Sales of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
            release as described in <font style="font-family: 'Times New Roman';"><u>Section 4.4</u></font>. Each Purchaser covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to
            the initial press release as described in <font style="font-family: 'Times New Roman';"><u>Section 4.4</u></font>, each Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in
            the Disclosure Schedules. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) each Purchaser makes no representation, warranty or
            covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
            described in <u>Section 4.4</u>, (ii) each Purchaser shall not be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that
            the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in <font style="font-family: 'Times New Roman';"><u>Section 4.4</u></font>, and (iii) each Purchaser shall not have
            any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its subsidiaries after the issuance of the initial press release as described in <font style="font-family: 'Times New Roman';"><u>Section 4.4</u></font>.
            Notwithstanding the foregoing, (A) in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets, the covenant set forth above shall only apply with
            respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement, and (B) in the case of a Purchaser that has implemented internal information barriers
            pursuant to information controls policy to &#8220;wall-off&#8221; certain trading personnel, this Section 4.13 shall apply only with respect to activities of such walled-off trading personnel.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.15</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Reserved<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.16</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Exercise Procedures</u></font>. The form of Notice of Exercise included in the Pre&#8209;Funded Warrants set forth the totality of the procedures required of each Purchaser in order to exercise the Pre&#8209;Funded Warrants. No additional
            legal opinion, other information or instructions shall be required of each Purchaser to exercise its Pre&#8209;Funded Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion
            guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Pre&#8209;Funded Warrants. The Company shall honor exercises of the Pre&#8209;Funded Warrants and shall deliver Pre&#8209;Funded Warrant
            Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.17</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Lock-Up Agreements</u></font>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up
            Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.18</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Form D; Blue Sky Filings</u></font>. If applicable, the Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser.
            The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the&#160;Securities&#160;for, sale to the Purchasers at the Closing under applicable securities or &#8220;Blue Sky&#8221;
            laws of the states of the United States, and shall provide evidence of such actions (if any, depending on the Company&#8217;s determination) promptly upon request of any Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">32</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.19</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Capital Changes</u></font>. From the date hereof until ninety (90) days after the Closing Date, the Company shall not undertake a reverse or forward stock split or reclassification of the Common Stock without the prior written
            consent of the Purchasers holding a majority in interest of the Securities, except for any reverse or forward stock split or reclassification previously approved by the Company&#8217;s stockholders and expressly contemplated by the SEC Reports.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.20</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>SEC Filings; Registration Statement</u></font>. As soon as practicable, the Company shall file with the Commission (i) all reports, schedules, forms, statements and other documents required to be filed by the Company under the
            Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, and (ii) the Registration Statement on Form S-1 (or, if Form S-1 is not then available to the Company, on such form of registration statement as is then
            available) pursuant to the terms of the Registration Rights Agreement providing for the registration of the Securities, and in any event no later than ten (10) calendar days of the date of this Agreement. The Company shall use commercially
            reasonable efforts to cause such Registration Statement to become effective within fifteen (15) days following the date of the Registration Rights Agreement (or within thirty (30) calendar days following the date of the Registration Rights
            Agreement in the event of a &#8220;limited review&#8221; by the Commission of the Registration Statement or within forty-five (45) calendar days following the date of the Registration Rights Agreement in the event of a &#8220;full review&#8221; by the Commission of
            the Registration Statement) and to keep such registration statement effective at all times until no Purchaser owns any Securities</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE V.<font style="font-family: 'Times New Roman';"><br>
        </font>MISCELLANEOUS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Termination</u></font>. This Agreement may be terminated by each Purchaser by written notice to the Company, if the Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; provided,
            however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Fees and Expenses</u></font>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other
            expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day
            processing of any instruction letter delivered by the Company and any exercise notice delivered by the Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchaser.<a name="BKMK_123"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all
            prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">33</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Notices</u></font>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of
            transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a
            Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
            hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the first (1st) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d)
            upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto and any and all such notices or other communications or
            deliveries must be provided to each of the addresses identified on the signature pages attached hereto to be deemed given and effective with respect to any party hereto. To the extent that any notice provided pursuant to any Transaction
            Document constitutes, or contains, material, non-public information regarding the Company or any subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Amendments; Waivers</u></font>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchaser. No waiver of any
            default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof,
            nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Headings</u></font>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations
            hereunder without the prior written consent of each Purchaser (other than by merger). Each Purchaser may assign any or all of its rights under this Agreement to any Person to whom each Purchaser assigns or transfers any Securities, provided
            that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the &#8220;Purchaser.&#8221;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>No Third-Party Beneficiaries</u></font>. The Placement Agent shall be the third-party beneficiary of the representations and warranties of the Company in <font style="font-family: 'Times New Roman';"><u>Section 3.1</u></font> and
            the representations and warranties of each Purchaser in <font style="font-family: 'Times New Roman';"><u>Section 3.2</u></font>. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
            assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in <font style="font-family: 'Times New Roman';"><u>Section 4.8</u></font> and this <font style="font-family: 'Times New Roman';"><u>Section 5.8</u></font>.<a name="BKMK_124"></a></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">34</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Governing Law</u></font>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the
            State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any
            other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting
            in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection
            herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any
            claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and
            consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
            Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If
            any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under <font style="font-family: 'Times New Roman';"><u>Section 4.8</u></font>, the
            prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or
            Proceeding.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Survival</u></font>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Execution</u></font>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by
            each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file,
            such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Severability</u></font>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions,
            covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative
            means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the
            remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">35</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.13</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Recission and Withdrawal Right</u></font>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right,
            election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time
            upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that, in the case of a rescission of an exercise of a Warrant, the applicable
            Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the
            restoration of such Purchaser&#8217;s right to acquire such shares pursuant to such Purchaser&#8217;s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.14</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Replacement of Securities</u></font>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon
            cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The
            applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.15</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Remedies</u></font>. In addition to being entitled to exercise all rights provided herein or granted by aw, including recovery of damages, each Purchaser and the Company will be entitled to specific performance under the
            Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in
            any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.16</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Payment Set Aside</u></font>. To the extent that the Company makes a payment or payments to each Purchaser pursuant to any Transaction Document or each Purchaser enforces or exercises its rights thereunder, and such payment or
            payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise
            restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the
            obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.17</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Saturdays, Sundays, Holidays, etc.</u></font> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such
            right may be exercised on the next succeeding Business Day.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">36</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.18</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Independent Nature of Purchaser&#8217;s Obligations and Rights</u></font>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be
            responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant
            hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with
            respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement
            or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in
            its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through Blank Rome LLP, the legal counsel of the
            Placement Agent, and Blank Rome LLP, as legal counsel of the Placement Agent, does not represent any of the Purchasers and only represents the Placement Agent The Company has elected to provide all Purchasers with the same terms and Transaction
            Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction
            Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.19</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Liquidated Damages</u></font>. The Company&#8217;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all
            unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.20</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Construction</u></font>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect
            that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common
            Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.21</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; font-weight: bold;"><u>WAIVER OF JURY TRIAL</u>. <u>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED
                BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</u></font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature pages follow.</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">37</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 64.8pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zfa6eeb489bd04981bb2c7c94ff9b3b08">

          <tr>
            <td colspan="2" style="vertical-align: top;" rowspan="2">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><a name="BKMK_128"></a><a name="BKMK_127"></a>MOMENTUS INC.</div>
              <div style="font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;" rowspan="2">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Address for Notice:</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
            <td style="width: 22.5%; vertical-align: top; font-size: 10pt;" rowspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman'; font-size: 10pt;">1762 Automation Parkway</div>
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman'; font-size: 10pt;">San Jose, California 95131</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Fax:</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Name: John Rood</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">E-mail: [***]</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">Title: Chief Executive Officer</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-size: 10pt;">With a copy to (which shall not constitute notice):</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td rowspan="1" style="vertical-align: top; font-size: 10pt;" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-size: 10pt;">Bradley Arant Boult Cummings LLP</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">1221 Broadway, Suite 2400</div>
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Nashville, TN 37203</div>
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-size: 10pt;">Attn: Stephen Hinton</div>
              <div style="text-align: left; margin-right: 1.8pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: <font style="font-family: 'Times New Roman';">[***]</font></div>
              <div style="font-size: 10pt;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
            <td style="vertical-align: top; font-size: 10pt;" colspan="3">
              <div style="text-align: left; margin-right: 0.8pt; font-family: 'Times New Roman';">&#160;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
        as of the date first indicated above.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" id="z71c1d7f831744674b1e29d1f7da669b9" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 13%; padding-bottom: 2px;">Name of Purchaser:</td>
              <td style="width: 87%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature of Authorized Signatory of Purchaser</font><font style="font-size: 10pt;">:</font></td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Name of Authorized Signatory:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Title of Authorized Signatory:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Email Address of Authorized Signatory:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Facsimile Number of Authorized Signatory:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Address for Notice to Purchaser:</td>
              <td style="width: 80%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>Address for Delivery of Pre&#8209;Funded Warrants to Purchaser (if not same as address for notice): </div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 100%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 15%; padding-bottom: 2px;">Subscription Amount:</td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);">$<br>
              </td>
              <td style="width: 65%; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">Shares:</td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td colspan="1" style="width: 75%; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z8816e717ab7640959b197e11af523ed5">

              <tr>
                <td style="width: 9%; padding-bottom: 2px;">
                  <div>&#160;Pre-Funded Warrant Shares: </div>
                </td>
                <td style="width: 5%; border-bottom: 2px solid rgb(0, 0, 0);">
                  <div>&#160;</div>
                </td>
                <td style="width: 33.33%; padding-bottom: 2px;">
                  <div>&#160;Beneficial Ownership Blocker <font style="font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font> 4.99% or <font style="font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font> 9.99% </div>
                </td>
              </tr>

          </table>
        </div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td nowrap="nowrap" style="width: 5%; padding-bottom: 2px;">EIN Number:</td>
              <td style="width: 20%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td colspan="1" style="width: 75%; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font><font style="font-size: 10pt;">&#160; Notwithstanding anything contained in this Agreement
          to the contrary, by checking this box (i) the obligations of the above-signed&#160;to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities
          to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur by the first (1st) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by
          this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition
          and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt;"> <br>
        </font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit A<font style="font-family: 'Times New Roman';"><br>
          <br>
          <u>Form of Pre-Funded Warrant</u></font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;<font style="font-family: 'Times New Roman'; font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(See attached)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit B<font style="font-family: 'Times New Roman';"><br>
          <br>
          <u>Form of Lock-Up Agreement</u></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(See attached)</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit C<font style="font-family: 'Times New Roman';"><br>
          <br>
          <u>Form of Registration Rights Agreement</u></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(See attached)</div>
      <div style="font-size: 10pt;">
        <div><br>
        </div>
        <br>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ef20075150_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%--> <font style="font-size: 10pt;"> </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-size: 10pt;"><font style="font-weight: bold;">Exhibit 10.2</font><br>
      </font></div>
    <div> <font style="font-size: 10pt;"><br>
      </font></div>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REGISTRATION RIGHTS AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Registration Rights Agreement (this &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is made and entered into as of
        May&#160;26, 2026, between Momentus Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), and each of the several purchasers signatory hereto (each such purchaser, a &#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser</u></font>&#8221; and, collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchasers</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Agreement</u></font>&#8221;).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company and each Purchaser hereby agrees as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z676ebd1d6b604faead0297c8c9526009">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definitions</u></font><font style="font-size: 10pt;">. <font style="font-family: 'Times New Roman'; font-weight: bold;">Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement</font>. As used in this Agreement, the following terms shall
                  have the following meanings:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Advice</u></font>&#8221; shall have the meaning set forth in Section 6(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Cutback Registration Statement</u></font>&#8221; shall have the meaning set forth in
        Section 2(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Effectiveness Date</u></font>&#8221; means, with respect to the Initial Registration
        Statement required to be filed hereunder, the closing of business, Eastern Time, on the 15th calendar day following the date hereof (or, in the event of a &#8220;limited review&#8221; by the Commission, the 30th calendar day following the date hereof or, in
        the event of a &#8220;full review&#8221; by the Commission, the 45th calendar day following the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c) (including any Cutback
        Registration Statement), the 30th calendar day following the date on which an additional Registration Statement is required to be filed hereunder (or, in the event of a &#8220;full review&#8221; by the Commission, the 45th calendar day following the date such
        additional Registration Statement is required to be filed hereunder); <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that in the event the Company is
        notified by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the 2nd Trading Day
        following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next
        succeeding Trading Day.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Effectiveness Period</u></font>&#8221; shall have the meaning set forth in Section
        2(a).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Event</u></font>&#8221; shall have the meaning set forth in Section 2(d).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Event Date</u></font>&#8221; shall have the meaning set forth in Section 2(d).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Filing Date</u></font>&#8221; means, with respect to the Initial Registration
        Statement required hereunder, the tenth (10th) Trading Day following the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the earliest practical date on which
        the Company is permitted by SEC Guidance to file such additional Registration Statement related to the Registrable Securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Holder</u></font>&#8221; or &#8220;<font style="font-family: 'Times New Roman';"><u>Holders</u></font>&#8221;
        means the holder or holders, as the case may be, from time to time of Registrable Securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Indemnified Party</u></font>&#8221; shall have the meaning set forth in Section
        5(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Indemnifying Party</u></font>&#8221; shall have the meaning set forth in Section
        5(c).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Initial Registration Statement</u></font>&#8221; means the initial Registration
        Statement filed pursuant to this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Losses</u></font>&#8221; shall have the meaning set forth in Section 5(a).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Plan of Distribution</u></font>&#8221; shall have the meaning set forth in Section
        2(a).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Prospectus</u></font>&#8221; means the prospectus included in a Registration
        Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule&#160;430A promulgated by the Commission pursuant to the
        Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the
        Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Registrable Securities</u></font>&#8221; means, as of any date of determination, (a)
        all of the shares of Common Stock or shares of Common Stock underlying the Pre-Funded Warrants (&#8220;<font style="font-family: 'Times New Roman';"><u>Shares</u></font>&#8221;) purchased pursuant to the Purchase Agreement, (b) all Pre&#8209;Funded Warrant Shares
        then issued and issuable upon exercise of the Pre&#8209;Funded Warrants (assuming on such date the Pre&#8209;Funded Warrants are exercised in full for cash without regard to any exercise limitations therein) purchased pursuant to the Purchase Agreement,
        (d)&#160;any additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the Pre&#8209;Funded Warrants (without giving effect to any limitations on exercise set forth in the Pre&#8209;Funded Warrants) and (e) any
        securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; <font style="font-family: 'Times New Roman';"><u>provided,</u></font>&#160;<font style="font-family: 'Times New Roman';"><u>however</u></font>, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness of any, or file another,
        Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable
        Securities have been disposed of by the Holder in accordance with such effective Registration Statement, (b)&#160;such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible for resale
        without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders
        (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company, and all
        Warrants are exercised by &#8220;cashless exercise&#8221; as provided in Section 2(c) of each of the Pre&#8209;Funded Warrants), as reasonably determined by the Company, upon the advice of counsel to the Company.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221; means any registration statement required
        to be filed hereunder pursuant to Section 2(a) and any additional registration statements contemplated by Section&#160;2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such registration statement or
        Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in any such registration statement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Rule 415</u></font>&#8221; means Rule 415 promulgated by the Commission pursuant to
        the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Rule 424</u></font>&#8221; means Rule 424 promulgated by the Commission pursuant to
        the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>SEC Guidance</u></font>&#8221; means (i) any publicly-available written or oral
        guidance of the Commission staff, or any comments, requirements or requests of the Commission staff and (ii) the Securities Act.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 54pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Selling Stockholder Questionnaire</u></font>&#8221; shall have the meaning set forth
        in Section 3(a).</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaf3043985c54464f8da9f8f79bd708c9">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Rights</u></font><font style="font-size: 10pt;">.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc00b6abf9f38457f986d78e9b536c2b1">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the Registrable Securities that are not then
                registered on an effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to
                register for resale the Registrable Securities on Form S-3 (which is the case as of the date hereof), in which case such registration shall be on another appropriate form in accordance herewith, subject to the provisions of Section 2(e))
                and shall contain (unless otherwise directed by at least 85% in interest of the Holders) substantially the &#8220;<font style="font-family: 'Times New Roman';"><u>Plan of Distribution</u></font>&#8221; attached hereto as <font style="font-family: 'Times New Roman';"><u>Annex&#160;A</u></font> and substantially the &#8220;<font style="font-family: 'Times New Roman';"><u>Selling Stockholder</u></font>&#8221; section attached hereto as <font style="font-family: 'Times New Roman';"><u>Annex</u></font>&#160;<font style="font-family: 'Times New Roman';"><u>B</u></font>; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that no Holder shall be required to be
                named as an &#8220;underwriter&#8221; without such Holder&#8217;s express prior written consent. Subject to the terms of this Agreement, the Company shall use commercially reasonable efforts to cause a Registration Statement filed under this Agreement
                (including, without limitation, under Section&#160;3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use
                commercially reasonable efforts to keep such Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement (i) have been sold, thereunder or
                pursuant to Rule 144, or (ii)&#160;may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144, as
                determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders (the &#8220;<font style="font-family: 'Times New Roman';"><u>Effectiveness
                    Period</u></font>&#8221;). The Company shall telephonically request effectiveness of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via facsimile or by e-mail
                of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The
                Company shall, by 9:30 a.m. (New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by Rule&#160;424. Failure to so notify the Holder within one (1)
                Trading Day of such notification of effectiveness or failure to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf987d3a1999e4837b4423dc370914461">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule
                415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the Initial
                Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable
                Securities as a secondary offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that prior to filing such amendment, the Company shall be obligated to use commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable
                Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2dfe7a46a3dd4e74818d892cd09a25f9">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(13, 13, 13); font-family: 'Times New Roman';">Notwithstanding any other provision of this Agreement, if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be
                registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used commercially reasonable efforts to advocate with the Commission for the registration of all or a greater portion of
                Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9033aa9835a14f3b9eafaff7a3688e68">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">a.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="color: rgb(13, 13, 13); font-family: 'Times New Roman';">First, the Company shall reduce or eliminate any securities to be included other than Registrable Securities; and</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfc7cceeabb8949f3be6150b2ba9c7a21">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">b.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(13, 13, 13);">Second, the Company shall reduce Registrable Securities represented by </font><font style="font-size: 10pt;">Pre&#8209;Funded <font style="font-family: 'Times New Roman'; color: rgb(13, 13, 13);">Warrant Shares (applied, in the case that some </font>Pre&#8209;Funded <font style="font-family: 'Times New Roman'; color: rgb(13, 13, 13);">Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered </font>Pre&#8209;Funded <font style="font-family: 'Times New Roman'; color: rgb(13, 13, 13);">Warrant Shares held by such
                    Holders.</font></font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(13, 13, 13);">In the event of a cutback hereunder, the Company shall give
          the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&#8217;s allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use
          its </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to
          registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as
          amended (the &#8220;<u>Cutback Registration Statement</u>&#8221;).</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf9a996e86dd7409dace3493ced7e542d">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without affording the Holders the opportunity to
                review and comment on the same as required by Section 3(a) herein, the Company shall be deemed to have not satisfied this clause (i)), or (ii) if the Cutback Registration Statement, if applicable, is not filed <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general</font> or (iii)&#160;the Company fails to file with the Commission a request for
                acceleration of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is notified (orally or in writing, whichever is
                earlier) by the Commission that such Registration Statement will not be &#8220;reviewed&#8221; or will not be subject to further review, or (iv)&#160;prior to the effective date of a Registration Statement, the Company fails to file a pre-effective
                amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is
                required in order for such Registration Statement to be declared effective, or (v)&#160;a Registration Statement (including the Initial Registration Statement or any Cutback Registration Statement) is not declared effective by the Commission by
                the applicable Effectiveness Date, or (vi) after the effective date of a Registration Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such
                Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar
                days (which need not be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &#8220;<font style="font-family: 'Times New Roman';"><u>Event</u></font>&#8221;, and for purposes of clauses (i) and (v),
                the date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for purpose of clause (iv)&#160;the date which such ten (10) calendar day period is exceeded, and for purpose
                of clause (vi)&#160;the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &#8220;<font style="font-family: 'Times New Roman';"><u>Event Date</u></font>&#8221;), then, in addition to any other
                rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is
                cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.5% multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase
                Agreement. The parties agree that the maximum aggregate liquidated damages payable to a Holder under this Agreement shall be 10.5% of the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company
                fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be
                paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof
                shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf13282f4426a4eedae03d5d3aa2f1405">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of the Registrable Securities on another appropriate
                form and (ii) undertake to register the Registrable Securities on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until such time as a
                Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission. It is acknowledged that, notwithstanding anything herein to the contrary, as of the date hereof, the Company is not
                eligible to use Form S-3 to register the resale of the Registrable Securities.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2dde2749174f49ffa35a0294b21daf0d">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as any Underwriter without the prior written
                consent of such Holder.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zacdddb81a70c4971905ee0637dd89b8c">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Procedures</u></font><font style="font-size: 10pt;">. In connection with the Company&#8217;s registration
                  obligations hereunder, the Company shall:</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdb01efe2307446aea8c5627b30d6ab3e">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of any related Prospectus or any amendment or
                supplement thereto (including any document that would be incorporated or deemed to be incorporated therein by reference), the Company shall (i)&#160;furnish to each Holder copies of all such documents proposed to be filed, which documents (other
                than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries
                as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act; provided, that the Company shall redact any sections of such documents
                that may contain material non-public information unless the Holder consents in writing to receive such information and agree to hold it in confidence.. The Company shall not file a Registration Statement or any such Prospectus or any
                amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of such objection in writing no later than five (5) Trading
                Days after the Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to
                furnish to the Company a completed questionnaire in the form attached to this Agreement as <font style="font-family: 'Times New Roman';"><u>Annex&#160;C</u></font> (a &#8220;<font style="font-family: 'Times New Roman';"><u>Selling Stockholder
                    Questionnaire</u></font>&#8221;) on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Trading Day following the date on which such Holder receives draft materials in
                accordance with this Section. Each Holder shall provide any additional information as may be reasonably requested by the Company and is necessary for purposes of complying with requirements under applicable securities laws and regulations
                or rules of any applicable stock exchange where the Common Stock is then listed.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae04f3d987d24ad5a1c242b0643fc939">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to
                keep a Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to register for resale
                under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended,
                to be filed pursuant to Rule&#160;424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible
                to the Holders true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein which would constitute material
                non-public information regarding the Company or any of its Subsidiaries), and (iv)&#160;comply in all material respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
                Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders thereof set forth in such Registration Statement as
                so amended or in such Prospectus as so supplemented.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb854348c3a114af1aba06c45265232bd">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered in a Registration Statement, then the
                Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6e24ce4426c2429ab2ee13a1c4e3439b">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an instruction to suspend the use of the Prospectus
                until the requisite changes have been made) as promptly as reasonably possible (and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such notice in writing
                no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
                there will be a &#8220;review&#8221; of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has
                become effective, (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional information, (iii)&#160;of the issuance by the
                Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that
                purpose, (iv)&#160;of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or
                threatening of any Proceeding for such purpose, (v)&#160;of the occurrence of any event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a
                Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so
                that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the
                statements therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect to the Company that the Company believes may be material
                and that, in the determination of the Company, makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <font style="font-family: 'Times New Roman';"><u>provided</u></font>,
                <font style="font-family: 'Times New Roman';"><u>however</u></font>, that in no event shall any such notice contain any information which would constitute material, non-public information regarding the Company or any of its Subsidiaries.,
                and the Company agrees that the Holders shall not have any duty of confidentiality to the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis of such
                information. In the event that any notice or communication provided to a Holder contains or is deemed to contain material, non-public information regarding the Company or any of its Subsidiaries, the Company shall, as promptly as
                practicable and in any event within one (1) Business Day, publicly disclose such information in a manner compliant with Regulation FD, so as to cleanse such information.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z21a59177af98453991f772458638fc68">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a Registration Statement, or (ii) any
                suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z017ca286b86c43959fe81fb8b2b5b78c">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial statements and schedules, all documents
                incorporated or deemed to be incorporated therein by reference to the extent requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly
                after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or successor thereto) need not be furnished in physical form.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="ze4564b187e9943408a774380beb57a8e">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the
                offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd8859d26bc4c41bb858885df5c1e051a">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling Holders in connection with the registration
                or qualification (or exemption from the Registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably
                requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such
                jurisdictions of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the
                Company to any material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf89d640f8cc74458872fe32d4edfef79">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates or ook entry statements, as applicable, representing Registrable Securities to
                be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such
                denominations and registered in such names as any such Holder may request.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb0a73ec87ce843d0be8c8d9803738329">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(j)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&#8217;s good faith assessment of any adverse
                consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus or
                any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a
                material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the
                  Holders shall suspend use of such Prospectus. The Company will use commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right
                  under this Section 3(j) to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed 60 calendar days
                  (which need not be consecutive days) in any 12-month period. The Company shall use its best efforts to minimize the duration and frequency of any such suspension, and shall not exercise its right to suspend sales for the purpose of
                  limiting or restricting any Holder&#8217;s ability to sell Registrable Securities for competitive or other non-disclosure-related reasons.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8c8eb23e9bcf41a2abf5eb7484aff39b">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(k)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act, including, without limitation,
                Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any time during
                the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take
                such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbee90f928914260889399a7105c0300">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(l)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">Acknowledging that the Company is not currently eligible to use Form S-3 for the registration of the resale of Registratble Securities, the Company shall use commercially reasonable efforts to
                maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1a54e14ca64142c3801ff0ba5ebabadc">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(m)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially owned by such Holder and, if required by the
                Commission, the natural persons thereof that have voting and dispositive control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities
                solely because any Holder fails to furnish such information within three Trading Days of the Company&#8217;s request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
                occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z66e6844690e24d4ebe57837b3d806b6b">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Registration Expenses</u></font><font style="font-size: 10pt;">. All fees and expenses incident to the performance
                  of, or compliance with, this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall
                  include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&#8217;s counsel and independent registered public accountants) (A) with respect to filings made with the
                  Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the
                  Company in writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii)&#160;printing expenses (including, without
                  limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so
                  desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all
                  of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or
                  accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be
                  responsible for any broker or underwriter fees or commissions or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6591430873e44082805872635adb5da4">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">&#160;<font style="font-family: 'Times New Roman';"><u>Indemnification</u></font>.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="za3fd459782974ec9995cc6004188085b">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification by the Company</u></font><font style="font-size: 10pt;">. The Company shall, notwithstanding any
                  termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as a result of a pledge or any
                  failure to perform under a margin call of Common Stock), investment advisors and employees (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other
                  title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees
                  (and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from
                  and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&#8217; fees) and expenses (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Losses</u></font>&#8221;), as
                  incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any
                  preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto,
                  in light of the circumstances under which they were made) not misleading, or (2) any failure to register or qualify Registrable Securities in any state where the Company or its agents have affirmatively undertaken or agreed in writing
                  that the Company (the undertaking of any underwriter being attributed to the Company) will undertake such registration or qualification on behalf of the Holder of such Registrable Securities (provided, that in such instance the Company
                  shall not be so liable if it has undertaken its reasonable best efforts to so register or qualify such Registrable Securities), or (3) any untrue or alleged untrue statement of a material fact contained in a Registration Statement, any
                  Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or
                  necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading or (4) any violation or alleged violation by the Company of the
                  Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such
                  untrue or alleged untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such
                  Holder or such Holder&#8217;s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or
                  supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose) or (ii) in the case of an occurrence of an event of the type specified in Section&#160;3(d)(iii)&#8211;(vi), the use by such Holder of an outdated,
                  defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the
                  Advice contemplated in Section 6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the
                  Company is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities by any of the Holders in
                  accordance with Section&#160;6(f).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9bb186b0fb7c4bd195ee1d9dd6dea5de">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification by Holders</u></font><font style="font-size: 10pt;">. Each Holder shall, severally and not
                  jointly, indemnify and hold harmless the Company, its directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the
                  directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
                  untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of
                  a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent,
                  but only to the extent, that such untrue or alleged untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
                  Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&#8217;s information provided in the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and
                  was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose), such Prospectus or in any amendment or
                  supplement thereto. In no event shall the liability of a selling Holder be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
                  amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to
                  such indemnification obligation.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z70e548f526bd4d769e7f67afb5a30d25">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conduct of Indemnification Proceedings</u></font><font style="font-size: 10pt;">. If any Proceeding shall be
                  brought or asserted against any Person entitled to indemnity hereunder (an &#8220;<font style="font-family: 'Times New Roman';"><u>Indemnified Party</u></font>&#8221;), such Indemnified Party shall promptly notify the Person from whom indemnity is
                  sought (the &#8220;<font style="font-family: 'Times New Roman';"><u>Indemnifying Party</u></font>&#8221;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably
                  satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of
                  its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such
                  failure shall have materially and adversely prejudiced the Indemnifying Party.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees
        and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the
        defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the
        Indemnifying Party, and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if
        such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable
        fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
        shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless
        such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the
        extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the
        Indemnifying Party, provided that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally determined by a court of
        competent jurisdiction (which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc22fdc5b25f749fc8884bba95d077e82">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contribution</u></font><font style="font-size: 10pt;">. If the indemnification under Section 5(a) or 5(b) is
                  unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is
                  appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The
                  relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or
                  alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&#8217; relative intent, knowledge, access to information and opportunity to
                  correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&#8217; or other
                  fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party in
                  accordance with its terms.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
        allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be
        greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such
        untrue or alleged untrue statement or omission or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the
        Indemnified Parties.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd24147c300244dffbb6ef01a30e161a9">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">&#160;<font style="font-family: 'Times New Roman';"><u>Miscellaneous</u></font>.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbf773491c2e34b1fbcec624a78c1c876">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Remedies</u></font><font style="font-size: 10pt;">. The failure of any party to exercise any right or remedy under
                  this Agreement or otherwise, or delay by a party to exercise such right or remedy, shall not operate as a waiver thereof. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
                  each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, shall be entitled to specific performance of its rights under
                  this Agreement. Each of the Company and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further
                  agrees that, in the event of any action for specific performance in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z402f722773654c15839da957999d7181">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</u></font><font style="font-size: 10pt;">. Neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements other than the Registrable
                  Securities. The Company shall not file any other registration statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission, provided that this Section 6(b)
                  shall not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new securities are registered on any such existing registration statements.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zae4cf7d05c3d426da899f58d0651c80b">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Discontinued Disposition</u></font><font style="font-size: 10pt;">. By its acquisition of Registrable Securities,
                  each Holder agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such Registrable Securities
                  under a Registration Statement until it is advised in writing (the &#8220;<font style="font-family: 'Times New Roman';"><u>Advice</u></font>&#8221;) by the Company that the use of the applicable Prospectus (as it may have been supplemented or
                  amended) may be resumed. The Company will use commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges that any periods during which the
                  Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be subject to the provisions of Section 2(d).</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z064eac9ba41d48dd87588e0f7fb45c41">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Amendments and Waivers</u></font><font style="font-size: 10pt;">. The provisions of this Agreement, including the
                  provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by the Company and the Holders of
                  67% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or
                  waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group of Holders) shall be required. If a Registration Statement does not register all of the
                  Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder
                  shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that
                  relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such
                  waiver or consent relates; <font style="font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-family: 'Times New Roman';"><u>however</u></font>, that the provisions of this sentence may not be amended, modified, or
                  supplemented except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement
                  unless the same consideration also is offered to all of the parties to this Agreement who continue to hold any of the Registrable Securities.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7ae4d76db779466d942ba2d1f2b904e3">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(e)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notices</u></font><font style="font-size: 10pt;">. Any and all notices or other communications or deliveries
                  required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd34b6503ca3c4be9a9c39f562fac8e54">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(f)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successors and Assigns</u></font><font style="font-size: 10pt;">. This Agreement shall inure to the benefit of and
                  be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder without the prior written consent
                  of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z2448127c5a09404da985f225baa2e0e5">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(g)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Inconsistent Agreements</u></font><font style="font-size: 10pt;">. Neither the Company nor any of its
                  Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing
                  the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule&#160;6(i)</u></font>, neither the Company nor any of its
                  Subsidiaries has previously entered into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zec579ee09ccc4034abfb43b37e48e10e">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(h)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Execution and Counterparts</u></font><font style="font-size: 10pt;">. This Agreement may be executed in two or
                  more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both
                  parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party
                  executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdbd57c8b3cf24923aff41d8a9dda8a0a">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law</u></font><font style="font-size: 10pt;">. All questions concerning the construction, validity,
                  enforcement and interpretation of this Agreement shall be determined in accordance with the provisions of the Purchase Agreement.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z89e7b041cdf44195a8a97e044a4fa6a8">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(j)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cumulative Remedies</u></font><font style="font-size: 10pt;">. The remedies provided herein are cumulative and not
                  exclusive of any other remedies provided by law.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z248f5ae0994b4f4499a643b8060d0802">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(k)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability</u></font><font style="font-size: 10pt;">. If any term, provision, covenant or restriction of this
                  Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in
                  no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
                  term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that
                  may be hereafter declared invalid, illegal, void or unenforceable.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7691b9e26f784cb38f8683574536ccc6">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(l)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Headings</u></font><font style="font-size: 10pt;">. The headings in this Agreement are for convenience only, do
                  not constitute a part of the Agreement and shall not be deemed to limit or affect any of the provisions hereof.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zda1a4af6d9fe43b6b1c8cb837a30266d">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(m)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Independent Nature of Holders&#8217; Obligations and Rights</u></font><font style="font-size: 10pt;">. The obligations
                  of each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained
                  herein or in any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other
                  kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the
                  Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its
                  rights, including without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with
                  respect to the obligations of the Company contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to
                  do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders collectively and not between and among
                  Holders.</font></div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">********************</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[<font style="font-family: 'Times New Roman'; font-style: italic;">Signature pages follow.</font>]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf501705ae3f7464ab85abf49f988ceec">

          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman'; font-weight: bold;">MOMENTUS INC.</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: justify; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;Name: John Rood</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: justify; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;Title: Chairman and Chief Executive Officer</div>
            </td>
            <td colspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE OF HOLDERS FOLLOWS]</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGE OF HOLDERS]</div>
      <div style="font-size: 10pt;">
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="font-size: 10pt;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td nowrap="nowrap" style="width: 13%; padding-bottom: 2px;">Name of Holder:</td>
                <td style="width: 35%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 52%; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Signature of Authorized Signatory of Holder</font><font style="font-size: 10pt;">:</font></td>
                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 40%; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Name of Authorized Signatory:</td>
                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 40%; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td nowrap="nowrap" style="width: 20%; padding-bottom: 2px;">Title of Authorized Signatory:</td>
                <td style="width: 40%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
                </td>
                <td style="width: 40%; padding-bottom: 2px;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[SIGNATURE PAGES CONTINUE]</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%A-%%-->
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Annex A</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Plan of Distribution</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Each Selling Stockholder (together, the &#8220;<font style="font-family: 'Times New Roman';"><u>Selling Stockholders</u></font>&#8221;) of the securities and
        any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the [principal Trading Market or any other stock exchange, market or trading facility on which the securities
        are traded or in private transactions].&#160; These sales may be at fixed or negotiated prices.&#160; A Selling Stockholder may use any one or more of the following methods when selling securities:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z89e18635500a453fa40690a34b013217">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">ordinary brokerage transactions and transactions in which the broker&#8209;dealer solicits purchasers;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z91822144e346455aaa38d9234440e3c9">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">block trades in which the broker&#8209;dealer will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zb2cef43767fa4429b0753d9e14d4968f">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">purchases by a broker&#8209;dealer as principal and resale by the broker&#8209;dealer for its account;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z788f001cff56454e8829f2f8f3146217">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">an exchange distribution in accordance with the rules of the applicable exchange;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9759d63c34ff49aea23788f705575963">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">privately negotiated transactions;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfa5ccf33a33b4e029fc3ec768a266b2c">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">settlement of short sales;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5f778cb0bca24284b78969b1bf69fe1b">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">in transactions through broker&#8209;dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7e94f22cfe814a1986a6ce9e9d98e5b4">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z9d549b76e2d54f74832b19d0b8ce118f">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">a combination of any such methods of sale; or</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z69b946d1d91645229866c1a4acebcaaf">

          <tr>
            <td style="width: 54pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';">any other method permitted pursuant to applicable law.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as
        amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221;), if available, rather than under this prospectus.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Broker&#8209;dealers engaged by the Selling Stockholders may arrange for other brokers&#8209;dealers to participate in sales.&#160; Broker&#8209;dealers may receive
        commissions or discounts from the Selling Stockholders (or, if any broker&#8209;dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the
        case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
        or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume.&#160; The Selling Stockholders may also sell securities short and deliver these securities to close out their
        short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities.&#160; The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one
        or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this
        prospectus (as supplemented or amended to reflect such transaction).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the
        meaning of the Securities Act in connection with such sales.&#160; In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or
        discounts under the Securities Act.&#160; Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities.&#160; The Company has
        agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
        without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or
        any other rule of similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect.&#160; The securities covered hereby will be sold only through registered
        or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an
        exemption from the registration or qualification requirement is available and is complied with.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the securities may not simultaneously
        engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution.&#160; In addition, the Selling Stockholders will be subject to
        applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the securities by the Selling Stockholders or any other person.&#160; We will make copies of
        this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">A-2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%B-%%-->
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>Annex B</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SELLING SHAREHOLDERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The common stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the
        selling shareholders, upon exercise of the warrants.&#160; For additional information regarding the issuances of those shares of common stock and warrants, see &#8220;Private Placement of Shares of Common Stock and Warrants&#8221; above.&#160; We are registering the
        shares of common stock in order to permit the selling shareholders to offer the shares for resale from time to time.&#160; Except for the ownership of the shares of common stock and the warrants, the selling shareholders have not had any material
        relationship with us within the past three years.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the
        selling shareholders.&#160; The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of the shares of common stock and warrants, as of ________, 2026, assuming exercise of the
        warrants held by the selling shareholders on that date, without regard to any limitations on exercises.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The third column lists the shares of common stock being offered by this prospectus by the selling shareholders.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">In accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the
        sum of (i) the number of shares of common stock issued to the selling shareholders in the &#8220;Private Placement of Shares of Common Stock and Warrants&#8221; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the
        related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was initially filed with the SEC, each as of the trading day immediately preceding
        the applicable date of determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants.<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;
        </font>The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Under the terms of the warrants [and other warrants held by selling shareholders], a selling shareholder may not exercise [the] [any such] warrants
        to the extent such exercise would cause such selling shareholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding
        common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect
        this limitation.&#160; The selling shareholders may sell all, some or none of their shares in this offering.&#160; See &#8220;Plan of Distribution.&#8221;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zdc82b0cdc4684c3396beaaf86e25e72c">

          <tr>
            <td style="width: 33.01%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 8pt; font-weight: bold;"><u><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
                    <br>
                    Name of Selling Shareholder</font></u></div>
            </td>
            <td style="width: 22.82%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><u>Number of shares of Common Stock Owned Prior to Offering</u></div>
            </td>
            <td style="width: 23.31%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><u>Maximum Number of shares of Common Stock to be Sold Pursuant to this Prospectus</u></div>
            </td>
            <td style="width: 20.85%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><u>Number of shares of Common Stock Owned After Offering</u></div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">B-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%C-%%-->
      <div style="text-align: right; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Annex C</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MOMENTUS INC.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Selling Stockholder Notice and Questionnaire</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned beneficial owner of common stock (the &#8220;<font style="font-family: 'Times New Roman';"><u>Registrable Securities</u></font>&#8221;) of
        Momentus Inc., a Delaware corporation (the &#8220;<font style="font-family: 'Times New Roman';"><u>Company</u></font>&#8221;), understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &#8220;<font style="font-family: 'Times New Roman';"><u>Commission</u></font>&#8221;) a registration statement (the &#8220;<font style="font-family: 'Times New Roman';"><u>Registration Statement</u></font>&#8221;) for the registration and resale under Rule 415 of the Securities Act of 1933, as
        amended (the &#8220;<font style="font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221;), of the Registrable Securities, in accordance with the terms of the Registration Rights Agreement (the &#8220;<font style="font-family: 'Times New Roman';"><u>Registration


            Rights Agreement</u></font>&#8221;) to which this document is annexed.&#160; A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth below.&#160; All capitalized terms not otherwise defined herein shall
        have the meanings ascribed thereto in the Registration Rights Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Certain legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus.&#160; Accordingly,
        holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling stockholder in the Registration Statement and the related
        prospectus.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTICE</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned beneficial owner (the &#8220;<font style="font-family: 'Times New Roman';"><u>Selling Stockholder</u></font>&#8221;) of Registrable Securities
        hereby elects to include the Registrable Securities owned by it in the Registration Statement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">QUESTIONNAIRE</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z1537069bb26142ef86800befbcd67d97">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Name.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z79d54f49ebf848a29e09c46ed0bd0780">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Full Legal Name of Selling Stockholder</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" align="right" id="z67908bf75d124455b86e91d6ab5722f1" style="border-collapse: collapse; width: 85%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 85%; vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt; clear: both;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zfb2394b11ea74fcd96b91223fccee5e0">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="right" style="border-collapse: collapse; width: 85%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; font-size: 10pt;">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div> <br>
        </div>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z8093703ba2a24805b518adf0c8da390d">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this
                Questionnaire):</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="right" style="border-collapse: collapse; width: 85%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; font-size: 10pt;">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc37a626204d24c8bafbb4ccafc95170e">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Address for Notices to Selling Stockholder:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z08d0cc9a0fa3441b879cf5b22cb435aa">

          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 7%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">Telephone:<font style="font-family: 'Times New Roman';"><br>
                </font></div>
            </td>
            <td style="width: 93%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 4%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">Fax:<font style="font-family: 'Times New Roman';">&#160; <br>
                </font></div>
            </td>
            <td style="width: 96%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 1%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
              <div style="text-align: left; font-family: 'Times New Roman';">Contact </div>
              <div style="text-align: left; font-family: 'Times New Roman';">Person:</div>
            </td>
            <td style="width: 50%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z639af40219ad4102bc822fb7150cc12f">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Broker-Dealer Status:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zaffec5a5829a4b9ea4ef39cf88f1d54b">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Are you a broker-dealer?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes &#9744; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744; &#160; </div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z071fa365cdd64a928ea338a49ec5da6a">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(b)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> If &#8220;yes&#8221; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes &#9744; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744;&#160;&#160; </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z6883629458ab46a1b5d84efdf5d6031f">

          <tr>
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 36pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">Note:</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> If &#8220;no&#8221; to Section 3(b), the Commission&#8217;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0f90c3f681a04d3c9a236fc8448e1ea5">

          <tr>
            <td style="width: 36pt;">&#160;</td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(c)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Are you an affiliate of a broker-dealer?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes &#9744; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744;&#160;&#160; </div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zcbe0879122074819b82a36a06015117f">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(d)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> If you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable
                Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Yes &#9744; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No &#9744;&#160;&#160; </div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z126f8a24dfc6456d8a3fe68ae8a140c7">

          <tr>
            <td style="width: 108pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Note:</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> If &#8220;no&#8221; to Section 3(d), the Commission&#8217;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc02bef8d02d14d519d0b74a9e290c159">

          <tr>
            <td style="width: 18pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="font-family: 'Times New Roman'; font-weight: bold;">Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Except as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the
        Company other than the securities issuable pursuant to the Purchase Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z0923283615354d29bf009c02c599f719">

          <tr>
            <td style="width: 36pt; font-size: 10pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">(a)</td>
            <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
              <div style="font-family: 'Times New Roman';"> Type and Amount of other securities beneficially owned by the Selling Stockholder:</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="right" style="border-collapse: collapse; width: 85%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: 400;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">

            <tr>
              <td style="width: 18pt; font-size: 10pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">5.</td>
              <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
                <div style="font-family: 'Times New Roman'; font-weight: bold;">Relationships with the Company:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders
        (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; State any exceptions here:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" align="right" style="border-collapse: collapse; width: 85%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

            <tr>
              <td style="width: 85%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>

        </table>
      </div>
      <div style="font-size: 10pt;"> <br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur
        subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or
        its affiliates.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the
        inclusion of such information in the Registration Statement and the related prospectus <font style="font-family: 'Times New Roman';">and any amendments or supplements thereto</font>.&#160; The undersigned understands that such information will be
        relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus and any amendments or supplements thereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person
        or by its duly authorized agent.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="ze2c32a736d974670a7f966672a30fc3a">

            <tr>
              <td style="width: 5%; padding-bottom: 2px;">Date:</td>
              <td style="width: 39%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 6%; padding-bottom: 2px;">&#160;</td>
              <td style="padding-bottom: 2px;" rowspan="1" colspan="3">Beneficial</td>
            </tr>
            <tr>
              <td style="width: 5%; padding-bottom: 2px;">Owner:</td>
              <td style="border-bottom: 2px solid rgb(0, 0, 0);" colspan="2"><br>
              </td>
              <td style="width: 3%; padding-bottom: 2px;"><br>
              </td>
              <td style="padding-bottom: 2px;" colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 5%;"><br>
              </td>
              <td colspan="2"><br>
              </td>
              <td style="width: 3%;"><br>
              </td>
              <td colspan="2"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 5%; padding-bottom: 2px;"><br>
              </td>
              <td style="padding-bottom: 2px;" colspan="2"><br>
              </td>
              <td style="width: 3%; padding-bottom: 2px;">By:</td>
              <td style="width: 32%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 15%; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 5%;"><br>
              </td>
              <td colspan="2"><br>
              </td>
              <td style="width: 3%;"><br>
              </td>
              <td colspan="2">Name:</td>
            </tr>
            <tr>
              <td style="width: 5%;"><br>
              </td>
              <td colspan="2"><br>
              </td>
              <td style="width: 3%;"><br>
              </td>
              <td colspan="2">Title:</td>
            </tr>

        </table>
      </div>
      <br>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;" id="z4808378c40ea41a9adb96bc9ee431633">

            <tr>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 70%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 70%; padding-bottom: 2px;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 30%;"><br>
              </td>
              <td style="width: 70%;"><br>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <br>
    </div>
  </div>
  <font style="font-size: 10pt;"> </font>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;">C-4</font></div>
  <div style="text-align: center;" class="BRPFPageNumberArea">
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-family: 'Times New Roman'; font-size: 8pt; color: #000000; font-weight: normal; font-style: normal;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ef20075150_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 26.3.2.5342
         Copyright 1995 - 2026 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr align="center" noshade="noshade" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-size: 10pt;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
      </font></div>
    <br>
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Momentus Announces Pricing of a $25 Million Private Placement of Common Stock Priced At-The-Market Under Nasdaq Rules with Existing
        Fundamental Institutional Investors</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">SAN JOSE, Calif. (BUSINESS WIRE) &#8212; May 27, 2026 &#8212; Momentus Inc. (NASDAQ: MNTS) (&#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Momentus</font>&#8221;
        or the &#8220;<font style="font-family: 'Times New Roman'; font-weight: bold;">Company</font>&#8221;) a leading U.S. commercial space firm specializing in satellite solutions, in-space transportation, and orbital infrastructure, today announced that
        it has entered into securities purchase agreements with existing institutional investors for the purchase and sale of 2,942,000 shares of its common stock (or common stock equivalents in lieu thereof) in a private placement priced at-the-market
        under Nasdaq rules. The gross proceeds from the offering are expected to be approximately $25&#160;million, before deducting placement agent fees and other estimated offering expenses.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The closing of the offering is expected to occur on or about May 28, 2026, subject to the satisfaction of customary closing conditions. The Company intends
        to use the net proceeds from the offering for working capital and other general corporate purposes. Existing capital and net proceeds from this offering, positions the Company with approximately $76 million in cash, cash equivalents, and short-term
        investments.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are pleased that our existing investors continue to support the company and our mission.&#160; We intend to use the proceeds for research and development,
        investment in strategic business initiatives and general corporate purposes&#8221; said John C. Rood, Chairman and Chief Executive Officer of Momentus.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The offer and sale of the foregoing securities is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the
        Securities Act of 1933, as amended (the "Securities Act"), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities have not been and will not initially be registered under the Securities Act, or
        applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act
        and such applicable state securities laws. Pursuant to the terms of the securities purchase agreement entered into with the investors, the Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission (the
        "SEC") covering the resale of the shares of common stock and shares of common stock underlying pre-funded warrants sold in the offering.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these
        securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Momentus</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Momentus is a U.S. commercial space company offering satellites, satellite components, and in-space transportation and infrastructure services. The Company
        offers satellites to support government and commercial customers for missions like communications, missile tracking, and cutting-edge science missions. Momentus offers services such as hosted payloads, support for in-space assembly, on-orbit
        servicing and refueling, and transportation of satellites to specific orbits.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains certain statements that may constitute &#8220;forward-looking statements&#8221; for purposes of the federal securities laws. Forward-looking
        statements include, but are not limited to, statements regarding the expected closing of the offering, the intended use of proceeds and fulfillment of customary closing conditions. These statements reflect Momentus&#8217; or its management team&#8217;s
        expectations, hopes, beliefs, intentions or strategies regarding the future, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, and are not guarantees of future performance.&#160;
        Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus&#8217; control. Many factors could cause
        actual future events to differ materially from the forward-looking statements in this press release, including but not limited to risks and uncertainties included under the heading &#8220;Risk Factors&#8221; in the Annual Report on Form 10-K filed by the
        Company on March 31, 2026, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the &#8220;SEC&#8221;), accessible on the SEC&#8217;s website at www.sec.gov and the Investor Relations section of our
        website at https://momentus.space. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation
        and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Contact:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Investors: </font><font style="font-size: 10pt;">investors@momentus.space</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Media: </font><font style="font-size: 10pt;">press@momentus.space</font></div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="font-size: 10pt;">
        <hr align="center" noshade="noshade" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>mnts-20260526.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<xs:schema targetNamespace="http://momentus.space/20260526" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:mnts="http://momentus.space/20260526" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20260526_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20260526_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mnts-20260526_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://momentus.space/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:element name="WarrantsMember" id="mnts_WarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>mnts-20260526_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://momentus.space/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="mnts-20260526.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://momentus.space/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="definition: EntityListingsLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityListingsLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityListingsLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalYearFocus" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityListingsLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityListingsLineItems to EntityRegistrantName" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityListingsLineItems to EntityCentralIndexKey" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityListingsLineItems to EntityTaxIdentificationNumber" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine1" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine2" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityListingsLineItems to EntityAddressAddressLine3" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityListingsLineItems to EntityAddressCityOrTown" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityListingsLineItems to EntityAddressStateOrProvince" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityListingsLineItems to EntityAddressCountry" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityListingsLineItems to EntityAddressPostalZipCode" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityListingsLineItems to CityAreaCode" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityListingsLineItems to LocalPhoneNumber" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityListingsLineItems to Security12bTitle" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityListingsLineItems to TradingSymbol" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityListingsLineItems to NoTradingSymbolFlag" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityListingsLineItems to SecurityExchangeName" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityListingsLineItems to EntityEmergingGrowthCompany" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityListingsLineItems to WrittenCommunications" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityListingsLineItems to SolicitingMaterial" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementTenderOffer" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityListingsLineItems" xlink:to="EntityListingsTable" xlink:title="definition: EntityListingsLineItems to EntityListingsTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: EntityListingsTable to StatementClassOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="definition: ClassOfStockDomain to CommonClassAMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="mnts-20260526.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="WarrantsMember" xlink:title="definition: ClassOfStockDomain to WarrantsMember" order="2.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>mnts-20260526_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain" xml:lang="en-US" id="us-gaap_ClassOfStockDomain">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonClassAMember" xml:lang="en-US" id="us-gaap_CommonClassAMember">Common Class A [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonClassAMember" xlink:to="us-gaap_CommonClassAMember" xlink:title="label: CommonClassAMember to us-gaap_CommonClassAMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsTable" xml:lang="en-US" id="dei_EntityListingsTable">Entity Listings [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsTable" xlink:to="dei_EntityListingsTable" xlink:title="label: EntityListingsTable to dei_EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityListingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityListingsLineItems" xml:lang="en-US" id="dei_EntityListingsLineItems">Entity Listings [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityListingsLineItems" xlink:to="dei_EntityListingsLineItems" xlink:title="label: EntityListingsLineItems to dei_EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="mnts-20260526.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:label xlink:type="resource" xlink:label="mnts_WarrantsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="mnts_WarrantsMember_lbl1" xml:lang="en-US" id="mnts_WarrantsMember_lbl1">Warrants [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsMember" xlink:to="mnts_WarrantsMember_lbl1" xlink:title="label: WarrantsMember to mnts_WarrantsMember_lbl1" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>mnts-20260526_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 26.3.2.5342 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://momentus.space/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="mnts-20260526.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://momentus.space/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="EntityListingsTable" xlink:title="EntityListingsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="CommonClassAMember" xlink:title="CommonClassAMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="CommonClassAMember" xlink:title="presentation: ClassOfStockDomain to CommonClassAMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="mnts-20260526.xsd#mnts_WarrantsMember" xlink:label="WarrantsMember" xlink:title="WarrantsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="WarrantsMember" xlink:title="presentation: ClassOfStockDomain to WarrantsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: EntityListingsTable to StatementClassOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsLineItems" xlink:label="EntityListingsLineItems" xlink:title="EntityListingsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityListingsLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityListingsLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityListingsLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityListingsLineItems to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityListingsLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityListingsLineItems to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityListingsLineItems to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityListingsLineItems to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityListingsLineItems to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityListingsLineItems to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityListingsLineItems to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityListingsLineItems to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityListingsLineItems to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityListingsLineItems to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityListingsLineItems to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityListingsLineItems to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityListingsLineItems to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityListingsLineItems to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityListingsLineItems to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityListingsLineItems to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityListingsLineItems to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityListingsLineItems to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityListingsLineItems to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityListingsLineItems to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityListingsTable" xlink:to="EntityListingsLineItems" xlink:title="presentation: EntityListingsTable to EntityListingsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityListingsTable" xlink:title="presentation: CoverAbstract to EntityListingsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 26, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 26,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Momentus Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001781162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1905538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1762 Automation Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Jose<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">564-7820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNTS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MNTSW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mnts_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20075150_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://momentus.space/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20075150_8k.htm">ef20075150_8k.htm</File>
    <File>mnts-20260526.xsd</File>
    <File>mnts-20260526_def.xml</File>
    <File>mnts-20260526_lab.xml</File>
    <File>mnts-20260526_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20075150_8k.htm": {
   "nsprefix": "mnts",
   "nsuri": "http://momentus.space/20260526",
   "dts": {
    "inline": {
     "local": [
      "ef20075150_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "mnts-20260526.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "mnts-20260526_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "mnts-20260526_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mnts-20260526_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 35,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 25
   },
   "report": {
    "R1": {
     "role": "http://momentus.space/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20260526to20260526",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20075150_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20260526to20260526",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20075150_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Class A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "mnts_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://momentus.space/20260526",
     "localname": "WarrantsMember",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://momentus.space/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001140361-26-023337-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-26-023337-xbrl.zip
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M+V2"O$/D1IKFPJA:#_7GS4,A[[T@^M>39].P7T5U:]P\QFVU!)>'0?X*+C:
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M^G2H*E-_S))TCI.X.,OAM)&U(?F,X$C2+V5U42C0K3*?D+JT$24X-SS%<54
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M)ZR7*PW*UE2E7/E/;0#\N1A@#ZPFZN_],!##+.%8]-*P1PY2BNQHSP;%>EN
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MIG.4(4U5@&*!_ZY5:!@T\"/@\_X&\'N),^M.&+(L%$(U=KBH:B]TR.B5NI1
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M8(E.@08PE,I=FNA$F0#DS&M5)*Q&5Y*%[SHGQXO.U&R_Z^KR1>H2&.D%&PG
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M% )X68=* JU[<9"?MP$NQ/T* ]=2IWT.2Z]U@E1,SN#8<\S&&JY)"K/<7?;
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M5-DY7._=E[SN6A"YKPF2V5UF3ZSQG\&A#/20\&*-3IPQ=J.,QE(:24T!X8G
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M?!\$%4Y)=AF,&'X;<(WQK!@#+Q<)F-=^E_%:PRG:[R6%\Q*('K>Q#O(%;!)
M'<*%=S7=S&@]X5[_^3"4GUZ06:)-"'<KZ?Q?=:*WF\\Y>CN[ 9.*0CX410^I
MZ;\U2:A]/LT^#YXM,:34"<Y\$<! VP7:\6*%VL@575J^9HG1S!S?1U=5)USD
MK<VS<#V/";>W1_49\Q'8@X>ZEH2$LY[K+/DMY./4G*!L5&&+[%U@8*V?B;[&
M<+EMCL@+#!:+M[>S<GG"["'G" O"O#N\KNXDU<_FAB\"D?!%!K$-PF0U1^3L
M7[!T4C)K-(<JJV5R!Z\0);$4Q9GXE.NJS,MN+]->5Y%N4\V&@,V!'L_JDG6@
M'M>K2PK=H\-2SSH+<YGZRR?:8?1,P^*&?;!HLXPZ;9#M)8J.32N$T (-H4\I
M,8<EMVGVX]7BPA#8VXI/KR8H:.Z2)FC+T@DKXN.^<A\LIPF66_9)CUR]L94
M<@YWMPIH_Z:MKGP]*#4FO,39<3LU3Z@<BL I&Z/0 #?[Q.Q"%)N6,U<.5S E
M>&C<&*8,D=XX/8'BUK?L@"C*_\;*NENGR4;T,U7ZSY^ZTO^QHN3W4V[,]4D<
M]YZDW0>-:Z(928+@P$EJ(!R[NE9(PI3B9VD8:"Q(T+AC@NN%*HI#K*+],0*P
M<Z=!_56O:*XTG+&5T1KW7D.UZ+]B>X\I L*]=Y+"%'"&#B\!)L"GN A'7&[R
M:_26S!@65#\;"V?RN963KI@FLT8@BVV[\8ZFK#O_F(-G_'P")M8_:\+@+?HV
MIC,P21I;D1KFA7"[9-L.VUA336_ATY#_3 Z*./I@^W$T^MB1QN -Z&3%Q;Q$
M=!XFHK/U$M%YC"+IXJF+I,]U?H[*GTE+N5]I9 20SY[N3AI5?FQFL ]S[O1Q
MUC@2Q(P7A-%#'JTS>O0^4#I\CU;(6JOQI< + MG4_S;\,<_?T_'KY%R5K(#7
M)H.M=M!V9:0@WO \5<*O3_W^@4KXD^0O'SNUP3Y^[H)ZDHX:U6\D4VL*2BKN
M!L) '<I<)< G>%%&*-E>9UI[5<PP@OZ<8,A;\EKZEIKS^O 58U';...[YTJA
MO2NY=FQ=2?(*MC92G-;,>2Q5W>CLE?X6@)A1&6VMKEFN$*2S>RSB4=Z8J/LR
MXU+]\__^7'Q9V]G>W%W=W-)E,=>BQZ7Y56[3Y=?RWM(<;I2N?-TK>0GB[F,@
M@]LSSC^?.N,\2;Y2_<GLFE5$B&;$43(8MICK%J58?:@RY&(Q^[7BJ*BP5H(:
M5C.:;8BJPC$A_!YKB,[0(]O"K&K5SNK2T2_8 )07827*FV7IH4 AXTR-$X$D
MH/H &T$F)2/YJ@S #?K%=+:OFT338(<R_5Z1# D!3+%[SO=EH6)!V3'6645P
M'HN[* 0Z2P#%06J/+CYD&,1QDJ/E)@D#Y ZSD((B:U+"M//PI\!4F35R4'JW
MZ&FL#TKJ!(SHZ1EV?O" SRG-! 4/PML-M>2X,3HZ-[X(SM\#QS&.4P_:7@Z0
MLBH,:G*(;:L31.3\^M.<X%4>^%8B;2#(^]_I%S@W $=(D.* F/##IF.;;0CE
M]I$8=]P0ABYZ=Z"E4HX,:!W-B)I9YPU[_2WJCAQ&#K>><^0P29XZ>]X'D^_5
M&[S4-3-B^N"7JE3SZ$-""AA>@2Y"NL,<C#NQ&[:AT)SQ*G9-*JO.^M$=79$>
MV[(>+.>:(E)*0W]P@2%!))URW+&JW9IVXEY,G_[0=56HIH-=8P&Z!,@IX\DS
M%F<^-7$T+Y7;I'G)C[H\(0 Z6,"<\?VY#C5J<%JNU&S\"G<"M\JP;[J;11DI
M*O8V>669FT$V5 A/^Q![K'Y<%45U@:O#=(P?*!_DU4@HA!#(G3#::-;2^BEW
M09(Y Q<H_"060/L0]=5:PYI5DBP7I(:NG"/[VB(9+)K&PEFX+X;-G,R*TT1^
M!MQ7&E[BBS\='KS%*FB-)07_#^8R8K&@;PU,_1TK'F /44CX$Y4S8U4I+$,*
MJ_'W807/&YV0XT32J4*4CO2M2A4Z.YDCK.W$T=K>WDX8Q/QUY7C%O/^@JNL9
M"/'/IM^K2?#?V;E=L_)W!Y_W>\$=;=5 +!/ZYXK9&WS]^NK:*KQ;\C>_MIUB
M!'M,RZ:5%^L\?0<8G!]*94DL,GYX;FX/4E.& P*>$$<K+$>[$B7;UX=*9^Z>
M:JPU3YM-Q<-[[I[:Z9_E;\#I+,\DA5-'Q'LG[<PW[DD;BJ,3@K!>VXU^!:(X
MJ!A_B=.V][:V:5_@'SM\4)^3MLYAQ?NZ*O<-5H,=(V!3.K>)W-Y*!S;3;^GK
M\"=R3/ 0;O.P8/EU-9MR+XO3I)1B\-A 3>/4WADU9)_7<Y(T7Y#L4X*J#>45
M0IHX_(-KXG49/#7:F]#58L\GB@)^6,=+\JKL^:'K-CTWA8*]LS=<N!&8C716
M,WYNF.%M[HY&?F'0 A*"-17RL02$#SJLR[$L2(.V#3_&CF2U:2'V=N'(=%8:
M((S<GDH )6D;7R)&#Q,QVGZ)&#U&U7XTNLO>J_>MQ9L,&U)=CHP8Z<9^]"?(
M'*PC==@WLRAW)\CG0L;*_NT&=&S&!6'GP31)#5N*DGIB9H-8LAAD=W+:%H#C
M#R8=7B$%K'5C/#:[MV8]PUWEP-+(A$X%5P21/(U(<@JQQWDV2[D%9-CSO=:0
M_28/6K9E.4QA"A/0;KUH(UMPIB Q3T&8$+IG-Y?2R09Q;29/\K$?XM1!K.F4
M0]]RPAW_Q4353%!IGG%OH3 "84AJZA!XD-7<>_9F;4U/BF)89V3>8EIPD>'5
M,HYE%60+F@6S3MB_*:;^:40-0>7J5#V]CI#IH1\+1U;G23'SZMHNS7D;P,0.
MSO91AE-NS\[3],E[:J[.XW5(&77E\[SU2]?WRSD&W4X-TL&^BV*LBD8Q)C$G
MB?:R(PYOUU0&B5>>$I8)0TA94(V;Y@HTO*\;*^M+8[?<C CVVH-NKF"1=9AX
MN8S.'<:KIWQKW0W(D0,ZR[V_;A[YP@\6ABS@&C[6>_.E"TB/#@K<]MB4FH9U
M*/AM1A#H:)0T+==7"G.36L9&464*AD"X'A!A;QJP =IX.$6,C #Q J"U=$[W
MWH =.T%EXD>5FR >\F4R&;IP)NBHQV!U3PB9!* !4L):!!=4;9HT1(52(@D6
M?"D=FJQE[?$Y>;?9M]C/W;W$7#[&K8J.$[%;!S>E]=PSICUY8,@1] -=CZ)J
M3(HAER?)@J:2Q6.Q6?RA$6>DQ" (-2]$9U0B3<)E%V" - 1?=R0?>I^*^2N"
M7LZ<<_, W8(-XT3U&<JP5[JU1EY>=3-T:9KI[HUT[&^,KR!RB_OA;%$11L6<
M-D/B/3(9(FT]#X,J92,7IA U#I#D5!\,C<!L9,C\G. 2=4EAC[51:1ABQR*3
M<:9E1XUUMW&NU;VAC0S8JMW5?C4EK SIJJRF17JP6MQ'1JG%*9W!+TB'9=E
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M,*0?N$GP'=.3C%+;>UZ_VJ>YV"=WJ2#\G8W*WM=0L%B^2,Z3O- ]%:0\0H,
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M /_[" S$^EQE_^=9G-7V7;M8[KO#WV"4=="+XL5'GTB<LM,0X/9!RX>(4_[
M(NB6,<I T[JK@.4#QRBCFX<G@X# W<0JW:SEOSXR.5)<?-=/FL.I1P\<K'R)
MB3@QD9V7F,BU!/8=54KMLU.(O-\+4Z1-ZG^3?XV6MI>!EY3D@BS1ORP-Y#L9
M,4X&LX'&-EE(O5AZ3B*X U)P:T "C?$"O.K_;^_:?]K(LO3O*^W_4(IVM7CD
M,#R2$-(]D8"8;K9IB#"9WM%JM2K;9:B.[?)6E:&9OW[O>=UW^4&  ,UHM4W
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M3'VA\W=Q4687&#_7"RFR32+%R7Z-(]P>P-._SD97F;5RMVCA-JW.<"VOF[&
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MYTVU $XUD_Q/AL18^!7KZA3'GAJR&EC-%]D$DRK]HISB-M.X5$G0<7*3$TG
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M435<%D,2N4W)0J-BF)K44<7H&."6IKUO0S]^:,85@2>$P17-8>->\7%+8!2
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MV6 ERQFE.-,^X^RC $3 AK83]0O&B="_<6NP:0TP*\-B-"JN8:/<08,<K-0
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M%'%K^A.K4LV#AM<<YY8HN@&>4'A1D\&4@)69,DD>$ :-<A!24/]0#Y<D.3O
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MXEGS#!&W%[A8VVS\1GDV2W3EN/4J? 9RU:;)1(UMXQ"UD]ZL)GT0IG6E(C%
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M;()!LSDM-K4NTF0#"\?O3CPT#;0&LGG&5;&2;1C4P:S6C1,3)8"[+A5;=O3
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M!^#4A^3@,L^&"5..767)*3'UONR\1[GS5NC.RY9[=%ONY8[WI]I:RP9#OT<
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M 7?,"]AT>8SPPI--?[LIK4JT43:^+6D._%I_+2 O-,5"V4X)8)S69!.5FR;
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MT?=@ ?\'GD".4./7X'X%#0QC,^C9;REIO3$5Q#^HT#-Y]C'88^+9/7$&34(
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M.=W($JC*0.B<3.*>8J2BD'9'4S9L:6FTF\)26[_J8%0:L4M$;_^1@S*PS?N
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MJI+U<H6*=J7M7UJ5@3]*3*96_\F4%D$GD5W+ GOGJ/)MFF&P59[)).'68$R
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M&!RL\RM99-U?@\-;N2RO@134:42KVEONJJU7U6 GRQKX0XEQ!%S"+4BP[]5
M.%+5C7F_ZI!QDPJ-%]):'02A=5*@.!J7\''*X;-H@N!?,(K6]K=/A2O:97Q;
M];*K"O@M1/=V=;O*EG6)].ZRI_!^L^6LA/J6-U9QJ))YH=-E;K9OUI-U<""A
M&>/ 8Y;&\WD4SF9I%(YC-DY'V3B.AB&?/%CK@'\GUL%K]$D=9 X\LPK D4O+
MJ8B]6FT**3!J"5<!8=+C/M(. Y!0FBF8]!.M=WK\ ;)5<GJTLE9X\'93)9<
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M)UVB3.*8K6-[.H!['L!XG/ LG,QG<W%3A>,H'LZGDU3<86$:1K-%=CJ W_8
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M@WQMW7E^[9&NCEKY!LW'M\HG_T:>V]M-Q>3)I&^_?;NI^$WJPSNGA +I[R&
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M^!(7QU>W".[(Z?=%"BQ@8!@#Q^M*R$P( A>E#'8;,2I==EKHY@41K2<HTZN
MJB+ID+=-RJX+7<O"+ACC@$JR);1@UJ_>Q%340[ORL+(V/ 5O;[ #&"._OH02
M35LJ=U1\Q7(AK3@DGS7YE3CIJA<#4PC*G@6L-B,+AV!MF[RB"B7]<Z&&+#MK
M5>4UMQW>:F7ENG'L]Y;6!+A7\I%4JOE9W.ZB6;@_I?+1'B(6:RD:/5%I7B?+
MLMX8+<'>+>+;4/G&;!?X'[+_U]>@9HA&P %=!R--"CI5E5JLJ81B'%B<2Q58
M=LH$?&9)G. PM@&$=D = RAUI:$7]6:]7DHDAJQ<)"UDN_RR/8&=*F:= 5WG
M8O/&UOA%WR%@B)6:8G?WYCC'A8Q0:GU)Z$=K)N<"U"/59V_!J+TF:^_A'\E.
M?_4Z^,>K#Z]?OG\?_./O+]^]?/-+>ZL/8*Z%S7995J#UIALA2R^$]"D&J+]B
M,?64@BA]I0<E@(=_$C($YA.^D(K%)%)"J=:+)20\CEEP,;-85Z:FM\I._!OE
M^UT7E+E;E>USO0]M=<WV1LAH"!\GDS&;3V9I- ]G\R&;9]%L-IN/V628)1-V
M>_T,-!\_J<0+YL<P>",KT0_[JT:W\&O,>GO;JV\YS7B?#:KR6BRUT+I'CV!1
MZ.>)'92]2V6S?\8Q\KMSRO><9C.2\:VF?-+;W<]IU+\ G]'5VTS_@5V_NXG\
M\B_^ KORFR[S83ORYYN]!=;XZPBL4?^\WKT9>Z1;&\B4O6"Y[VP>/N3-<K^)
MV-ME8-OVNU3,._$SO_WUY;/W+X-?GOW?X%GP_,W;_PK.WKP+7O[V[-6OXH,G
M;U_\@I^>!T+W_/#WE^(?OXE'/KQ\$3Q[_2)X^7]?/O\=_O$:ZSWB9TZ!L>##
M&X_O;H</X[XJ=^%BN)C,%TDXY"P<L8BE<32+DXCS<#*:32:W5^XFPZ\CY>;#
MV]X>GWW6OY,AWKKOG]_-0_R3VTZB_HWYW/JIXY=H>3?)P8!?/48,0=C!$-QF
M&'(>O; !&4"@9K3\^EQ8@*]NI!/>H0"O_*BBE]!G="AA%@K^XS>;^C8IYE_^
M')?I#?YPV:R6XH?_'U!+ P04    " !FIKU<%59+CB).  #J%@( %    &5F
M,C P-S4Q-3!?97@T+3$N:'1M[7UK<]M&EO;WK=K_@/5L=L6W: TOX,W)I$J6
MY8EV;-DKR9/9VMJ::@ -"0D)< #0LN;7O^><OJ ;:% D9262Q>QL8DLDT-=S
M?<YS?K@N%_,?__5?/.^':\XB^A/\N4S*.?_QAS^*_\H?_MO+E]Z[).1IP2.O
MS%YYK_.,17D277'O;9*R-$S8W+O(YJLRR=*BZYVFX:'X+OWS)@M7"YZ67IAS
M5L(S5D627IE/^7C^(4[FW!N,#X>'@\/1T!\8WS_.EK=Y<G5=>OW9;.2]] :]
MP=C\^LN78B9_E%/Y(<BB6R^X"K-YEO_IQ1]B^N>%5Y2W<_ZG%W&6EB]CMDCF
MMZ^\_[Q,%KSPSOB-=YXM6/J?WWOT^R+Y)W_E]7O+\GNOY%_*EVR>7*6OO#F/
MX2?TY%?>'WKTS_<OQ/OQB]9+C(>\^!'&AS\4'XV2SVIYKW,OS8IK%L&WY!]>
M>/2V/[V 12]YKD=^S7$97GG^\DMC#%[ PE^O\FR51B_KOS(G(![YO;=@^562
MOL3YO/+8JLSTCW+Q$O&S(,LC#L]*LY3+>8KAJS&9SZ9OTE0;2W$CAQYD\ZBY
MQ"]^//ERG01)Z?F'?;E.=RSG#T'^HSHDZAM_-)85_WC7EFSR#/W[ECG_LBK*
M)+Z5<]KF6#77!4;$O)0MX!7__'NX_'MXS=(K_O<^_/R/[,>SD]/+GT[.O<N?
M3B^\BY/C3^>GE__CG7W GYRH'YR>7'AOX4<__W1Z_%/MH_#GD[^=G!^?7AR]
M?G?B_73TUQ/O]<G)F7=^\N?3B\N3\Y,WWL_PCMKSJJMX=/8&GG#\T]'9GT^\
MXP_OWY]>7)Q^./.:0S!_^1:^]S_>Q>71Y8EWBB][=WIT=GSB??H(OSTZPS&]
M_WB)'WU[_N&]',SY$?WDT]F;D\;#CXXO\:G]V7#8]8[@[^]/X&-OO /\W'_\
M83H8]+ZW/TX_['_?Z>(4X%_'QQ_.WYR>_?G=_W2]]T>XB)>P$O#0M[0(,)^+
M#^]HKB<?+[V/G\XO/AV=77J7'\RU\$[@X\>7I["*UIAIIC"DRS6C/S<?BL\Z
M^NO1Z3O:%GLYNOA96+4C#QY_=@%?QM_@>"\^O?XO>#U\OTNOL,9P?O+?GT[/
M:107N%:.,>!FXH-I+6A#:.^//GY\=WI,(Q%;YCH([XY^OCBLG2Y\7NTU< (^
MT9-HJ^79.Q'C,;^*6P#+__'=R9L_G]"HCC^<G9V(N8I1>:\_G!UY;T_?G,"G
MS_\L!_[IC-;R ]V+=Q]@'>F9\(S7<.(^P0VH1G-H7FW[/C<EPW_\H3_N?=_^
M#9=$W48 #(3\62>>-GM>37Y\/#]Y^1:/W9O-I*B<9^-#6[X6KSN=_ _'?\&3
M#2("]OGGHW,XLY=:LC8$[.^]"ZUB^/T'O#F?X 2?'7^5<_-C=7=^*%D MD[(
MY_-BR4(PA?[THO>"_KYD4:3^+A0O_7%7NZ5N!MPD47F-O^Q]]_T++XE R_ X
M9@&?C$?CJ>\/QQ,VF Y[\9"%P<0/IJ/XA3%PSS/_C!/)?[1_@C^+U'#5VP;?
M?>_)B;T,LK+,%J^\ 1@P#W'\?V9YSN"9%]<LY\5F5^"5/IAEM,E\8/'DYIC3
M\8ILGD1>?A4<]+H>_J_C,G-,BT._8[,7^^.6A?RZK_E-]^NT*%;<>P->P;>U
M5_3B#?>J2_Z,X\'PH[SE^L&O4(@8QFM#X&QC^SJMWPU,7OIADD8@>E]YP_'&
MI\ :")D"E=[RUNH2[Z"\YLK&VT9MP8172CS\\,>5TD;*, 3QF\.<$OA2><W*
M+HPS]SZS^8I7:Y3SD">?>=3U_E[_QX-/)V7AL:* %2KN-\J?X&[PW#7(I/!@
MJ=$WAT&LEEGJX7M [2W@U2D<PE7P"P]+<-+I%_-DD92,G'(//LN_\#Q,"DX?
MQ=^'61HEXM?7/.?@RL?P+*_@)4Z_O.YZK(0/WWHEC!.?D.75:HC/XF,BN+[T
M@"R^W\1/4Q@-FWLG:J!",#37 2>P@H68P_MA3934Q^617XV\)/7BU7Q^OQ%=
MPM+"LN :M0XF6)7@'9?5RI2X%K0\7=P)V)0BS). TYG"H2]7.7AV,+\XSQ:.
M>[JE$+6,E:X<GL>\-WS.;D /PC[GRRP7L[C7<AQGBR6<!\<JX''$R=Y[,L:=
M*DPE[AVPPCS?+$(I1&$E7.X5""%<[OL+!VT[-'<:SC>^0*X"_K@_^;[ OR]@
M92_*+/P5G"+XA-K@ZDPL\R3D^( LY6)B^!?SFQY-P3[0\$$XP7!R^#]6<"_D
MM=;7XR,^%"YIX44\3E)QZ"]@@7"C!P=!Y_ZFZV:V*IF2DR@<AY-9;SP8SGP>
M^\R?!8-X%//1:,+9J ]?FX-\_-.+-Q<?W[Y+BO(2G[V[=6M:LYN&Z.IZU&7$
M-K7YR,?W?48-$;*Y>DV9+7=1=VI_^H<NE=]XMXC".=_M4LDOFL9)?=-_.P^5
MKM4;/)I"RQAWZ@[CY% <1N^8+4&#S>%7D51S*Y3M*$1!Y'H9BMH;O KJ @@]
M5E\#_$?<I6OVF=,E6G"6PO$M*FV'EP=U/YD"3-RD50XCATE]5!+[Z"KGG*3.
MO01I\WE.F1I1N/P]NQ7+ 4)1&(MPYT%N7)G22"MU)7M C\/)8&66W[J6@Y14
MF1TZ#3]E$];.9\T@K8S/FC'ZH&)F$/3'T73H#_K]L1_W)D%O-.M/>J-^,)K&
MTWBV%S.6F!D\$S&CE.(6,N9Q''W\ACRQK\\_OOW(KOAK,!]_/8)_Z5,;SCG+
MT48JKW6:!C9'+9#\B7(TY>L,[Z[M)?H%2_C)RP!_])(L5S@1\QMV6]1VVIVL
MDL\0HZ#LE-=#7]>Z.M(-ES\#V:Z268,MDUGF6KRH>ZSVW_[MY4N96L09GZT6
M <_/.4C\[^#/WPV^^^X[F3K<5@A%?#H<!A$;^3/FQY-1,)D->GPRGO')M#<>
M39^N$#*\^#N"(1O)E?[T*\HTUGE>L@Q=A&;(8D/3R7R(:1>()&WAY7P);@X&
MS2,O:#$1#%=DP6[1$5G A>^BI71SG<%EP;!'ZBU97M9B!3G]MQ!! R-6X'3Q
MR781GPPXV&+"0JO[WC!*,//F"6SLK7*%E/$#<V1>M)K?8@ @7.&<8A86R0)1
M!6&VO,5G?WSS5OP9W,A%4HJ)>_SE@B5SU_P/X#OBMS"WDH77:*=I+_ L*Z5+
MI^>2B'@,S& !4TIA*,(@17>U\%2&^^A^IF/SO0[341V"GQ/81#$J$)KS!'8!
M@S1)A_S0@W['N\P9BC9886%"'B3P2_B\:T%2$J#X!.-;!:SI MQ;PG3@BRY*
M> [+(["?RW(NC.6//$^RB'QXIZL:=7!,PGCOP +.Y]F->AZ%E^"=5?BJ@ ,%
MIZ1@221<?A$QDR:^/"/T"W8%]O45/L!VFBD4@Q^PG7ZO6/(0HX XO!:KV6/+
MY1P$"^H*QQF $W63X F&QQ8QKE;NA:RXAJ77 8/PFH._'^7L)L5CS[Q/<"O@
MG;!R)0PB8"E& ^:\*$28#KY.?]$KL,RSD$<K>(TY8&,]PP[<)%A##(E9'[ES
M H?WCN H*T>$;<XR>.VO+S.0.G"9YZXETU&.G/]C!6L'FYIF:C?Q=B]X!'_$
MF5VM&&X7YW0YR?WSRMLE/:_Z789&2LGRY)\D/>C*XG-<V^4\Z&H@ZAK!%V_@
M)A5XLO%8PL/P7EW)$ZND40@SSEE^ZSB4Z*T:,\1O+*]O"U10<Q1(><Z;X9^:
MD%,13_UH$.=:K(-3#*^1LJEVJMEGD&&TWSI4)MW%ZF6N9<#G!YRGS:BJ5 %)
M>(VGDSLFO-F48KH=*=I80M#?*(&5XQX/.[:DD=,3$D$-@$1NV]E*"B4/Q*(;
M+S_T/H+> F7DFKJ:L7RG,0-8T-6\Q"&AYI.K7P@-M,QRFH4<9PF'<&Y(S0VV
MI1:EX'&,\4[X+EQFD*%2)&:K4I_%UL?+L=5> (-F*88/X#3IL.(&HNZNUU27
MY;(Z"BHFH;9;S XT:DH!EIR'X!2 A+JNI/W=[]%/58JA6,$IT#LA(K#V&Y5*
M(%.!0LBX2ZB63:G@6@5]D.3!=*E-& *EAI:E'DU*SU0K<F^16EM2"O=0IHG#
MU0.-P\*0+TN\1_7C"F99^&N:W<PY B7IRQAQDDDN^"JX?(4^L:X5P-AU]AG4
M.V61Y-/!XH/GL.5UMZ:LM97IN@^U':W%[3>X)R@N]!L,628LSRO8XU38G]):
ME2J42;TG#GU14E1-)L_ 3%3)J\-U0!7QS^,,B0WC(6?1M!\/_<@?Q^/99!C%
ML1^SF/79</:$0V*/V1L-GILW2I;S]H[HI66'&S9LXA)7_ N*,I<@HNPI2-8%
MZ?KF<_Z]=XCGK>\M0218(J3KW:"EE/.7,0J,NB$@74]X$#H%V7H_M8M67@&*
M$]R:^2U:JAY>1Q1S\''\70(B2>9:I8&J!-!=8Z>ANZ9NS:;3-)AQU/#7)3A$
M*-,-8TSJ./"_"J'QI$6!/^16A*#:A$-3A5OFJP(?J%4"UW:5T^+E')>6I#Y:
MAYG0M5+^=RLM#7M HVP[$*[9*X/UU@N3/%PM"JGI<IE0UTKL!I1:D7&X:V(*
M.4=3 U73*J6WUA9^*>:W92Y6G;/N7>GH^_GYZN3]Z[^XM;+7N(_:^7]R"JP7
M\N$H8O[,G_3\V: W8X,X"H?]R!^R8>3OPZD/HL#"9Z+ CE7\9(<<D7<:HWE)
MWAP%-HTXE(0\4285'<W4Z4<)@0NF*8BC*SBZ4C>0%4KR0OR8G#L2G&1&YQF&
M;<I504$%1A&S4D8;Z%5ES2S&;R5%L5*B$<-C<]YB>8/ PEBKJ2G(!D^;,5\V
M+TBWZ!! >_07);S3D\2%"VXIY2X=92D4&Y$M*<*JZ$(CKE#30A*3AX9!F_M@
M86?^L0+/#%<]"^2J8E0Y^9R0-_>_!T<O7W>\@[]U_@]_?G#4 =,!5_W5XQ"I
M6^$Q7PIA8=5Y30:[831A);P_4>!51P1>41@9U_2O/Q]]5.Z4Z1<GBP6/$CCF
M\UM4_"&/ZB'=N\.I25P[5NX8#[KDF!"LPO_HZE:1'W :\6J0JJZBI*RC[C!%
M82-V*P @ZH+97C[H\\%7>(OY3,ODS):<;!7XH+P>(!E6<Y9C+!F_4BW"=09O
M4G>E%E0_7\%*CGN]@Z!S,)Y2[/.<GD/#.7M_@<)EL9I?B5),:>B $.%HM\Z]
MHD*]S-E-@9D"8;L9 ^^*-($4C-G2=/*5..$)&;\'MU_WD*P]";A'_Q3O>PWF
MWL?*Q>"V?2<' NN?ALD29JV&])[EO_(23WK.T7H5 N+U/,M0NEQY[PX_'N)O
M581/ZH1JXCK(+\Z(L3 ;'?26\ZT/7+3*K9/@/BGV 6D<.SRU5F!415UO,CKC
M]&T#Q@J[G8;S520L:0I"6Y^LTGOA/!/^Q"[CZMQ]@7 HB4/LR+-B87#O7O!&
M$-&]^,W%6_/A^\B'W=>Q?D'7*(['!DMI+^5Z41^  '#0"!R&VV8*;>HJC+)B
MKFF6+]A<?0E?H'_VXL=!BR'P7!$VOY]%\AHMDB8<VA$ +Z1W+K/QI/*^QZOY
M4*6(O\'L_Z9FWVKVDB5SDZWF$=K,Y!J@)*2JD;;(#V6'0DS*D!N!:L&H,)$?
MKDZK_I84G_JQ-^@1V18_FOK5!\ )TI$QUDQP/UBIKMX9:Q<$\'+[7=@UM*-M
MDV;P1BQ95T>V4#UUE:T2(LZY)%@,UX&^.,F+4MD8.AE3;1((I56AS@.I1%Z
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MXUM5>T.)DMIN]5V+<.>&J!M]0KV&;6V0J,Y@=7R;($.Q!8#%(,H[R+;4-29
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MD>O^2)=,/CV,Y!:WP!_.1KVP'PS[//2GT]%T/)J.^(C'HW PG@;^T[T%CQF
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M]7Y+O'_S3#T1FWQ# ]SIJ"J;W)KW(['(Z_>[;H_+D;4 R^W4V)T9'9=5OF8
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M\BN6)O\T@"$R:J%_YJHF%M<"]V@U+[+<B= 1;63TDC>WL?'8I*@P+=3D4+%
MT6TU]B_:<,\$MNUK+B<*E]5B(7A>=/BE??KZVK"KG-=B),&J0 !@86%S[J2K
MJNU9M[%C(J#SD@(ZE51TQFLZBK_&O'[X:<'X A]6M'TW:-\'TD6K?=HU>_$
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MW7!2J9!4DV=WB+[)DMU<8U$M9=4EYJHXIUX/I3"83%21='7U( 5@5'>H.TH
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M<B0B"KGFC\7P?0Y.<^E.KU9%)Q6[UX9-B$$W*8?]2/4:?B2.XQ;2@,5\ E*
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M)U8G(9L.HE$\&<Q\?S :L&B&PI6/9\.QSX;[8MX'$:N_/A.Q>H$E1D61Y2*
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M>M'7.[,[',S_Y_CGH>KH=AVEY24G)3PMA#<?7% _-XP4H1_LO<WF\^RFZ/S
MB/P=/.2_O/_+W\<S]"U9W;_<QRJ^5JQBO(]5;%5#2C]$TR,M+96UU:T]/?-^
M/KT\.[FX\'[^Z>3\Y,-;&PJ)G=9"1E*TGL87Y%2Z!Z%!OR)J*%>I:E5H\MC8
M7=/B)"]*4:==[10&99$W(+I_#>9FYHS870,&SR:^#W9,?SR._*@73?O#(9_U
M_& 83L?Q</25;!AYJ!!YR98%?$;]Z:&; >#+V\T1:U77F07-04JQE(N[T3N<
M;J;M+3D[Z0DYZ]I/K?W6&$";30S7$XY$^J<7@_M-LK_1)&TY&&3S".;]_L/[
MD[/+3Q?>Z=GQX2[FP-/<[F]J8[>:SH-OGQK+5U[&EL?NI_/M7"[E^3ZNV;R^
M?;7S5/Q)VURDWE7&,YAP'E$+>?E5<-#K>OB_SA;G<7]P'MW!N>=LVL_.[S.=
M,S"/7GG_E5VG\+,L>AS*Y@GLX_Y4/N1T+A&Q^,H[ODYXC*P_X IBN/V#< (?
M*K[5&@>R0[6V3]&7L1LC@/M[167VD0RU>W3<=@WBU7RIDR^4N?&.'F?(L3;:
MLP^7I\<GWH>WWLG?3LZ/3R].MAGV':=X7<QH^P#1Y8=78IEV^_?VP<3U3K(C
M0OA@BV4%V*;]W0)L!_T.920H?2F[6$N((L>"V\*JB/F[_*?1>JO63LSHFJ6I
M)]6'6%FR\!I>HYYQ0'F+Q$AN5*3R24H,@K)?!X$+\T*SRVI26OEHC8$713+R
MRXU>X,AQ6>5I-9NGI)45N>"M8GN_^R8..MY'N10B]T-\CY*T<H'+<P!+CFS<
MU;R#[$OGU6\T2XM/<#8Y'.PVS_^5*;3_H^8F[ 9VEPH'=-'4IY0R\Q=(?5)\
M[V7YDYU?;); $M>JHR]-*SDB0ZKRBG*PVU;IBJ=C-6<V?6JQ"@K=XB_L&%Q8
MK55S]$!%CRPO_8)]21:K1?L@I52Q^J+K)KUU]AM!'1!A$FS=8)_6M1W"M9T+
MRE8B2RV0)K7)JUW6VCR;LEJ0'=!I$. U^J#8?UEM@OD//L]NUESVN^>X^Z'^
M6JN\^P@,"W?KA,NNF92Z.6H:N0J@$DX&L_%P-.GWAGY_.F1!+PK#P; ?LEDX
MF/9LF[KN?=6=92>R8P06M9R8&4]R.&!B-]:X@$XGT.G4&F;\'3&LAQS&Z*'G
MW@A@&,>L[A\^M8NW@QW>Y$QS$"Y(Z1X3@H&Z OU\=.P=@69"^FN1Y:^+*7,6
M:\7YH[OFS^#^-B%GW]@%W1^SK[ 3^V-FO<".>C^^,U0_1>YS=.^3M,%RM^SR
M@YRG+=ZUU9G:?9J-DU7#TC1.EZTM&V+M@1&6_WMQ^N>SH\M/YQ0Y_.G#NS<G
MY__W]?VQ)R"1A7T?#GJQ/^WY81Q&_G@TF\U8/PS8:!2$V$!P>'_!/=A:MMT3
M^'PFO=#3]#,7375/D!@"T^"MH.&-)?5D]/4UPMX&V/ H#=N/TKW.C!O27"&:
MX3"9;1"3S;#TVX3M=T(,U\:+H\T$-4K]Z,L!5S= _F>C(S]^K$>^D8.]XQB\
M^-&3,__VKL9@\#!7HQ*GU@V09^W59C?!:S-EMCF&D^GO>@R_H:/2:SLJ7I[=
M"(1?_]['AH -=YZ;S;9^NH79;,]A?PQ:%[55EUHKB(S6KS8UCF9;: KK+>T@
MU=]'3VRGNAOBK:YF]R"9;P\D\_IADWB[>[A'%^CB(N##>_OA_/WOD6N<'?JC
M7=(!+:6%EYFD@+([7%;$&+*$2J1["4Q !::KY7)^6S$V)RFQV6$:5I6YOLE$
M.Y/"_*Z=0#9JJESTJZ)%^&'G*2WSBQ_A8'A_/7KWZ<0[/SD^.?WKR9NN>VUI
M(3%#(BG#*HJP4K$-YEP3#Q8RWUMF7VDY=BL]FX[#*1NP<3R:<#^.Q]-@Y/?'
M Y]-X\ETY,^>>.G98' X&7]]%&L=)W*_ K2A (L2Z/KARY1&3P)[/#X<SAX7
M^OB>$VI'NN]<'O+(9KU3 < #7="G4"^XOXB/["+^;OK@0(+&/N9)6G;VEVV#
MS=Q?MB<QH2=<W_68;M@]Y<M1%('C5>R-R^=WS?;&Y>];_K^_$(_L0NR-O*>S
MF?O+]B0FM#?R?O<I?[Q&:FPGWGZ3C=Q?M"<QH;V9YUR61W@?]QKOF5[$1S^=
M;^6&G2Q8,O?VD8UG>]/V*N_;V.C]17P2$]JKO#53W@ <*L:+$-'HU48+OC'Y
MVDXHTDVW: <XX*"!5*HV8L?#U__J&_$??Y@.!N,[@KW;LOIMJI.:"^P:8O<W
M6!IK*)JL_W[+U=]84GQE_/.]A/ F*/_=VK%L+CDW/KU[(Z(VH[T1\20FM#<B
M'D,F2O1,1)'>GWQ?>+IV\]77T=E?U5O;7]G]E?T6KNQ>*>YO6,N$]C?L$2I%
M'5C>J\3]A?UF+ZSZTSK^^UUK\C;_7O5GXT_X]?9'F>04[KI;6M<_O1 Q#5W%
MMFM=K:O<U.((%OU/[?T3/Q/7'!L/IIP.Q ]_#++HEOYP72[F\(?_#U!+ P04
M    " !FIKU<DX4 *25&   A9 $ %    &5F,C P-S4Q-3!?97@T+3(N:'1M
M[7UI<]M(DNCWC=C_@.>9WI%>T&KJM.4^XLFRW*T96_)*<O=,3&QL@ 0HH0T"
M7 "4S/GU+Z^JRBH %&79;GM;'3,V30)U9&7E?7Q_U4SS'__]WZ+H^ZLT3N@3
M?&ZR)D]__/Y;_EN^_#^/'T>OLG%:U&D2->6SZ'E5QDF5)9=I]#(KXF*<Q7ET
M7N;S)BN+>A =%^,-?I?^>U&.Y].T:*)QE<8-C#&OL^)2C_+F['22Y6FTM;>Q
MO;&UL;N]LZ7>/RQGBRJ[O&JBS?W]W>AQM#7<VM.O/W[,._E6MO+]J$P6T>AR
M7.9E]<.C/TWHOT=1W2SR](='D[)H'D_B:98OGD5_N<BF:1V=I#?163F-B[]\
M%]'O=?:O]%FT.9PUWT5-^KYY'.?99?$LRM,)?$,C/XO^-*3_OGO$\R?9M8*9
M;.I-?)F>S*>CM#I+Z[3Y!CY_L_G--]_(HO$ JJ@HZZLX@;7)AT<13??#(X!Z
MDU9VZ5<IPN%9M#-[WUI$-(K'[RZK<EXDC\.?] YXR.^B:5Q=9L5CW-"S*)XW
MI?VJXDGXNU%9)2F,591%*AOEK9HUZ;'I37@J^AZ!Z '\1I8^*O,$GCAZ?Y6-
MLB;:V=CZ_EM\X,?O1Y49_5L%2?QXZVA1:XS^-?XVKYMLLI!S#@8Z.3J^^/GH
M++KX^?@\.C\Z?'MV?/&/Z.04OSDR7QP?G4<OX:M??SX^_#EX%#X?_?WH[/#X
M_.#YJZ/HYX-?CJ+G1T<GT=G13\?G%T=G1R^B7V&.<+R#DQ?PXN'/!R<_'46'
MIZ]?'Y^?'Y^>1.V9]8\OX;U_1.<7!Q='T?&)NS-G1Z^.#TX.CZ*W;^"Q@Q-<
MT^LW%_C.R[/3U[*8LP/ZYNW)BZ/6+ >'%SC\YO[V]B Z@'^_/H+'7D1K^-Q_
M_.GIUM;P._]Q^G+SN_4![@7^.#P\/7MQ?/+3JW\,HM<'",0+@ 0,^I*  !L[
M/WU%FSYZ<Q&]>7MV_O;@Y"*Z.*7UPE.'%\< /&^IM%-8R<6219\Y, 2#'OQR
M</R*CL4'QP 7<PR_1S#/R3F,@K_@>L_?/O\KK />']!<WF+.CO[S[?$9+><<
M8=6Q&#Q5')A@00="9W_PYLVKXT-:"9^=>NW5P:_G&P%2X3#!Z( !;VD .F%!
M.82NV[T_!AX!@/_-JZ,7/QW1J@Y/3TZ.>*^\JNCYZ<E!]/+XQ1$\??:3+/SM
M"0(U.J5[\>H4X$ACPAC/ ?7>P@UPR]K05U<N[W_\:7-O^%W[AZZ[:6A3U]5\
M\^K@D,_^X"?\$^\!H<3IX=_PI.'N  !^/3B#,[SXA.MX?8J+> M'<'+8OU]W
M#-\W\0AXVSC-\WH6CX'U_?!H^(C^/8N3Q/R;Z2Q]_% ^%5+]FRQIKO#'X3??
M/8JRY(='_WH2CT>3)(EW=W:>[(RWAOO)UFX\&0]WGVR-=K?2Y-&/BO%&^C-N
MI/K1_P:_2\QR9;;=X0;-=SO1_C6NJA@>.;^*J[06"@[+W7DR@"6#$)*L--TW
M/GLS+.C6Z4_A29!>\NBXKN=I] )$$[N&U_$BVGHZ($FC8R'P5=4#*/@)C]NA
M1"^^Z>/;FG4O69WN(X^Y19;CK83/AN<]^I&(@EP2)(OVXIS_?'!V1'3,NUAK
MS556&X+__=P<VO??SG\T!!]0N8+1,T#/YBIN!H"8570=YP#4*AVGV76: #O8
M^&GCS<:W!WF>@<"81C_EY0A@_R:NFB*MZ@A>R9HZ2M(:%IRF]$5<XS]J7$.J
MEO SG%]:>2N )<*-1:$5IIK/R@)6DCI8P5V>UE%< /+,1[^EXP;$6'PBRK-I
MUL0DMD;P4OH^K<99G=*C^/NX+)*,?[Y*JQ3090)C12#'X2:;JT$4-_#P(FK@
M=N((N&IZY*2\3E'HB[:V&8W"71P7,#! X,C,R0BH-H6+X"%G509_PIIWGPV'
MT6QCNA&M(27X1UF]BPZSAN=?QZ<)<_=PRNW-<,H+  -L ??S[_^FT;<U]6C>
M@,#7( Q 9L<-#7!Z@%X]KK)12D>,ZYO-J_%5#*N?5.7T=JDOH)V$P0##Z$6:
MQS= !0#@U:RL:(GAZ@_+Z0Q K=>)9XWKNG5>H2E13:3&< *:OIR @C&=(D@,
M.,Z;<OQN$,UB@\9_1IHV'&Y&,SQ\'*-C<3 $KXT&G_](H_BKA;GP-=E)M!;7
M&B'C!*\I:4H(=I#C">S>/"'-=*.#S !/VO, E(%;!A."V!YY;T4T<$3WVOP
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MI7)AD@)W^B&^!!YVB0/88R,Q@F1(?,"7::)ZEHY1FTC,Z<:S69Z-28GN0 '
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MN:$N"UCK M P!H1C3.JZJ68M1!S[<"FK%7WD=;BMRX(V2$-'/=5LN69 JBT
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MBP._N.X4,9V%A&()&0)^?4WE#XUG@5&^DQL/M*3K,Z0'D7=UD7?O0>3]%-'
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MH$=&N*=HT%-V8*F,X,Y6_$QM9/D8DL%?>F4")PIXDWZ (."V_PDD@O#ZA/*
M++%/+%AB7*.@X4 86#+;NG.;N2@<_%U5:=-OWRX1\)J#JL>?74#X8+G@#^A#
M>?K@0_DRRK@C)7P)BX^GG/YVX<0#XX^XHP_"MB&V=E_.A,P7['<U_R(! >-T
M4&;D\"..0U,22BU&LMK7NZ8I&=4Y1JXN<RQHJL(=75(7IE548@XO=.;#P)4[
M]A/J%A$:IC)@D]5BO7_ILBRFBC'6%,E3DG#R;(P9J$AC3$;DP.8:#CA49V&4
M<"L5VQ8#2&BI" U:_Q"B#856J^USXFM76!G+QPJJ,<BAE<3^= '7."'4(>E]
M#E0UD0FMOC$E]B8,_=2$^?$W:R;BLQTIYD.?BO :D<DO^L!B@I(-NJ-Q4"*0
MPNW,\= NYQ:HE@;39K8NQ:130B>IOU36-^1/MLHQMY9QSB.UMMWA-Q9[Y5"N
M2^[K \*%+3PUYBT8SUC@%2%'S(KW105EK'AQI$IQJ$6 3!ET+H)G6#NRW_5[
M)OBBX '.\[HT#A,'\_:!DJS>;P"RIG J]&/R)NC>JK-4%JC5#I(=7:N#]W:H
M(KV93Z<<:>RT/MZ_O2Y4E-=7OT;S&OU\M6?(OU73#,YIH$V0_G&QTOB8E$9'
M'CMUPG43-ZVO)#[-T<'PL,D.HY;WI@9Z]].BH-<,,U*BZ59\V&V(UDACU%JI
M8DZ:OP=\RK=CBUV:Y7+K9NA/)6R)U%T%&<D'I.IB^T7W>BM:.1W1K\CE]UK7
M;><QU+M*=?6#3A@H" R6%1J[7?-$S/<"K<KEI436PY#6/CK!RW#Q1D@X"%_"
M_/2R:I'%#,U#IGM"/:^N*;A/531WK[OD1N,PBBG8#MAX*A,$GI"#'"1']&W"
M?.HQKR$)GS@=7Y>"TR,TL:]:!U:M "A7M6U9KD0+8SR7S-)%?7P4: ?H6RW8
MK_[22@M9YO/'7G(E["WP.IMX2;-/M_&>@XR\"O2NCE??X_:B^J5(D!W4G4WQ
MC%+= _"^E _8A:B\'5" 98IVV;M,K[B[;7^7FD!+R3ZP)8@IL0:(D>OQ1Z9+
M%-:0("(#ART6KDQQS\04E=0CDQ'_QGA%B7B_*FDOMH#%4D&+C3JV'0,%C?:"
MU%@_6K'I%GUX&=8NV%I++UP;LX;:<8Y>2YYK@;H,!:A2'%X[52=_P:7C7-@^
MM1,;^#5>R/>_# CMDK56<S&$]@AM08N.].>@IG;8'VK&DVBJHW4_6#'S)I2>
M<&\D8$G*!?R!1[JV/5S'Z..:+<4#LU46FQ0-Z*558EA$Z:M29D1YC;-:M#ZH
MTEO*5AN)GEG6![H0MSY<;,:JF"?V/8H7K021 ;?%Q%)=(P/<@:I#A<X&#\5L
M82JR'N4Q7)SS,=:4JJ-?Z'9VG%49Y$+K)&-E*N])92O;[37"8UA.PHS%=!")
MJ93-I-8#U'> DIUJT:*MJ1+FE[DV:E,#$J3^UZTP/?O:\S+FOC4O2&8O*R I
M80TAI@5E02;NSB@>>\*WW)Z!&*[O T1'BYK%C%0+C'=O8\>:)"/9QUT %F J
MD>_$W-DNY/%#%_UL]![\,.6E3!]%4N$ED)^*9C6N@6(7V0\$]YXJO+W(Y9)#
MXR8 ADMGM<"B[C5UH'P:-<K;.CM+2)XR$_3OP;$N.EAF%R&J,%N.A770UZ6D
M*(Q#[GP'$'SGDF@F\PJ7:DZDG]4&,,?EP[W1F1H3TT*&CI !%:QQ^:6G7_OF
M-S%!+A68=!W+O_TXT38[8AFW];WIW:FVMAJ/7?=,(LNYL4H<:U^@[HXS5FSR
M2TUHT9+&>FS&.F7U"\4Y:A]3)FGNZF%;PB-+.?W%3&EJ<>&HKE^X3OY3E&AA
M,"]DJ([K.9CTT24JFR#+M$(\I^9:$1+35V,L+_SN\01KRMH^S>1]IDP<3/I/
M%'-\NW&^ ?-(&&UEXBYCTW[5XX(D4HS2YB9-VZRJ*WFUS=V]_.7;M&0KDU\H
MA81KY%/R;$'E REY][I$R3F7\'5>\N9P2-!7O[6/]N=?+GI.<TT=YQS?_Q<7
ME=[>VZ5R:YS\:XQO6-*^K-;5P>M,5JT)NIOR\:2C 64%,R-),"')MBI73<CG
MM>I&K*M,>&'.EX ,36K['K(R/[6G'(SILR(IC^^JX,_R>7 SD5849?$8G].V
M 47S5!']</2EK-OKB7B575XAZE,SLX1#9F@#C->C]#(K"ND^O^RT7 D3.HD/
M.AWR5'1((KX(L,HIHT.4^U*R3S;ER]RQ!\^BY(+D)"=[2<AV(LTE7Q ML9*L
M&*J(!'QDHG [\>NC [S2(USIO](*DPTYWWP$I*Z\D01)OSUAES!FN"1%LV.D
M#P8PV7*3&/:DP\%M_6\@&TEMI.8)RAG/C<V8^F]V'X$IHQNJ38%8% :;+]?!
MUOO[&HN51QAXR@Q\F=X>V4X#GK@H;;:M;0\-];Z-SHH)7B,8%AD\0QU:A["Q
M;:K3^9V?3(E'JC5 ($I)-V;-YPV6L-U;[^A%.9YS$/I*S5W:-\+SCTB= ^LS
MH%%)\I6.I]*CU)I[%J[K2>D:J)IF!L:4[-O)EET%WR30W:NBM_6&]?EP+(:&
MGS']+'H%0E-Y7S)\#"@R2BJF:^9Y06T,6S> #/%II;4P^@765)9+?"FFRU#;
M2FDBIM&6;:5 PBPFTQI?C'6=_&;L8;<&E+$89HW/RRNZ=5MVNXIWU;?:='WD
M66[;-)TI[&#,RB6&C LP^;/Q U[K\R#4V ?U&M:::^)WE/]$'GSI3MYMVO1@
MVQ-'UNK[?!N'L*,O6^D@+&S1MR,; 1W A.42&\_&XCB^#G2D4?;<%!A^.04&
MV*V8]/3P4*ZENY@NI .XO3M]Y&?)731T0E5U\9U;UF6PS-S9OFO,CX@+D1;*
M*QVE/'_68(UIWU6\5I>L7+-&7R2Z$[7PP]L7TD'6[\(L0+5*JTII2X[7"1MJ
MURRA=X@@IK$UR80 D:-"-=IB5DKUFLE]Z1>8]GRQUI)@<]>$DZHPDX_/-2V?
MY.A=*?9:H_3235PQ-I<<JEC!/#'EC\PJ.)SW(>)N><3=_D/$W1=9*OG0:<Z2
MD7% PK;[5E\S*T8&+1ILJXJ8+#1CB3W1WVU^"\#&@#C;ZJ.KD%C+KQODQ-L%
MK!@#X%4-E"Q\2I+6#:39?RRF6*+'G@U!&0SND-?=G\[=O8S/G<HS60ES(O\O
MZBQC*C\Q=_VL53!,9]#[-@9U53QP([XCG&_!KU=ID5X+CPX\Y=C"W,0&^$TR
M%XY)MU6OKGIQ6'YPUJ@.5F'U6^<'1.-%CJTU^ #:E>Y"?[Y+U%<Y[B94A<-)
M"/T]6/A8'O;Z*))@WC@:5=B_BSH(:LL$RF>F\JJUH[NI'MCE<G:Y.7S@EU](
MU_& =#CZ=X"6;W?KX(HJBH@A*T$!SB!7,789BB;VNR--D<Q7<+>0-J"B8T.C
M_'1#]" T7;$9X9S4EB_&K)VB0OL(Q\)A8(S+ERPX>KM*$VP5Z4>VZSD/N[87
MSYNKLH([(/;WV-:'ILA&Y]H+![0MRRM;I8 5Y1&'.7#0;:7"7+MJOP3U-(R:
M)Z4**O/O2C+-T3 L]EL@W'%NU4)=C"-0.ZQP8.M*=[A>N^*>N\%HO*0JCZ R
M,;1> +,R7L:48K48V 0 KWB2-O9VA?-K]4JB]L/PQUMCK$UL;NL4*;3>#Z%N
M5@N4/KH=G:[+? [*<27!T_:?7N$H@*3D".89') #ZDW& A]'&=/N)Y,X:YUP
MF$'JDD>[3-(F,]#4-;2LVC=62M\Y0(C&L/(DJ="\3NE@+D(/2**K:V$8\%EZ
MB<4"VW&JV*43Y$RE96\-47R'BPSC4""49X-1?AE)A$0[NF^=9XU6Y =NXTE=
MA:WHT7!;5-,,>DD="*[6[56#4 8FKZ+-P"-\ T5^!AVD@5 &)>JNZA!DVW=3
M+TD&74:/RHG9"8^EHWF6K+R^;>G=^:1X Q9=\#3IK:U$;$4R5&0^4XZ!I 4Y
M4E"%-Y@,TN)PIM4$58,PO0F[4;E@TA8$L\8?!4U<JT&T*_VZ)VFF:R#*"78$
M1;E>A;($]6SD=@;!\+<!=658JF :F[:KFM3:[K2J%*H06"X*BB]03KC+@[4]
MSQH.*E+)MO'$O(.6V"S)&D7_;)282=,7\U?0 \%>:]='D-;5V?Z O=RT;+M/
M4^C3$"@JQ4JV3[Z:4A*TQIK @./ =ZB5RF/QH694>366I:'KP%B9@[ XZ[N1
MK#C;6,$CQ8KK9UBX+2[2<EYC> )F"VJX=Q0T]W6XZ)!#3('D4AUT^)U:"CY]
M_+>./M)24\S'8A$(/?BTG?:8B)(68^7Q]DS!?H7E;O\I1>QJOI]=7J9.W9(A
M4MO2!&TL?B/5]]C" P'ENIU\@#US:?E-]*6*9+1#HO$]JG!>*,E&(/M55N$T
M^XA'%,G#&L.Y:^L0]D@A([GCW*IV5Q[?U)9 V_Z4K>XUR@ZQ0U7*"FO.]]T*
M\I1#JIV-38-NMG+.@7$6!PT\30=)X7G.V1:K$ 3J;,%Z39E+,6029P>&-$L#
MT+:7HY$%8[_,&0GK$UONSZ,<*&EA:>/+@EM+7/):_<8=SO?MNH>6?=6W?0%:
M!XC>H=>H61JMARA<TY15D;('A",P_-ZAU/,S:!>JRI=:.7'*CDI#/,SCXOIB
M]Z&%*_6DSR:6)X@'46)+>H+\3=LMVA>MU[ UD O3&Q?W79F/=5<#6X9UR@Q0
M/M?<7M7B]\ T1V!&*!4L18C7_ZX[^)CRWJ/ZH]*@G9>)"WH9B9@>*8-]J%(H
M'"5@J7=/O#MRYKHT>TJ,U-2J0FDM?M3\"6YXGIOF C8T.INX6MQFP"#8P_0K
M&ICP51=Q3<$,N)4KUR)9!&^33AT:]HP7_RJ^YK! >+U]!]AP_>67>B0SM3M*
MV^M1G85MDLS2# DL5 I70@M8?K2(3/=,NEVYPNOEQ)"D&*O9U!CSW$F26J1'
M!8<(#3*J%>'SPO:3X:;.=-DTVMN@)H6Q[5;,<*\9=58C0DLYD.8> ]72QQ(F
MK]8]J>;7ZE::2J*>G4(%T7>IUW>F-4$P4-KYG"A>'0??$4WE2<;H&'/3L1,'
MR:] H-:YXJJ9=V*J/E''<T597UA)+F"AKJT6W@V@B;D16]6#3JJ[S6IOLPN=
MG"M-IA^,\,N-\)L/1O@OIXI@: KKZ^!;&5.9GVY$)-STSV8B@*J;1- ')4.8
M@,2--58%P:%=:W$U +(@^%7+/V+_,%7?F(MP_#[5"2[I;W]?2%31D<TB!4:T
MRU \>6J':Q$3]J_'(S*)IEQ1RT[:ML=Y>:?RF#%4=%2_TWW]*)X1S<I(6U3\
MEWCR![@(\C^.FSFY'[1V:U)1/Y[2:=C5[GVTS==9C>(9&Q.^2CWSI#35:0$5
MSE5'^;=4G,SXKKZ+3K"*==-PCQCDA(=Q?=4A-R5ERN95L7AHN4(D BFZ83PL
MB6TU8<URE5V2$H1TO_M H?,,V"%^AIU:71F!9'TM6Q\H1MEE[5!O;&]$O^HJ
M*)(T;2VXKO.;3M(+F"U&;QI"@<;('"W\9LTFN*ZSQ_?:>%V9\;PYR*HIZEEW
MZ7'9+5U%_[OK=;'H#+PF6$PK-92U0PM&+@!$-&]->.$%VP9TYLO1"-KA*J_*
M&I 0J.D$>,"+%'7#L5$E7V,BE/7,:7N21W[')4",94=D"8:1I-FLW=!P8H/*
MEP7,VUJ!*E":UMGP.A-_G5-OG7Z6=>7<E2 J@6I*QFP3H>R"/7TTM1JV*?>O
MII>V4&8! TH9@3.9%M)8Q<;5+]^A:: 2-!90BU%V^W8W%=:UZT;,&H2A99%(
ML&E@*<*O1)GVHXL5G%HP(CU;8(O*DCY(2J*14L)+M(\VW!&6V3LL2$\FA2(1
M^9_=)GY6A%XQP2G/TOE*2__RZSZ[&W@>-_,*'9$#T"\+_O S.5GP4]J,O<9#
MY!]%R,UF94:MW# [T<@JC35SD474WA!F#+.LLJ=O";<C:E0T*J8QQ=T2^ ZD
MDFGL93Y)X0^.7^()3<(PN35+\>OP9"UCC-CG"H"S"1G''>@9/O=AWKU*HSO,
M ^..3X22W$8N!QV>#TV/6N6]&[Y[:&NI3 X\F2O<S$0 "M' _306G8YM[:BM
MJ$WN=8>$VF*67TVZQ=:MH57S0))-C%%-I(1V3+H/'4FV#YE*)B:%KH+6KGVC
M>-A@$!<9T0B]]3HFH@VJP@)J)1F%8(75I>[FF\PY+0JGM+8FVQ=PE;U[!L45
M]TX'VQ!1S7/C@K5%A$SN2VTND5N0I-B9.F<>>91%PCL. "K6MW8N2[GTQM9Y
MG96Y1RZ4@R6/;[@HH6D4/="Q0TQ0IKIRD4E6?1U7[U*1$;S('8>CLKL<=;=D
MJ:01.X.3-=1Z5C;>HSF?CNK=/0=5I6++-)JO0C8\I$%7UM?=AN$Z'IRL:BMX
MAX:I'HLV&LW0B>*N_( ]W>AY$<LF7H&%*3.1:!I>8$A37=M<-BH>P(DWA'[O
M4?P!3ENP897O1AV-*5.\90GP*W(92I%:M_R:*M_/OAG_#<]&RNE'7'V.*@>4
ME?54.WLC3?!0PODVX]S6@W'N3M)!ERAP)+JQ\P9+W ?0S9N8BJIP+(?<<K2;
M:5]"E]F>I*B%$M!4G:6>.J-3R?Q'+A@(T]@HURO4V%P!I"ZO_#33H$ZI'P%)
M$8Z]L3U>P&"[TX_7)<O%Z+I 1)N5BCTB63U*WQ''HB\0/N4(91E3=1F$((I]
M44F(0EG\WL.N)?I<9")A"6@@K#TCXV4)4M4D)M=2C5V%G=)55>1,0I!+-"@[
MB+E?EG.S*LG:/&.*SG9Q9);03;%$$:@:$Y;D+"8F^+$K(,&RBDL,%,($4B#G
M%64'M TQ..QE6J15G+N4;B_+,KTL6YW4"&QH%Q'-TC4CG\657\8C3'7 -FYL
M/>62:L;E3H0?.=JJ157%*^V:;-NI315P3R):(@8%0/?J,5>)J6:E]X]#&,Z)
MAYVGEQR_0'CN\]" =:XF! 8<GPMZ8U0L13=58PZ74%)>.D$D(!&<R]>HG0N[
MCR6*$F::2L,:1X1JDT.KDXPYIDRD-;1 C,ID89S9O\$%KI/,%D3C$ET6O@-?
MSDP+<\H6B(C<?&>)0.F$U Z)]V,I<UWD^KET3>&[JE1@%@O#EA]8#] E]YA@
MC#XWX6I58%V$HI]NU,4)@@-6B<#>2;/?U)ZU/2)]Z.*Q''3>"X,1?8@  \'?
M2,.7H,3GUL+ODKF)FO=?U9I=HB85P,FD-#BPSL+02M(6K0G/Q(G"I<+ 2ZE=
MP^0?6 &(\4VW?=%YL5VD<G?5$9WS[^>I=P6.?9G9CDL\*6=H$67H*YN'86_C
M=T5YDZ?)95I'K5:?AJ.8]I&WDE)I;-0H#Y\+PI8IK2.&BWFEVJH8>!T&S :E
M5I[;AK%DDZP#S+>4X"'*Y6/5*<4J5GD8;_BY#^_R_FZP@J19-L@>O9]ACPPY
MQA.,=9E7? I)"DM$,<A$9^<QD0\5S&T/S5D879RC'"Q&,RKI1ZCA+*TD@#Z.
M9#DMDS /:#QE-URD(_T-A.>Q]K7Y?2*QRQN65>#>KYCP#"?5X\RR@?%!EJJR
M-O>%>@:=]Q"I6() H.(%@#DPY!I@5=L0HH4+8.V==,!\1XOSR,)JT]S*1)!'
M23R-+],Z]#^W.0^&3?KI-RQAD"A'$JTE;'Z\)5I@3.I3W;"$G J^:#4&97*\
M?01;J0*B;5D24E7+0<%-H@QP6V\63D9LB+,9N0!\^BEF8GX%O1QA#!=EG.6F
M5")) K*W9*X"?20DE9FV0REF A8E)JX=52<J.01_,$K<8I38?C!*? H.<'5_
M#H#Q)J;"A92<$6L%_N""$U!QF1>2$52S,Y2\?UEJXH:L1=F_DXX-K-#!4]*(
M=8&+(\NO70"@JBCG_)!8=H#ZH*!R1:U&T\>843A@\T/12 @P32<*V+B\+,AY
M@@2N("Z#;"^CS,SJFB1X24A,K3%(9QEN/MG;B@[F<!594GP35^]NT#UV#FK&
M7RE/[/ @VM_=W-X<1 <8TXJ//8L.K[ ^P!'%<F(LPRD[)P:<!*ET I[\6=1Q
M-?F64;N9,6##;^55L5&59?+_IB6RIGF]4<]BK-Q =V]@?7)\HGZV);)VEW@9
M*LL2?^M,UK84R6@1!"WQJ=?W0R?/9Q'BE:XPQ(CUNR"&CQ>4$>MR6DF.?=P'
M8>/+-L]3=JO+>%*[+\MW81HN0];ERW4 -(!G!Z"D (SI$)'H!$>1PJD$*9?:
M-#5B*18/5X-V1$D3&]@"46Y)_F*R6AW$=19;P'2"J4X;SW[5D:IC;4B[S[:'
MT6QCNA&M86#[/\KJ771(KC]8*)4$('&5BPF;HK'D<]955%W1L<^TOYYM48Q4
MHAUVIA8\I3?ZE5\K+BG*'I;5X*#>-SWF<'TU%K!+O-']ZL4FM0ZW87I-FUM#
MI:7O3%$QJ1<CL+BK!X<^NM A/TJ4,OHYX[^<>@>1U5&0ODGH_+G5L.P><0.N
M-RD"^%7F);Z=E$HW< V'3>RJ+M<7 _>@O-%KZS#VF7!O B9:\8Q2TQ$,I3V(
M(!_/IZ9DO<G,G7B6;:IT>IWEZ:7+4#;J"-,>/"*L7IZZ;D>R:?_Y=GH.5V64
M#;<ZW]G&;YVQDJZS 2&0FS/C!HU5AXL3S6,*%\> 9AEVMPC)\6=&M]_N;[)A
M]24TUQ!NF59=?*&0 G3F\*IL1A,[!-#+XQNMS"$MH%QMM""PBCJP99B]J@&<
MK:8*I ?.(*>'W1I,005[Q=H$&)*2,\HHR*Z9,,8S)5CBFFKF3U&3C6T)?D++
MLJX]+9/56 YW17T$T B^=>V-;RE#*75!S/)*-G6(@Z'Q1!Y&2":]Z01U;*/Q
MJS8!!F8>J#@\@A74!=7 B&]DTVK#GQMCW]T78VWE238\'%#J7]W*#N[/!.[(
MQU54BRK.*>^%JW]L&BUR=F0AIBY\5?6V]J@D@'EDRZF()%7[RW<-4CF'L55(
MQRQOE?=,*=>+6S"PXD8116)Y94>7;IS<4-\P]6)I1I8*L6$[.AU"*[W.D6:?
MTWQNA,SOBY 'Z)E'%:L_A7):)IR B_1DRH W',V=DT3+2$R!C4,SV8_BYVF7
M(9*RO44:75'6<F %;]6'M!9%\R;Q0GSW<\-^>@?84XF$ZZ <P*\(,[1&@OY9
M9Y063<2XWW:KM$-QZJ@,3.G1%QLCAM.#$*;D(!*>X\?!L:V3:U=V^'CZ%P&/
M7&6C3%@FUVM:,@MKVW98M1>W4C]&Q2B79B+1!V4:\G89ZXM\%ZO>A)C\E3@3
MO$=4*O4,]QXQOP6%5C[0[_M'M(SN/%A&/P69*>Y+XG].21U64O*5?&-;[+0X
MK&&I5.BMR(R"1M7"^1]%KJMZ@^ WL *G6-0&RCH36X_9QPRE$&PW8*OX2(<;
MFRU8\G>/?OR_'?]]QD4,=VD5_[S= GI.E4U03,/+(6:,6F[8?SV0HN6D:/>!
M%-V3%#WZ\?@D^O7XXN3H_#SZ]>>CLZ/3E[X?]@H$#:J/&!1!$>%#E<>AF"IV
M"G LSKPP571TSH??#'.2574C07JHAF"XZ.HB7L/=V](\1[\!T+H?'@T?T;]G
M:!>0?_-1T,<L^>$1K&)O.-G:&F^-GCS9&<;C_;WM9&>X/=S9WTI&R9X[8<*Z
M23S-\L6SZ"\7%*Z)YLJS$H2POQBL)%3F2]2% >C>C6<U/&,^R4'(Z2#1:"&$
M1D,/(9O*0U#\)C'+E=GW<'*LVXD%)\PL<-,1>T:MU[]MDOX1.T?!M0*XBQ\>
M;3T*7O5QT">5FQMTW;WK/0+I'Y;U^O3UT<G%V_/H^.1P([S,G:N$+_R=?'&
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MD2IDS11.5EH5<#-@-9$5/Q<%D,Y2:+1I[^'"Q/'TA^GY=.\8#HRN1(D?2K.
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M3\+'& &KV ]H0$!].L4V5%(CJ:(>)& *'X8-(G#<0><&M_RI2I@32OZ9/WR
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M562W"%[UQ.UXUG0#M9X:;N"IR-09,:^[6R(=(-)[\SZ;GPA5?^3Y151+ME[
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MZWM%KRGYD>8:7#Y2B&M-VA7<AC%T1KCNWPMSM9O&^O;RC) ,"'A372'J[0Q
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M3<MW_M_!-$UI_=^G1'\!4$L#!!0    ( &:FO5R7.WDCZ08  .Y,   5
M;6YT<RTR,#(V,#4R-E]P<F4N>&ULU5S1<ILX%'W?F?T'UOML$^,FN\DT[7C=
MIN-IFF02[W1W7SHRR+:F@#P2;IR_7PE+#@@AA.VD\DOBH,/1/?<>!-R W[Y?
M)['W Q**<'K9Z?=..AY,0QRA='[96=$NH"%"G??O?OWE[6_=[B>80@(R&'G3
M)^\O@D%$4#2'WMW][0S%T O.>H->T#L=O D*P]TNWSU&Z?<+_F,**/38M"F]
M6%-TV5EDV?+"]Q\?'WN/@QXF<S\X.>G[_WRY?@@7, %=E-(,I"'L> Q_0?.-
MUS@$61YS8??UE,228.!OYZI%\+^Z$M;EF[K]H#OH]]8TZH@0^;#%)!*^KN"%
MIO[Y^;F?CVZAC @9J+>R6?8\;Y,_@F-X#V<>__WW_;AV[W.?(_P49M=@"F,V
M9;Y[]K2$EQV*DF4,Y;8%@3,]3TS(EH9GYYQGIW_&L_/[,[._3WAS;J8)SD!\
MF#ASOFJLE6GV#_KF4*DUA7QSR"RS@QR^0I8+T^P?]!TD"$<?T^CE U>G.E3P
M#QD@KV"5ZF3["WCYJ%N$FN $IMF*]N@2A'!#_@&'*[YUF++"92A[&J<S3)+\
MS- <=Y)FE,45G)V<!INHS'S%*)<$4@;,1Z[9AM)D<)W!-(*1G(['NKN.?%8Y
M;XS#TE0Q/P]B4BT(95/EU: P[,WQ#S^"B%4X..4?N.K37#'[X]L(LPN X91F
M!(299(IY92X[VC$6(1>DC/DO'N@F-]>(9NSRA$[ ]+FB(EP#0@2M1>P;^@S0
M:6Y[=L4T!V"YB1_&&95;GH6(#=_8H9I!7O11#"B]G3UD./P^7".J2&K$"6$&
MW,^05XSB TX 2E5GU0*DO32 GZ($)PE.\VB&7V RA:1RC-0!M@=*%5!64EQ.
MAJ2L"I!0\K&/I;6D>M$H$/X2$,;7#1<HWBY#,X(38]ZQA99BI!=>E<S+L*<C
MP22"Y+)SPN\P&,<,$B*6?X.:7$I</$>T*GUU@>=;OGT%A #V05M,_: 0KPXZ
M6D2C!IL"J@2B>/T#%>\5$]6\>F*+I:B<LUK.W/L:K@-[_Q739SJ?8OMS4SE_
M&E*>.0/9SU@\]KHV89>$<,S4J"?S!I3V&J6 >GD9\DITPAB5V'5#(N#RD"-N
MK687&T683+KEXD8M<QR!-X<LVHA'?!6#N5)5[9C(B#+F<EU-,JP+JY <^*SW
MDH?KMGGQ@:VA-<>M%J,<P K&Y8K;R&I]2"MDP@'!$3C@"M$0Q/]"0*[8%O6\
MTX!27%!!'8,/S-):.Z%")[PP.!HO;+S<[ 8-3NN'$NYX'%$O;T=/E B%*]XX
M[(J-L"L4PYN5YH:W;KAT+5H<=KGT#6*L*U[E$84^=;[0]W".>$LVS6Y HN^/
MZB&E@JL0]XMN%-6R\"J7*/Z9\\4?,9$$Q.,T@NO/\$E;_1I,J?P5C/OU-\MJ
M:8 *F7# '\X[8)R&F"PQR97F+9417C$Q3R,<Z5<#JSU*[FC8PWVOM)'<TCD-
MU,)'?SKOHPE8CR.F&\W0YDD;P\5# [;DG5JL^ZZQD]G2+[6DPBGGSCME&$5,
M,A6_N,2^UB4&7,DA6IS[[FB6U](96D+9DW*YW5@7?F!IB\#2%L%QVD*5M[<M
M@F=;N-RKK M_8&F+@:4M!L=I"U7>WK88/-O"Y09F*?P1^WA+)OA1?5JD :6S
M1!%U-(:HE;:;'8ITT@PN=S!+P>=7S[?DCN ?://X=ZTC:J Z6U2@1^,-L\C=
M#%+AE"YQOZ,I+;ZYO3*N%V6(=K&0D*-Q@U[4CLN$Y)+5=[_-*2*_PS0#\7]H
M6=O>, %U3E" 1^,'D\#=7*$P2F^XW 7EY[LA@4#C!MV02$]YR.6*&T18U[C,
M(:OJ<F>3O^P5WRUPJO\/5MVP2$QUV.4*-XBQKG*51U;:Y=[C PQ7A$GJ!],)
M%ZQ4NFY8)*<Z['*E&\185[K*(ROM<N]P0@!_R?3A*9GB6"FS=DRD11ESN< F
M&=;554CD$TDN]_]N<"EHS4.'!H3(CQ;A<K&;)5F77$LE"^]RAT^N1!_7X0*D
M<ZAY ,$$45;Q,L3EVEN(:KV:E[ED]=UOY'U,()DS59\(?LP6(YPL0:J_.3<B
M2W=F-4B7+6$OL>6]60VE-(C+S;VOS-<93/G;8:M4_+=3?331B!$9J\&X; <;
M6=9&J"&3%G"Y<_> 8Q0B+ND+R"!!0+WTJP?(LX,&X'+E&P79GQDT3++F+O?K
M[@CD5H5IF+_=->&OQI/;V:QR']\,%"DS 5WV@K5 :T^8&*4W7.[7*?&/*5U!
M8NV06KC>)QKX$;FE2>RNGM'P2N<<JB?HS@NK36EO\;IJ+=7QOBRM_[*/2MIT
M7ZNAO%5>)*HF2Q <Z,W)MWXE3ZP:W_EWCFU&^ _^'5WO_@=02P$"% ,4
M" !FIKU<7EE%D=L>  "^O@  $0              @ $     968R,# W-3$U
M,%\X:RYH=&U02P$"% ,4    " !FIKU<0N8K&>ZJ   $] , %0
M    @ $*'P  968R,# W-3$U,%]E>#$P+3$N:'1M4$L! A0#%     @ 9J:]
M7'!,8P#)90  <+P" !4              ( !*\H  &5F,C P-S4Q-3!?97@Q
M,"TR+FAT;5!+ 0(4 Q0    ( &:FO5P55DN.(DX  .H6 @ 4
M  "  2<P 0!E9C(P,#<U,34P7V5X-"TQ+FAT;5!+ 0(4 Q0    ( &:FO5R3
MA0 I)48  "%D 0 4              "  7M^ 0!E9C(P,#<U,34P7V5X-"TR
M+FAT;5!+ 0(4 Q0    ( &:FO5R-2^7T8@L  ",F   5              "
M =+$ 0!E9C(P,#<U,34P7V5X.3DM,2YH=&U02P$"% ,4    " !FIKU<U4JQ
M?; #  #0$   $0              @ %GT $ ;6YT<RTR,#(V,#4R-BYX<V10
M2P$"% ,4    " !FIKU<,!XG"-X&  !C1   %0              @ %&U $
M;6YT<RTR,#(V,#4R-E]D968N>&UL4$L! A0#%     @ 9J:]7%[E$0D'"@
MB68  !4              ( !5]L! &UN=',M,C R-C U,C9?;&%B+GAM;%!+
M 0(4 Q0    ( &:FO5R7.WDCZ08  .Y,   5              "  9'E 0!M
J;G1S+3(P,C8P-3(V7W!R92YX;6Q02P4&      H "@"4 @  K>P!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ef20075150_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mnts="http://momentus.space/20260526"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mnts-20260526.xsd" xlink:type="simple"/>
    <context id="c20260526to20260526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
        </entity>
        <period>
            <startDate>2026-05-26</startDate>
            <endDate>2026-05-26</endDate>
        </period>
    </context>
    <context id="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-26</startDate>
            <endDate>2026-05-26</endDate>
        </period>
    </context>
    <context id="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001781162</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mnts:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-26</startDate>
            <endDate>2026-05-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20260526to20260526"
      id="Fact_465ff8118f4045be9d4bbfe221be34fa">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20260526to20260526"
      id="Fact_e02417e95d0f41cbac55512ae4b05b2a">0001781162</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_21def3db9b1348bd8a8873b5a03b05b3">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_58245bbc1d454731b2fed7c423e50cb8">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20260526to20260526"
      id="Fact_026ff3f0ceda44c0a4735e027f52eba4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20260526to20260526"
      id="Fact_8734d42f6ca14e3d890fc68480fad957">2026-05-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20260526to20260526"
      id="Fact_7d899f1182f3430cbea00ea306701886">Momentus Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20260526to20260526"
      id="Fact_4bb28ae4bbc649dfb2d91d7d4bbd6e8f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20260526to20260526"
      id="Fact_301dfe8e69f74a8b921cd390ed98f876">001-39128</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20260526to20260526"
      id="Fact_8f60f2de694942d5a46063fb67610198">84-1905538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20260526to20260526"
      id="Fact_e965dc006950484caabf13b509adfd1b">1762 Automation Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20260526to20260526"
      id="Fact_5891f18e8f504472924584e213edf96d">San Jose</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20260526to20260526"
      id="Fact_f6a0d8b78f464a15b98a0f16be138c8f">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20260526to20260526"
      id="Fact_686573007ba2406e8df9796fe62e148e">95131</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20260526to20260526"
      id="Fact_de7078c75aea471881bfb4bfc07ed435">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20260526to20260526"
      id="Fact_8ad297f377524545b238390c2a639fd7">564-7820</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20260526to20260526"
      id="Fact_75216e99b7db45cbb1007e3fd915798d">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20260526to20260526"
      id="Fact_fc7d882b610c4d2ca1ac4addec3772e7">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20260526to20260526"
      id="Fact_0b417816a1264f4da4ded0cb6b553fd3">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20260526to20260526"
      id="Fact_afd6e1c5866e4fad9d202eb56fa2f902">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_389490f996294a02937db8d594af3d23">Class A common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260526to20260526_StatementClassOfStockAxis_CommonClassAMember"
      id="Fact_6bd51fce4ac841638e4b9243c26cece9">MNTS</dei:TradingSymbol>
    <dei:Security12bTitle
      contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_9b3b2fbf1cf64d83a1674cc56488f4a7">Warrants</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20260526to20260526_StatementClassOfStockAxis_WarrantsMember"
      id="Fact_e667dfd95c824c20b27d53662efdcf06">MNTSW</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20260526to20260526"
      id="Fact_3b7bfca47e1e48b68de5832128790588">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
